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Zusammenfassung 
Rund eine halbe Million Menschen sterben jährlich im subsaharischen Afrika an 
Malaria Infektionen, die von der Anopheles gambiae Mücke übertragen werden. Die 
Allele (*R1, *R2, *S1 und *S2) des A. gambiae complement-like thioester-containing 
Protein 1 (TEP1) bestimmen die Fitness der Mücken, welches die männlichen Fertilität 
und den Resistenzgrad der Mücke gegen Pathogene wie Bakterien und Malaria-
Parasiten. Dieser Kompromiss zwischen Reproduktion und Immunnität hat 
Auswirkungen auf die Größe der Mückenpopulationen und die Rate der 
Malariaübertragung, wodurch der TEP1 Lokus ein Primärziel für neue 
Malariakontrollstrategien darstellt. Wie die genetische Diversität von TEP1 die 
genetische Struktur natürlicher Vektorpopulationen beeinflusst, ist noch unklar. Die 
Zielsetzung dieser Doktorarbeit waren: i) die biogeographische Kartographierung der 
TEP1 Allele und Genotypen in lokalen Malariavektorpopulationen in Mali, Burkina 
Faso, Kamerun, und Kenia, und ii) die Bemessung des Einflusses von TEP1 
Polymorphismen auf die Entwicklung humaner P. falciparum Parasiten in der Mücke. 
Informative Einzelnukleotid-Polymorphismen (SNPs) im TEP1 Lokus wurden 
identifiziert und als genetischer Marker für PCR-Restriktions-Fragment-
Längenpolymorphismus (PCR-RFLP) Hochdurchsatz-Genotypisierung von im Feld 
gefangenen Mücken-Proben validiert. Wir haben ein neues Allel identifziert, hier als 
*R3 benannt, welches ausschließlich in A. merus Populationen in Kenia existiert. Die
Verteilung von TEP1 Allelen und Genotypen in Populationen verschiedener 
Mückenarten wurden in spezifische biogegraphische Gruppen in vier ausgewählten 
Ländern im subsaharischen Afrika kategorisiert. Die Analysen der TEP1 
Polymorphismen zeigten, dass die natürliche Selektion auf Exone, sowie Introne wirkt, 
was auf eine starke funktionale Beschränkung an diesem Lokus hindeutet. Außerdem 
zeigen unsere Daten die strukturierte Erhaltung natürlicher genetischer Variation im 
TEP1 Lokus, in welchem die Allele und Genotypen spezifische evolutionäre Wege 
verfolgen. Diese Ergebnisse weisen auf die Existenz von arten- und habitatspezifischen 
Selektionsdrücken hin, die auf den TEP1 Lokus wirken. Des Weiteren habe ich den 
Einfluss der TEP1 Polymorphismen auf die Mückenresistenz gegen P. falciparum  in 
experimentellen Infektionen evaluiert. Meine Resultate haben gezeigt, dass TEP1*S1 
und *S2 Mücken gleichermassen empfänglich für Plasmodium-Infektionen sind. 
Außerdem habe ich einen hohe Sterblichkeitsrate in der *R1/R1 Laborkolonie im 
Vergleich zu den empfänglichen Mücken-Linien beobachtet. Da die *R1/R1 Mücken 
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ausschließlich in der A. coluzzii Mückenart in Westafrika gefunden wurden, postuliere 
ich, dass *R1 ein konditional-lethales Allel darstellt, welches gewisse, noch unbekannte 
Bedingungen für erfolgreiche Erhaltung und Verbreitung benötigt. Insgesamt tragen die 
Resultate der biogeographischen Kartographierung des TEP1 Lokus und der Züchtungs- 
und Infektionsexperimente zu einem besseren Verständnis über den Einfluss der 
verschiedenen Vektorarten und lokale Umwelteinflüsse auf die Vektorpopulationen und 
Malariaübertragung bei. Des weiteren kann die hier beschriebene hochdurchsatz-
genotypisierungs Methode, zur Studie lokaler A. gambiae Mückenpopulationen, in der 
Feldforschungsarbeit eingesetzt werden. Dieser neue Ansatz wird die epidemiologisch 
relevante Überwachung und Vorhersage dynamischer Prozesse in lokalen 
Malariavektorpopulationen unterstützen, welche die Entwicklung neuer Strategien der 
Vektorkontrolle ermöglichen könnten.    
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Abstract 
About half a million people die annually in sub-Saharan Africa due to malaria 
infections transmitted by Anopheles gambiae mosquitoes. The alleles (*R1, *R2, *S1 
and *S2) and the genotypes of A. gambiae complement-like thioester-containing protein 
1 (TEP1) determine the fitness in male fertility and the degree of mosquito resistance to 
pathogens such as bacteria and malaria parasites. Because this trade-off between the 
reproduction and the immunity impacts directly on mosquito population abundance and 
malaria transmission, respectively, the TEP1 locus is a prime target for new malaria 
control strategies. How TEP1 genetic diversity influences the genetic structure of 
natural vector populations and development of human malaria parasites is unclear. The 
aims of this thesis were to: i) map distribution of TEP1 alleles and genotypes in local 
malaria vector populations in Mali, Burkina Faso, Cameroon and Kenya, and ii) assess 
the impact of TEP1 polymorphism on development of human P. falciparum parasites in 
mosquitoes. Informative single nucleotide polymorphisms (SNPs) at TEP1 locus were 
identified and validated as genetic markers for PCR-restriction fragment length 
polymorphism (PCR-RFLP) high-throughput genotyping of the field mosquito samples. 
We identified a new allele, herein named *R3, that is private to A. merus populations in 
Kenya. The distribution of TEP1 alleles and genotypes in mosquito species populations 
were categorized into specific biogeographic groups across the four selected countries 
in sub-Saharan Africa. Analyses of TEP1 polymorphism revealed that natural selection 
acts in concert on both exons and introns, suggesting strong functional constrains acting 
at this locus. Moreover, our data demonstrate a structured maintenance of natural 
TEP1 genetic variation, where the alleles and the genotypes follow distinct evolutionary 
paths. These findings suggest the existence of species- and habitat-specific selection 
patterns that act on TEP1 locus. I further evaluated contribution of TEP1 polymorphism 
on mosquito resistance to P. falciparum in experimental infections. My results revealed 
that the TEP1*S1 and *S2 mosquitoes are equally susceptible to Plasmodium infections. 
I also observed high mortality rates of the *R1/R1 laboratory colony as compared to the 
susceptible lines. As the *R1/R1 mosquitoes were restricted to the A. coluzzii species 
and to the specific ecology in West Africa, I propose that *R1 is a conditional lethal 
allele, which requires certain yet unknown conditions for successful breeding and 
maintenance. Collectively, results of my thesis on the biogeographic TEP1 mapping, 
and on the breeding and infection experiments contribute to a better understanding of 
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how the vector species and local environmental factors, shape vector population 
structures and malaria transmission. Furthermore, the high throughput TEP1 genotyping 
approach reported here could be used for field studies of local A. gambiae mosquito 
populations. This new approach will benefit surveilance and prediction of dynamics in 
local malaria vector populations that may have  epidemiological significance, and 
therefore inform the development of novel vector control measures.  
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RBC  red blood cell 
RNA  Ribonucleic acid 
RNAi  Ribonucleic Acid interference 
RT  Room temperature  
s   seconds 
xx 
spp. Species (in plural) 
T.A.E Tris-acetate-EDTA 
T.E Tris-EDTA 
Taq Thermus aquaticus 
U enzyme unit 
UV Ultra-violet  
V volts 
WHO World Heath Organization 
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General Introduction 
1.1 Summary 
The female mosquito Anopheles gambiae species transmits deadly human malaria 
parasites. These parasites are protozoan pathogens belonging to the genus Plasmodium. 
P. falciparum is responsible for the deadliest cases of malaria leading to deaths in sub-
Saharan Africa (1-3). Plasmodium life cycle takes place in both the mosquito vector and 
human hosts. In A. gambiae, complement-like TEP1 (Thioester-containing Protein 1) 
plays a significant role in elimination of malaria parasites (4, 5). TEP1 is encoded by an 
exceptionally polymorphic gene (6) whose allelic variation correlates with the distinct 
phenotypes in resistance to Plasmodium infections as well as in male fertility (5). 
However, little is known about mosquito ecological factors that shape natural genetic 
variability at the TEP1 locus in mosquito populations along the geographic clines of 
sub-Saharan Africa (6-8). Moreover, how this genetic variation affects the development 
of P. falciparum, human malaria parasites, is poorly understood (6-8). In this context, 
high throughput genotyping strategies are needed in order to define local adaptation of 
malaria vector populations to different ecological niches. This chapter reviews our 
current understanding on the key dynamics of malaria transmissions and advances in 
understanding of the mosquito immune responses. It identifies research gaps, and 
introduces the aims and outline of this thesis. 
1.2 Malaria in the world 
Malaria is one of the deadliest human infectious diseases worldwide, and especially 
in sub-Saharan Africa where about 400,000 deaths occur annually (1-3). It is a 
mosquito-borne disease caused by the protozoan pathogen of the Plasmodium genus. 
The species of human malaria parasites include P. falciparum, P. vivax, P. malariae, P. 
ovale and P. knowlesi (2, 9, 10).  However, P. falciparum infections contribute to the 
greatest burden for the most devastating deaths in sub-Saharan Africa (2, 9, 10). For 
example, in malarious holoendemic (i.e. where malaria transmission occurs throughout 
the year) regions, such as western Kenya, P. falciparum causes up to 100% of all the 
malaria cases accounting for 50% of all clinically diagnosed infectious diseases (11-13).  
P. vivax is able to survive in cooler and higher altitudes, develop in the mosquito 
vector at lower temperatures, and undergo long dormant liver stages (2). However, in 
most African human populations, the presentation of malaria complications resulting 
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from P. vivax infection is relatively milder than those of P. falciparum malaria because 
many African human populations lack Duffy antigen (i.e. Duffy blood group antigen) 
on the surface of red blood cells (1). The Duffy antigen acts as a receptor for the 
invasion of red blood cells by the P. vivax and P. knowlesi malaria parasites (14). 
Human malaria cases caused by the P. knowlesi in South-East Asia are associated with 
zoonotic transmission, where mosquitoes acquire blood from an infected monkey and 
then pass the infection to humans during the subsequent blood feeding (2).  
Mosquitoes are two-winged little flies of the Culicidae family, consisting of over 
3500 species described so far (1-3, 15). Human malaria vectors (carriers) are those 
mosquitoes that are infected with human Plasmodium malaria parasites and pierce 
human skin to acquire blood meal, and in the process, transmit the parasites to humans 
(1-3). Female Anopheles mosquitoes are the major and the most effective human 
malaria vectors that constitute about 30 of over 400 species of the Anopheles 
mosquitoes (1, 2).  
Globally, thanks to the deliberate efforts comprising vector control, 
chemoprevention and case management strategies to eliminate malaria, there is a 
significant drop of >35% in malaria cases and deaths in the last 15 years (1, 2, 16). 
However, despite this drop, incidences of global malaria infections are still high. For 
instance in 2015 alone, the total malaria cases and deaths worldwide were 214 million 
and 438,000, respectively (2). In addition, most malaria cases (88%) and most deaths 
(90%) occurred in the malaria endemic regions of Africa (2). Moreover, the currently 
existing vector control strategies are limited to the use of insecticide treated bed nets  
(ITNs) and indoor residual spraying (IRS), which are suffering a severe drawback due 
to resistance development in mosquito vector (1).  
The increasing knowledge on the mosquito’s immune responses against pathogens 
such as Plasmodium parasites could provide promising alternatives towards the 
development of novel vector-based malaria control strategies (5, 17, 18).  
1.3 Malaria transmission cycle   
1.3.1 Life cycle of the malaria mosquito 
The life cycle of the mosquito is relatively short, involving egg, larvae, pupae and 
adult stages i.e. complete metamorphosis (Fig. 1-1). The adults feed on sugars from 
nectar and in particular, the females require blood meal as source of protein and lipids 
for egg development (15). Thus, the females have to actively look for a vertebrate host 
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to bite and acquire the blood meal from. It takes about 48 h post-blood-meal acquisition 
and mating, for the eggs to develop. The female then searches for stagnant water and 
oviposits about 200 eggs onto the surface. The egg hatching, larvae, pupae stages are 
aquatic and the period between the egg and the pupae takes 1 to 2 weeks depending on 
the species, food and temperature conditions. The larval stage consists of four instars 
(phases) where the larvae molts four times, as it grows larger and larger before 
ultimately reaching the pupae stage. The terrestrial life of the adult stage can take up to 
a month on average (15).   
1.3.2 Lif e cycle of the malaria parasite 
The life cycle of Plasmodium parasite is very complex, comprising of multistage 
sexual and asexual developmental stages that take place in two hosts; a primary host 
(female Anopheles mosquito vector) and a mammalian or vertebrate host (secondary 
host) (9, 10) (Fig. 1-2). Both sexual and asexual replications occur in the mosquito 
vector, whereas asexual replications involving two distinct cycles in liver and in red 
blood cells, take place in a vertebrate host (Fig. 1-2).  
Fig. 1-1. General life cycle of the mosquito. 
The life cycle of a mosquito undergoes complete 
metamorphosis i.e. egg, larvae, pupae and adult stages. The 
stages of eggs, larvae and pupae are aquatic while the adult 
stage is terrestrial. In each stage, life span is dependent on 
the species, food and temperature conditions. For an adult 
female to lay eggs, it takes up a blood meal from a 
vertebrate host, and gets mated by a male in the male 
mosquito swarm. Two days later, the female lays about 200 
eggs on the surface of water. The eggs hatch to larvae after 
24 h. The larval phases consist of 4 stages i.e. instars in 
between which molting occurs as the larvae grows bigger. 
Pupae stage does not feed and lasts for about 24 h during 
which the adult body parts are formed. The adult emerges 
from the pupae and flies away to start the terrestrial life. 
Figure source: Scott Charlesworth, Purdue University. 
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Fig. 1-2. Transmission cycle of human Plasmodium parasite. 
A female mosquito (1) is infected with the parasite gametocytes as it takes a bloodmeal from an infected 
human host. The ingested female gametocyte differentiates into a single haploid female macrogamete (2), 
whereas the male gametocyte exflagellates and forms eight haploid male microgametes (3). The 
macrogamete and microgamete fuse and fertilization takes place to form a diploid zygote (4) which then 
develops into a motile ookinete (5). The ookinete invades the midgut epithelium of the mosquito and 
moves to the basal lamina to develop into an oocyst (6). The oocyst undergoes asexual replication cycles 
to produce haploid sporozoites (7). The sporozoites are released into the haemocoel when mature oocysts 
rapture. Sporozoites migrate to and invade the mosquito’s salivary glands (8) and the infected mosquito is 
able to transmit (9) the parasite to the human host during feeding. The sporozoites injected into the human 
skin, reach the blood stream and invade the liver cells (10). In the liver cells or hepatocytes, the 
sporozoites undergo asexual replications to produce thousands of merozoites (11). The infected 
hepatocyte raptures to release mature merozoites that infect the red blood cells (RBCs) (12). Within the 
RBC, the merozoite undergoes rounds of asexual replications and transitions through a series of 
developmental stages resulting in thousands of merozoites (13) that are released to infect more RBCs 
upon the rapturing of the schizont. Some merozoites (14) differentiate into male (15) and female 
gametocytes (16), which circulate in the blood stream. The gametocytes (17) taken up by a mosquito 
during acquisition of the infected blood meal, complete the transmission cycle.  
Figure source:  Le Roch Laboratory, UC Riverside, adapted with modifications. 
Mosquitoes are infected with Plasmodium parasites during the acquisition of blood 
meal from an infected mammalian host carrying male and female gamete-precursor 
cells called gametocytes (10, 19, 20). In the mosquito midgut, these gametocytes 
differentiate in about 15 min and mature into gametes through a process called 
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gametogenesis. The female gametocyte differentiates into a single haploid female 
macrogamete, whereas the male gametocyte undergoes exflagellation process, which 
gives rise to eight (8) haploid male microgametes. Within 1 h of acquisition of an 
infected blood meal, macrogametes and microgametes fuse and fertilization takes place 
to form a diploid zygote that develops within 18-20 h into a motile ookinete [reviewed 
in (21)]. The ookinetes migrate to cross the midgut epithelium of the mosquito and 
move to the basal lamina within 24 h post-infection [reviewed in (21)]. At this stage, the 
mosquito’s immune system efficiently eliminates most Plasmodium parasites (4).  
In about 2 days post-blood meal, ookinetes that survive the mosquito’s defensive 
responses develop into oocysts, which undergo asexual replication cycles to produce 
haploid sporozoites (22). Subsequently, the mature oocysts rapture a week later to 
release midgut sporozoites into the haemocoel. Sporozoites migrate to and invade the 
salivary glands (22). At the salivary gland sporozoite stage, the infected mosquito is 
able to transmit the parasite to its vertebrate host during feeding.  
Sporozoites that are injected into mammalian blood stream are invasive to the liver 
cells (hepatocytes) (9). Sporozoites in the liver stage undergo asexual replications for 6-
10 d to produce thousands of merozoites, but at this stage the patient shows no clinical 
symptoms (9). In the liver, some P. vivax and P. ovale malaria parasites can remain 
dormant (i.e. undergo latency period) for months to years with occasional malaria 
relapses i.e. reoccurrence of malaria episodes due to the liver dormant malaria parasites 
without new infections (10).   
Infected hepatocyte raptures to release mature merozoites that initiate the blood 
stage by infecting red blood cells (RBCs) (9). This period is also called an erythrocytic 
or blood schzogony stage. It involves asexual replication within the infected erythrocyte 
and undergoes three developmental stages (ring, trophozoite and schizont) producing 
dozens of merozoites per schizont. Schizont’s rapture releases the merozoites that in 
turn infect more RBCs. Duration of the sporogonic process varies between Plasmodium 
species. For instance, it takes about 48 h in P. vivax and P. ovale, 72 h in P. malariae 
and 12 h in P. knowlesi (23).  
Some merozoites differentiate into male and female gametocytes, which will not 
invade red blood cells but stay in blood circulation (9). Only the gametocyte stage is 
infecting the mosquito vector as it acquires the infected blood meal, and the 
transmission cycle begins all over again. 
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1.4 Distribution of species of malaria vectors in Africa 
1.4.1 The sibling species of the Anopheles gambiae complex  
The malaria vector species are distributed across the world, but the most efficient 
vectors are found in sub-Saharan Africa (3, 24) (Fig. 1-3; Fig. 1-4) (25). The A. 
gambiae complex, often referred to as A. gambiae sensu lato (A. gambiae s.l.), consists 
of the following eight cryptic (i.e. morphologically indistinguishable) African species: 
A. gambiae sensu stricto (A. gambiae s.s.), A. arabiensis, A. coluzzii, A. merus, A. 
melas, A. quadriannulatus, A. amharicus and A. bwambae (25-29). The following five 
species were first described through laboratory crosses that resulted in hybrid sterility 
(26): Three fresh water species; A. gambiae s.s., A. arabiensis and A. quandriannulatus, 
and two salty water species; A. melas in West Africa and A. merus in East Africa. Later, 
the A. quandriannulatus was subdivided further into A. quandriannulatus A (in South 
Africa) and A. quandriannulatus B (in Ethiopia) because the cross-mating experiments 
between these two species produced sterile males and displayed extensive asynapsis in 
the ovarian polythene chromosomes suggesting that they were different Anopheles 
species (27). Most recently, the two species were renamed A. quandriannulatus and A. 
amharicus, respectively (28). A. bwambae, one of the least distributed members of the 
A. gambiae complex, is found in geothermal salty water in Bwamba County in Uganda 
(29, 30). A. comorensis [often not listed among the above eight because little is known 
about it] was described in populations in the Grande Comore islands in Indian Ocean 
(25, 31). 
1.4.2 A. gambiae s.s. speciation into new molecular forms  
Mosquito genome is organized into 3 pairs of chromosomes namely; X or Y sex 
chromosomes, and autosomal chromosomes 2 and 3 (25, 32). Each of the autosomes has 
two ‘arms’ connected at the centromere - the longer one named right (R) and shorter 
one is left (L) (25, 32). Based on the analyses of A. gambiae s.s. polytene chromosomes 
(i.e. chromosomes appear thick and correspond to different densities) in the adult 
females’ ovarian nurse cells especially on the 2R chromosome, five configurations of 
paracentric (outside the centromere) inversions (32) were described [Reviewed in (33)] 
(Table 1-1). These are the j, b, c, u and d inversions, and in the wild type status, where 
no inversion occurs, is indicated by a positive sign (+). The j, b, c, u are non-
overlapping, while the d overlaps with the u. Based on these five inversions and the 
wild type chromosomal forms, 12 main karyotypes were observed: +++++, jb+++, 
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jbcu+, jb++d, j+cu+, j+++d, +bc++, ++cu+, +bc+d, +bcu+, +b+c+, and +b++d. 
Accordingly, five geographical subdivisions of A. gambiae s.s. chromosomal forms in 
West Africa, namely; Bamako, Bissau, Forest, Mopti, and Savanna, were described 
based on patterns of inversions on the chromosome 2 (2R-j, b, c, d and u, and 2L.a) 
(Table 1-1) (25, 33, 34).   
Table 1-1. Five subdivisions of chromosomal forms.  
Form Inversion karyotype Geography 
Bamako Fixed j+cu+ and jbcu+ Bamako in Mali, north Guinea, 
along the Niger river.  
Bissau +++++ and ++++d Gambiae. Restricted to West 
Africa 
Forest +++++, sometimes with single 
inversion of b, c, u or d 
Associated with wetter ecological 
niches in Africa. 
Mopti +++++, +bc++, and +++u+ in 2R, and 
nearly fixed 2La 
Predominate in drier habitats in 
Mali, Guinea, Cote d’Ivoire, and 
Burkina Faso. They breed 
throughout the year and are 
associated with flooded/irrigated 
fields.  
Savanna High frequencies of +bc++, ++cu+, 
+bc+d, +bcu+, +b+u+, and +b++d in
2R
Most widespread across sub-
Saharan Africa. 
Although, the reproductive barriers among the species in the A. gambiae complex 
exist even in sympatric species populations, extensive introgressions between the 
species have been documented (8, 33, 35-40). Cross talks between introgression, 
reproductive isolation and adaptation to ecological habitats may lead to new species 
and/or change in vectorial capacity i.e. how efficient the vector becomes in transmitting 
the malaria parasite, hence complicating the malaria transmission (32). For instance, the 
A. gambiae s.s. in West Africa underwent speciation into two molecular forms formerly
named ‘M’ and ‘S’ for Mopti and Savanna, respectively (32). The ‘M’ and ‘S’ incipient 
species have since been renamed as A. coluzzii and A. gambiae s.s. respectively (28). 
1.4.3 Feeding and breeding preferences of the Anopheles mosquito species 
The A. gambiae s.s. are the most dominant and efficient malaria vectors in sub-
Saharan Africa (Fig. 1-3, Fig. 1-4) (3, 25).  
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Fig. 1-3. Geographic distribution of A. gambiae malaria vectors in Africa. 
(A) A. arabiensis (red).  
(B) A. gambiae s.s. (green).  
(C) A. melas (blue), A. merus (orange) and A. bwambae (cyan).  
(D) A. quadriannulatus (former species A) (yellow), A. amharicus (former A. 
quandriannulatus B) (magenta) and A. comorensis (cyan circle). Figure source: 
Reference (25). 
A. gambiae s.s. breeds mostly in the rain-dependent water pools and in fresh water 
puddles, whereas A. coluzzii shows preference for larger habitats associated with plenty 
of water especially from floods, rice paddies and irrigated agricultural farms (25, 41). A. 
arabiensis species can either breed in large and/or small temporal pools of water, such 
as those commonly found in irrigated farms (3, 25). Coastal salty or brackish water from 
pools, swampy and marshy form suitable niches for breeding of A. merus and A. melas, 
whereas other species have to adapt to such environments in order to co-exist together 
(25, 42-44). 
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Fig. 1-4. Geodistribution of A. gambiae chromosomal forms in West and Central Africa. 
A. coluzzii (former M form) and A. gambiae s.s. (former S form) in West and Central Africa.
Abbreviations: BAM; Bamako, FOR; Forest, MOP; Mopti; SAV; Savanna, and BIS; Bissau.
OTHER represents karyotypes that could not fall into any of the above chromosomal forms.
Figure source: Reference (25).
Notably, the structured distribution of different species of malaria vector 
populations in Africa match specific climate zones and biomes i.e. areas of land 
characterized by their climate and type of vegetation (Fig. 1-5) (25, 45). 
The A. gambiae s.s. breeds mostly in humid savannas and during the rainy seasons 
but  A. arabiensis are adaptable to dry conditions in Sahel, arid Savannas and flooded 
breeding sites (33, 46). In addition, sympatric populations of A. arabiensis and A. 
gambiae s.s. are widely distributed in Africa with fluctuations in their population 
numbers depending on geographical breeding zones and seasonal patterns (46). In West 
Africa, A. coluzzii breeding zones are ecologically wide in the Sahel and transition 
zones, floody zones as well as during the dry spell in contrast to the A. gambiae s.s. 
whose population densities are rain-dependent (25, 46).  
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Generally, unlike A. merus and A. coluzzii species, both A. gambiae s.s. and A. 
arabiensis mosquito species are considered climate-generalists as they are able to 
colonize most of the ecological habitats across sub-Saharan Africa (3). Both A. gambiae 
s.s. and A. arabiensis species are well adapted to evading predators, and they prefer to 
breed in open and well-lit breeding sites that provide optimal environment for larval 
competition and development over the other species (41, 47, 48). Additionally, A. 
gambiae s.s. is highly anthropophilic because it exclusively feeds on human blood, 
while A. arabiensis species is zoophilic (attracted to and feeds on animals), exophagic 
(feeds outdoors) and exophilic (independent of humans) species (3, 49, 50).  
1.5 Mammalian complement system in pathogen infections 
The complement was discovered by Jules Bornet in nineteenth century as a heat-
labile component present in blood that augments or ‘complements’ the role of 
antibodies in opsonization and killing of the bacteria, hence the name complement (51). 
It is now understood that complement is part of the innate immune system, which labels 
the pathogens and mediates their destruction (51). 
1.5.1 Complement proteins  
The complement system in vertebrates consisting of at least 30 serum proteins that 
circulate in the blood (51-54). Activated proteins work together to recognize or mediate 
the destruction of pathogens through either lysis or opsonization of pathogens or 
production of inflammation mediators (54). The complement proteins were classified by 
 
Fig. 1-5. African Climatic zones showing the 
ecological habitats and biomes. 
In reference to Fig. 1-3 and Fig. 1-4, A. 
arabiensis and A.gambiae s.s. inhabit 
considerably different climatic biomes and 
zones, including equatorial and humid tropical.  
A. arabiensis does well in semiarid 
environments.  A. coluzzii species are confined 
to far-West, West and Central Africa climate 
zones. A. coluzzii also inhabits semi-arid climate 
zones in West Africa. Salty water breeders; A. 
melas and A. melas are restricted to coastal 
biomes in West and East Africa respectively. In 
general, the climate zones of 
equatorial/monsoon, tropical dry savanna and 
warm semi-arid provide key mosquito 
ecological niches. 
Figure source: Koeppen Climate classification. 
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assigning letters e.g. ‘C’ for complement, and numbers according to the order in their 
discovery (51).  For example, the first complement protein (C1), is a complex consisting 
of C1q, C1r and C1s zymogens, the second complement protein (C2), the third 
complement protein (C3) and so on. The proteins are synthesized by a variety of tissues 
and cells. For instance C1 is produced by the intestinal epithelium, the macrophages 
synthesize C2 and C4, the liver - C3, C6 and C9 and the spleen - C5 and C8. During the 
activation process, C2, C3, C4 and C5 are activated by a proteolytic cleavage into 
smaller ‘a’ and bigger ‘b’ moieties, e.g. C2 protein is cleaved into C2a and C2b 
fragments. The smaller protein diffuses away while the bigger protein remains attached 
to the surface of the pathogen, with exception of the C2 whose C2a binds to the 
pathogen while the C2b diffuses away.  
1.5.2 Activation pathways of the complement system 
Activation of the complement system (Fig. 1-6) occurs through one of the 
following pathways: i) classical pathway (CP) activated by antibodies e.g. IgM and 
some subclasses of IgG, bound to the antigen; ii) alternative pathway (AP) activated by 
microbial surface proteins; and iii) lectin pathway (LP) that is activated by lectin protein 
bound to the specific polysaccharide sugars (e.g. mannose) on microbial surface (52, 53, 
55).  
Both the AP and the LP are antibody independent and, therefore, play especially 
important roles in cases where the body encounters pathogens for the first time (52, 53). 
It is important to note that all the three activation pathways share a common step that 
involves generation of the C3b component that plays a crucial role in the complement 
cascade (Fig. 1-6) (52, 53). The C3b contains a thioester site exposed by a cleavage of a 
thioester-bond (54). In principle, the C3b uses this thioester to bind to the surface of a 
pathogen and acts as a C5 convertase that consequently activates the C5 into the C5a 
and C5b fragments. The C5b together with other complement proteins (C6, C7, C8 and 
C9) successively form a circular C5bC6-9 complex, the so called a membrane attack 
complex (MAC) on the surface of the pathogen. The MAC mediates lysis (destruction 
of the pathogen by piercing its plasma membrane) using perforin-like C9 domains (52-
54).  
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Fig. 1-6. Complement activation pathways.  
The activation pathways of the complement 
system consists of three pathways- classical 
pathway, lectin pathway and alternative 
pathway. All the pathways differ at the 
initiation steps, but converge at the central 
step-the generation of active complement 
protein, C3b, which  forms a C5 convertase.  
Cleavage of C5 by a complex formed by C3b, 
results into C5a and C5b fragments. Both C3a 
and C5a meditate inflammation reactions. C5b 
recruits terminal components of the cascade 
that ultimately forms a membrane attack 
complex on the surface of the pathogen that 
damages pathogen’s cell membrane. Figure 
source: Reference (51). 
1.5.2.1 Activation of alternative pathway  
The activation of the alternative pathway (AP) is initiated when C3b binds (from 
spontaneous hydrolysis of C3 in blood) to the surface of the pathogen (Fig. 1-6). 
Another plasma protein, B, binds to the C3b to form 3CbB. A plasma protease D then 
binds to the 3CbB and splits B to generate C3bBb and Ba. The 3CbBb molecule is an 
active form that remains bound to the pathogen surface, and yet at the same time acts as 
a convertase to cut more 3C molecules and convert them into 3Cb active forms. Another 
protein, called properdin or factor P, is a positive regulator that binds to and stabilizes 
the 3CbBb convertase hence enhancing amplification of the activation. The 3cbBb 
molecule can bind C3b to form a convertase that splits complement protein, C5, into 
C5a and C5b fragments. The smaller fragments, C3a and C5a, that diffuse away, 
constitute anaphylatoxins, which mediate inflammation reactions (52, 53). The C5b 
fragment forms a complex with other complement proteins (C6, C7, C8, and C9) to 
form the MAC. The MAC structure anchors on the surface of the pathogen and makes a 
hole to lyse the bacteria. A strict control of the cascade activation to prevent MAC 
attacks on its own cells is ensured by a set of specialized proteins in the blood (51-53). 
For instance, further amplification of the complement cascade is stopped by membrane 
co-factor protein (MCP) that cleaves active form of C3b into inactive molecules on the 
cell surface. Factor H is another complement-regulatory protein that binds C3b to stop 
conversion of C5. The C3b molecule can also be cleaved to inactive form by the plasma 
protease factor I, with the help of cofactors such as membrane cofactors of proteolysis 
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(MCP or CD46) and complement receptor 1 (CR-1). Decay accelerating factor (DAF) 
protein found in human cells inhibits the MAC formation by destroying the assembly of 
C3bBb complex. Another protein called protectin (CD59) binds to the complex formed 
by the C5b, C6, C7 and C8, thereby inhibiting the recruitment of C9 molecules and the 
MAC formation. Protectin (CD59) and vitronectin (S protein) inhibit the MAC 
formation by binding to the C5bC6C7C8 complex.    
1.5.2.2 Activation of classical pathway 
The activation of the classical pathway which was first to be discovered, (51) is 
triggered when the first complement protein, C1q, binds to the pathogen surface (Fig. 1-
6). The bound C1q together with the C1r and C1s, act as a convertase to clip C4 and C2 
complement proteins. The C2 is converted into C2a and C2b, while the C4 into C4a and 
C4b. The C2b and the C4a diffuse away leaving a C2aC4b complex. This C2aC4b 
complex binds to the surface of the pathogen and acts as a C3 convertase to split the C3 
protein in blood into C3a and C3b (52, 53). C3b binds to the C2aC4b complex to form a 
bigger C2aC3bC4b complex, which acts as a C5 convertase that cleaves C5 into C5a 
andC5b. The terminal process is similar to the alternative pathway activation. The 
activation of the classical pathway is regulated by the C1 inhibitor, which binds C1r and 
C1s. As in the alternative pathway, the C3b molecule can be deactivated by cleavage by 
factor I. In addition, decay accelerating factor (DAF) inhibits the MAC formation by 
blocking the assembly of C3bBb complex. The C4b-binding protein (C4bBP) is a co-
factor of factor I, and may block the action of C4b.  
1.5.2.3 Activation of lectin pathway 
The lectin pathway (LP) uses proteins similar to C1q to activate the complement 
reactions in the absence of antibodies (Fig. 1-6). These proteins include the mannose-
binding lectin (MBL), which is produced in the liver and present in tissues and blood. 
This protein binds to a carbohydrate molecule, mannose, present only on the surfaces of 
many pathogens and not own cells (Fig. 1-6). The MBL activates the LP by binding to 
and activating serine proteases MASP-1 and MASP-2. MASP-2 bound to the MBL acts 
as a convertase that cleaves C4 and C2. The rest of the LP activation cascade is similar 
to those of the classical pathway, ultimately leading to MAC formation. The C1 
inhibitor by binding to the MASP proteases may regulate the lectin pathway. 
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1.6 Insect innate immune responses against pathogens 
Insects mount robust innate immune responses against invading pathogens such as 
viruses, bacteria (18), fungi (56) and malaria parasites in mosquitoes (57). The immune 
system is categorized into humoral and cellular defense mechanisms.  
In humoral defenses, receptor molecules mediate recognition of pathogens through 
the activation of specific serine proteases which trigger processes such as melanization 
(i.e. deposition of melanin on the surface of the dead pathogen) leading to lysis or 
killing of pathogens. Examples of these effector molecules are A. gambiae antimicrobial 
peptides that are produced against various pathogens. These include defensin (active 
against Gram-positive bacteria), cecropin-1 (against Gram-positive and Gram-negative 
bacteria, and fungi) and gambicin (against Gram-positive and Gram-negative bacteria) 
(56, 58, 59).  
The cellular immune responses are mediated by the mosquito blood cells 
(hemocytes), and include phagocytosis of the pathogens. Extensive studies in the fruit 
fly, D. melanogaster show that humoral and cellular immune responses involve three 
signaling pathways: the Toll pathway (60, 61), Immune deficiency (IMD) pathway (62), 
and Janus Kinase/Signal Transducer and Activator of Transcription (JAK/STAT) (63, 
64). In A. gambiae, activation of Toll and IMD pathways induce transcription of 
effector genes (e.g. antimicrobial peptides) through NF-kappaB REL transcription 
factors (62, 65). REL1 (analogous to D. melanogaster Dif) and REL2 (orthologous to 
D. melanogaster Relish) are A. gambiae transcription factors in Toll and IMD pathways 
respectively (66, 67). The Toll signaling pathway in A. gambiae is more effective in 
eliminating P. berghei (murine) than P. falciparum malaria parasites (68). The IMD 
pathway also plays a role in regulation of melanization reactions, and is involved in 
elimination of P. falciparum parasites (67). The A. gambiae JAK/STAT pathway 
contributes to anti-plasmodial immune responses against development of early 
Plasmodium oocysts, through activation of transcription of nitric oxide synthase (NO) 
(64).  
The interaction between the malaria parasite and the mosquito vector is 
characterized by immune defense reactions mounted by the mosquito against the 
development of the parasite within its body (69). The immune responses against the 
malaria parasites are broadly divided into two phases: early (first) phase- targeting 
ookinete stages about 18-24 h post-infection, and the late (second) phase- targeting 
Chapter 1 General Introduction 
16 
oocyst and sporozoite development. Malaria parasites experience the highest dramatic 
losses at midgut stages- the early phase of the infections, particularly the ookinetes (4, 
5, 70, 71). The immune responses against the ookinetes are mediated by A. gambiae 
complement-like proteins that circulate in the hemolymph (4, 5, 18, 71, 72). 
1.7 A. gambiae complement-like system 
The A. gambiae complement-like innate immune system is activated to attack and 
eliminate invading pathogens (18, 57, 69, 73). The system was originally discovered in 
sea urchins (74) and later on, it was confirmed to be present in many other invertebrates 
such as ascidian, Halocynthia roretzi [reviewed in (54)] and mosquitoes (18, 69). The 
complement-like protein components share similar sequence and structural homology 
(including the thioester motif) to the complement C3/C4/C5 protein components in 
vertebrates (54, 74, 75).  In A. gambiae, a key protein that is activated to mediate the 
complement-like innate immune responses is the thioester-containing protein 1 (TEP1) 
in the family of TEPs (18).  
1.7.1 Thioester containing protein 1 (TEP1) 
The TEP1 was first discovered through gene known-down experiments as an 
opsonin that mediates phagocytosis of bacteria (18). Later, it was shown that TEP1 is 
recruited on the surface of the ookinete to promote lysis and melanization of the 
ookinetes, resulting in dramatic losses in parasite numbers (4). As research on TEP1 
advanced, the protein crystal structure of the TEP1 was elucidated and found to be 
similar to the human complement factor C3 (18, 76, 77) (Fig. 1-7). Its main domains are 
8 macroglobulin (MG), β-sheet CUB and α-helical thioester (TED) (77). The TED 
region protects the intramolecular β-cysteinyl-γ-glutamyl thioester bond between the 
TED and MG8 interphase (18) from spontaneous hydrolysis (76).  
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1.7.2 Activation of the TEP1 and binding to the pathogens or cells 
 The TEP1 is constitutively produced and secreted as a 165 kDa full-length 
molecule by primarily produced in the mosquito fat body, which is an equivalent of the 
liver in vertebrates (78). Activation of TEP1 is triggered upon septic injury or infection 
by pathogenic bacteria or parasites but the exact mechanism of its activation is unclear 
(4, 18, 78). 
 
 
 
 
 
 
 
 
 
 
 
 
During the activation process, cleavage of the full-length TEP1 generates a ~80 
kDa C-terminal fragment (TEP1-C) [reviewed in (79)]. The functionality of TEP1-C is 
comparable to the vertebrate C3b fragment, as it carries a similar thioester site (71). 
Like the mammalian C3b, the TEP1-C carries an exposed thioester site that 
covalently binds to: i) the surface of the Gram-negative and Gram-positive bacteria and 
mediates phagocytosis (18); ii) the surface of Plasmodium ookinetes, where ookinete-
bound TEP1-C mediates a powerful anti-parasitic immune response resulting in killing 
and clearance of dead parasites through lysis (for Plasmodium susceptible mosquito 
strains) or melanization (for Plasmodium refractory mosquito strains) or both (4); and 
iii) the surface of damaged sperm cells and clears defective sperm cells during 
spermatogenesis, thus, promoting high fertility in males (80).  
1.7.3 TEP1 immune responses against the invading ookinetes 
TEP1 binds to the surface of P. berghei ookinetes between 24 and 48 h post 
infection (71). Heme peroxidase 2 (HPX2) and NADPH oxidase 5 (NOX5) are key 
enzymes that modify the surfaces of the invading ookinetes in order to ‘mark’ them as 
 
Fig. 1-7. The structure of TEP1R1.  
(A) Domain arrangements of 
TEP1R versus that of human C3. 
The different colors represent 
different domains. This show 
similar structure of TEP1 to the 
human C3. The TEP1 lacks ANA 
domain and hence it is less stable 
than the C3.  
(B) Schematic representation 
depicted different domains of the 
proteins as coloured in A. It 
consists of 12 domains in total. The 
interphase of MG8-TED harbours a 
TE, thioester bond crucial for TEP1 
activation. The MG8-TED 
interphase also protects the TE 
from premature hydrolysis. Figure 
source: Reference (77). 
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targets for the TEP1 binding (81). TEP1 binding on the surface of the parasite is 
mediated by the interaction of TEP1 with two other proteins from leucine-rich repeat 
(LRR) gene family: leucine-rich repeat immune molecule 1 (LRIM1) and the Anopheles 
Plasmodium–responsive leucine–rich repeat 1C (APL1C) (82, 83). LRIM1 and APL1C 
protect TEP1 from premature activation (83). When either the LRIM1- or the APL1C-
depleted mosquitoes were infected with P. berghei parasites, two observations were 
made: (i) in the hemolymph, the TEP1-C fragment got depleted, and (ii) binding of the 
TEP1-C to the parasite was abrogated (83). The family of APL1 genes consists of 
APL1A, APL1B and APL1C members located in chromosome 2L. Of these, only the 
APL1C is responsible for the elevated P. berghei oocyst loads in the APL1C-depleted 
mosquitoes (84). 
Major parasite losses within a mosquito take place during the ookinete stage, 
making this stage one of the most promising targets for controlling malaria transmission 
(21). There is no evidence that TEP1 acts on the subsequent developmental stages- the 
oocysts and the sporozoites (71). 
1.7.4 TEP1 polymorphism 
TEP1 gene is on 3L chromosome and it is exceptionally polymorphic, coding for 
the 1338 amino acid long protein (5). TEP1 allele variants are broadly grouped into two 
classes with two subclasses: refractory TEP1*R (*R1 and *R2) and susceptible TEP1*S 
(*S1 and *S2) (5). These TEP1 allelic subclasses are found both in laboratory strains 
and in natural mosquito populations in sub-Saharan Africa (5, 8, 35). The allelic 
subclasses are distinguished by fixed allele-specific nucleotide and amino acid sequence 
variation present mainly at the thioester domain (TED) region (5, 8, 76, 77). 
Importantly, two hypervariable loops; the pre- α4 and the catalytic loop in the TED, 
have amino acid substitutions that clearly segregate the *R and the *S alleles. TEP1*R 
is further separated into TEP1*R1 and TEP1*R2 alleles mainly by five amino acid 
substitutions; T919G, V936A, N937K, V946M, and C1142S (35). These amino acid 
substitutions are located in the hypervariable loops of TEP1 alleles and potentially 
affect TEP1 reactivity, binding and, thereby, functional variation of TEP1 towards 
pathogens, including Plasmodium parasites (76). Indeed, polymorphism i.e. sequence 
variation within a population, in TEP1 alleles was correlated with the phenotype 
variation in Plasmodium resistance and in male fertility (5, 35). 
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1.7.5 TEP1 genotypic and phenotypic variation in Plasmodium infections   
The susceptibility and the resistance to P. berghei infections correlate with the 
TEP1*S and *R mosquitoes, respectively (5, 71). Transcription of the TEP1 gene is up-
regulated within 24 h post-Plasmodium infection leading to activation of TEP1 for 
binding the invading ookinetes (71). The binding kinetics of TEP1 to the ookinetes in 
the TEP1*R mosquitoes are faster, and higher number of ookinetes are melanized than 
in the TEP1*S mosquitoes (71). Silencing the TEP1 gene by RNA interference, 
promoted higher number of surviving P. berghei oocysts (4, 5) [reviewed in (71)]. 
To directly correlate phenotypes of TEP1 genotypes bearing *R1 or *R2 or *S2 
alleles, Blandin et al. (5) conducted P. berghei infections in laboratory-bred mosquito 
intercrosses between two mosquito lines. They showed that *R1/R1 mosquitoes were 
the most resistant (>80%) and melanizing (>60%), while the *S2/S2 genotypes were the 
least resistant and melanizing (>18%), and the *R2/R2 genotypes and all heterozygote 
mosquitoes portrayed intermediate phenotypes. White et al. 2011 (35) also observed 
melanization (100%) and the resistant phenotype of  the TEP1*R1/R1 mosquitoes to P. 
berghei infections. However, the infection experiments of the TEP1*R1/R1 
homozygous with human P. falciparum parasites were not successful due to strong 
selection by the mosquitoes against the TEP1*R1/R1 genotypes. Instead, they observed 
lower numbers of P. falciparum parasite oocysts in TEP1*R1/S heterozygote than in the 
TEP1*S/S mosquitoes suggesting indirectly that the TEP1*R1 allele was more resistant 
than the TEP1*S alleles, but the phenotypes were not compared at the level of TEP1*S1 
and *S2 alleles (35). 
1.7.6 TEP1 genotypic and phenotypic variation in male fertility 
Recently, Pompon and Levashina (2015) reported a new role of the anti-
Plasmodium TEP1 complement system during spermagenesis (80). They demonstrated 
that TEP1 is present in the testis of A. gambiae and mediates the efficient removal of 
damaged sperm cells leading to higher male fertility. In addition, silencing the LRIMI 
and HPX2 proteins results in disappearance of TEP1-positive spermatogonia without 
affecting the TEP1 expression in the hemolymph. This observation demonstrated that 
the LRIMI and HPX2 proteins are required for TEP1 binding to the spermatogonia, and 
that the complement-like cascade regulates the binding of TEP1 to the damaged sperm 
cells. Interestingly, comparison between homozygous TEP1*R1, TEP1*S1 and 
TEP1*S2 mosquitoes revealed that the highest degree of the male fertility correlated 
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with the homozygous TEP1*S2 mosquitoes, suggesting that male fertility is dependent 
on TEP1 polymorphism i.e. allelic variation. The role of the susceptible TEP1*S2 allele 
in reproduction may underlie one of the reasons why mosquitoes maintain the 
susceptible alleles in their populations, and this, could have important consequences for 
malaria transmission. Therefore, the evolution of the TEP1 locus and genetic factors 
shaping resistance to malaria parasites may be a consequence of TEP1 pleiotropic trade-
off between TEP1 allelic fitness in immunity and reproduction.  
1.7.7 Ecological significance of evolutionary forces 
1.7.7.1 Concept of population genetics  
Maintenance of genetic variation in gene loci in mosquito populations, for example 
in the TEP1 locus (5-8), provides insights into biological processes and evolutionary 
forces underlying functional traits in natural populations (85).  The change in the DNA 
sequences caused either by mutations or by genetic recombination brings about the 
genetic variation (6, 86, 87). Mutations are sources of new alleles or genes, and are 
more frequent and more beneficial in unstable environments (88). Genetic 
recombination on the other hand occurs through new allele combination (88). It is the 
source of most of the genetic variation in a population and the main source of variation 
underlying gene evolution. The phenotypes or traits that are manifested in an individual 
organism are defined by their genotypes, or their genetic makeups, and may depend on 
the interactions of different genes and the environments (85). These aspects form the 
basics of the population genetics i.e. the study of genetic variation within populations, 
through the manipulation of allele and genotype frequencies from one generation to 
another (85). It also deals with the study of various forces that bring about evolutionary 
changes in species populations over time (85). In this context, it provides an 
understanding of ecological and evolutionary processes and impacts of demography on 
local populations, gene frequencies and phenotypes (85, 89).  
1.7.7.2 The Hardy-Weinberg principle 
One of the basic models in population genetics is the Hardy-Weinberg principle or 
the Hardy-Weinberg equilibrium (HWE), [named after the English mathematician G.H. 
Hardy (1877-1947) and the German physiologist W. Weinberg (1862-1937) who, in 
1908 independently and concurrently formulated the principle] (85) (90). The HWE is 
used to deduce theoretical genotype frequencies and infer certain evolutionary processes 
of a given population (85, 90). The principle assumes that in sexually reproducing and 
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non-evolving population evolutionary forces are absent or are negligibly small in 
magnitude, the alleles or genotypes remain constant from one generation to the next (88, 
90). Let us, for example, hypothetically consider TEP1 locus with two alleles, R and S, 
in a given mosquito population. The allele diploid combination under random mating 
gives RR, RS and SS genotypes. In the first generation, the allele frequencies of the R 
and S alleles may be denoted as p and q, respectively. Summation p + q = 1 (100%). 
The mathematical relationship for the expected genotype frequencies is given by 
(pR+qS)2 = p2, 2pq and q2 for RR, RS and SS, respectively. Hence p2RR + 2pqRS + 
q2SS = 1 (100%). In the second generation, the frequency of say R remains the same 
that is p.  Therefore, p2 + pq / p2 + 2pq + q2 = p (p+q) / (p+q)2 = p / p+q, hence p = p as 
in generation 1.  
The principle of the HWE is based on the following assumptions (88, 90):  
1) No mutations - no random change in base sequence of the genetic material 
within individuals. These changes are heritable and result in genetic variation, but they 
occur rarely with the majority being harmless or neutral (91).  
2) No migration - no movement of individuals into and out of the population. 
However, this does occur when some new comers enter into a population or some 
individuals move out of the population, hence causing successful movement of alleles 
i.e. gene flow, and genetic variation (91).   
3) Large (infinite) population. This provides all the possible kinds of zygotes to be 
formed in frequencies determined by the gametic frequencies (92). But bottlenecks and 
founder effects often occur (92). 
4) Random mating - no sexual selection. Mating should not be determined by any 
preferences associated with specific genotypes (92). But most animals mate selectively 
and may have differential mating success among individuals (91).  
5) No selection. Thus, all genotypes should have equal reproductive ability (92). 
But genotypes are not equally adaptive, hence natural selection does happen (86). 
Additional assumptions include (90);  
6) The organism is diploid, and is equally fertile to produce gametes according to 
the frequency of parents (92). 
7) Generations are non-overlapping. Gene locus under consideration has two 
alleles. But other genes such as TEP1, are multiallelic (5).  
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9) Allelic frequencies in both males and females are identical. This means that the
gene frequencies in both males and females are the same (92). 
10) Reproduction is sexual, with equally fertile gametes to have equal chances of
becoming a zygote (92). 
When any of the selection forces operates in the population, the frequencies of 
alleles and genotypes in the population change from one generation to the next. 
Significant deviation from the HWE expectation shows that selection is happening in 
the population (88). Hence the population is undergoing evolution resulting in selection 
for fitter individuals (Fig. 1-8) (86, 93).  
Although its applicability is not universal, the HWE principle provides an 
important platform to form a hypothesis about genetic structure of a population and 
design experiments in population genetics including mosquito populations (86, 88, 90). 
Given the genotype frequencies and the number of individuals per genotype in a 
population, it is possible to use these parameters to test for the HWE deviation by 
calculating the expected genotype frequencies (90). A commonly applied test in these 
analyses is the standard Chi-square (χ2) test, which is calculated as follows;  
Fig. 1-8. Selection forces acting on 
the life stages of an organism.  
Selection in a sexually reproducing 
diploid organism occurs in many 
stages in the life cycle. Fitter 
individuals are selected to survive 
through to the next developmental 
stages of population (86). Between 
each developmental stage, there are 
selection bottlenecks that determine 
the survival of fitter individuals to go 
the next life stage. These selections 
are classified into viability, sexual, 
gametic, fecundity and compatibility 
selection forces (86, 93). Figure 
source: Original to this thesis. 
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In cases where the expected genotypes are high for some genotypes and very low 
e.g. 5 individual, the following conservative χ2 test can be used;
Where, absolute (i.e. negative signs are ignored) difference between the observed 
and the expected genotypes is calculated, and 0.5, which is meant to reduce the χ2 value 
is subtracted first before taking the square (90).  
The χ2 and number of degree of freedom (df) associated with χ2 value provide a 
number for assessing goodness of it. The df is given by; 
df  =  Number of classes of data – Number of parameters estimated from the data. 
The df for a multi-allelic locus in a population is modified to capture complexity of 
alleles and genotypes analyses, where in general, df is given by the difference between 
the number of possible genotypes (m) and the number of alleles (n) present at the locus 
in the population, i.e. df  = m-n (90).  
The expected and the observed genotype frequencies provide parameters to test 
inbreeding and outbreeding in populations. Inbreeding within population occurs when 
organisms which are related or identical by descent (e.g. same genotype) mate together 
(94).  The inbreeding coefficient (F) – the probability that two alleles at a locus in an 
inbred individual are identical by descent. It takes into account immediate inbreeding 
and reveals whether the population is inbred or outbred (decrease in homozygosity) (88, 
94). Decrease in homozygosity occurs when mating between different genotypes leads 
to increase in heterozygosity commonly referred to as ‘isolate is breaking' or the 
Wahlund principle (94).  Between two or more populations, the comparison forms the 
basis of population fixation index (FST) (94). The FST considers only the autozygosity 
i.e. genes in homozygote as a mating between related individuals, occasioned by
population subdivision and gives a measure of population subdivision that indicates the 
proportion of heterozygosity found between populations relative to the amount within 
populations (89, 94). Another F statistics, FIT, unites both inbreeding and population 
structure, and gives the probability of autozygosity of an inbred individual relative to 
the whole population, where all the subpopulations combine and undergo random 
mating (95).  
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1.7.7.3 Natural selection at the TEP1 locus and other TEP loci 
Selective pressures that drive evolution may come from the environment itself, 
either naturally (non-random natural selection) or by chance (random genetic drift) (6, 
96, 97). Ecological niches are sources of selection forces that act on standing genetic 
variation at gene loci in natural populations (98, 99). This enables adaptation of 
Anopheles populations to different breeding habitats. Immune genes such as TEP1, are 
functionally constrained under evolution by predominantly purifying selection (6), and 
so detecting evidence of sites under positive selection is difficult (100).  
White et al. (35) identified candidate gene targets underpinning divergent 
speciation and selection in A. coluzzii and A. gambiae s.s. natural populations. To 
evaluate the extent of the divergence between these two species, they complemented 
genome-wide scanning in paired field-caught local mosquito populations from Mali 
with re-sequencing and genotyping samples from West, Central and East Africa. 
Marked divergence on chromosome 3L was observed between the two species, 
underscoring putative gene [AGAP010817]  and known [TEP1, TEP3, TEP10, TEP5 
(annotated as TEP11 in Vector Base)] immune genes. In TEP1, TEP3 and 
AGAP010817, the divergence was uniform within all the A. gambiae s.s. across all the 
countries of study suggesting that A. gambiae s.s. geographic scope for these genes was 
limited at this genomic regions. Population pairwise-comparison between geographic 
sites was significantly high in Mali and Burkina Faso, but indistinguishable between A. 
coluzzii and A. gambiae s.s. populations in Ghana and Cameroon suggesting geographic 
differences in mosquito species and genomic regions.  
Interestingly, the TEP1 locus exhibits the most extreme divergence due to the 
existence of multiple TEP1 alleles: A. coluzzii *R1 (Mali and Burkina Faso), A. coluzzii 
*S (Ghana and Cameroon) and A. gambiae *S (Mali, Burkina Faso, Ghana) alleles.
Geographic- and species-restricted forces correlated consistently with the TEP1 allelic 
variants. For instance, the *R1 allele was geographically restricted to Mali and Burkina 
Faso at near fixation within A. coluzii local populations i.e. presence of the TEP1*R1/R1 
homozygotes, and the *R1 gene flow was spreading to  Ghana. On the other hand, the 
TEP1*S and *R2 alleles were detected in all the A. gambiae s.s. populations.  
In addition, microarray scans of TEP1, LRIM 1 and APL1C gene loci between A. 
coluzzii and A. gambiae s.s. populations sampled from West and Central Africa, 
revealed that TEP1 locus was under significant ecological pressures of divergence and 
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speciation (35). The authors hypothesized that selective forces act on the TEP1 locus 
and contribute to the adaptive divergence in the A. gambiae species, whereas another 
study did not find significant evidence of selection acting on the LRIM1 and APLC1 
gene loci (101), even though their gene products interact together as a complex to 
stabilize and promote TEP1 binding to the pathogen surface. Indeed, pathogens, 
demographic and other ecological factors that are present in the larval breeding sites, 
and/or the vector species,  are implicated as key contributors to the TEP1 allelic 
diversification, and natural selection driving forces of adaptive divergence of local 
malaria vector populations at the TEP1 locus  (6, 8, 35, 102, 103).  
1.7.7.4 Contribution of recombination to the TEP1 gene diversity 
It is important to note that within any given gene locus, different sites are not under 
equal or similar selection forces (6). Obbard et al. (6) showed that the TEP1 locus is a 
target of natural selection and that the hallmark of underlying TEP1 genetic variation is 
the independent gene conversion events due to recombination (genetic exchange) 
between TEP1 locus and TEP11(5) and TEP6 loci. For instance, the TEP1 chimerical 
sequence similarities with the TEP5 and the TEP6 were exemplified by a TEP5-like 
portion upstream of TEP1, and a TEP6-like region towards 3´ end of the TEP1 gene. 
Moreover, the TED of TEP1*R carried a TEP6-like portion, which overall translated to 
TEP1*R (3.2%) and TEP1*S (14.6%) divergence with the TEP6 gene, suggesting a 
more recent ancestry of TEP1*R than TEP1*S, to the TEP6 (6). In summary, the data 
suggest distinct histories of TEP1 allelic variants. Therefore, in addition to natural 
selection, the high divergence and functional polymorphism between the TEP1 alleles 
could have been driven by gene conversion mechanisms.  
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1.8 Research gaps 
Understanding the biogeographic distribution of TEP1 allele/genotypes in A. 
gambiae s.l. offers an opportunity to infer their impact on malaria epidemiology and to 
inform future research directions, and malaria control stategies and policies (104). 
 Targetted-control measures (105-107) as well as climate change (48, 108-111) may 
significantly modulate abundances of the local mosquito species populations. This may 
promote selection of efficent malaria vectors which could be resistant or susceptible to 
insecticides or pathogens including human malaria parasites. Having genetic markers 
that offer high throughput genotyping of local A. gambiae s.l. mosquito populations 
across Africa are of great importance, especially for monitoring dynamics in the 
mosquito populations that may have implications in malaria transmission. 
Previous genotyping methods provided clear distinction, and species and 
geographic distribution ranges between the TEP1*R1 and TEP1*R2 allelic classes (8, 
35). However, these studies were unable to distinguish between the TEP1*S1 and the 
TEP1*S2 alleles. Therefore, the species and biogeographic distribution ranges of 
TEP1*S1 and the TEP1*S2 alleles across Africa remains largely unclear. Moreover, 
phenotypic differences between TEP1 alleles with respect to infections by human 
malaria parasite are unknown.  
1.9 Aims of the thesis 
This thesis aimed at a) characterizing TEP1 alleles/genotypes of local A. gambiae 
s.l. populations sampled across four countries in sub-Saharan Africa (Mali, Burkina 
Faso, Cameroon and Kenya), and b) assessing the impact of TEP1 variability on P. 
falciparum development. The following specific research questions were formulated in 
order to achieve the research aims: 
1. Identification of single nucleotide polymorphisms (SNPs) within the TEP1 locus 
that could be harnessed as genetic markers for high throughput genotyping; 
2. Distribution and frequencies of the TEP1 genotypes and alleles across Africa;  
3. Structuring of TEP1 genotypes along the ecological sites and geographic 
regions;  
4. Forces that shape distribution of TEP1 genotypes; and 
5. Impact of TEP1 variability on resistance to human P. falciparum and murine P. 
berghei parasites. 
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The findings of this thesis are expected to guide the formulation of hypotheses that 
may motivate future research on selection and roles of different TEP1 alleles and 
genotypes in the natural vector populations. The high throughput TEP1 genotyping 
strategies as used in this study, may be adopted and incorporated in the malaria vector 
control programs for routine genotyping of the local malaria vector populations across 
Africa. This will offer prediction of vector population dynamics due to the impact of 
human activities and climate change which may influence malaria transmissions.  
1.10 Outline of the thesis 
This thesis is divided into four chapters:  
 Chapter 1 gives background information on malaria and its transmission 
cycle. It reviews the relevant literature on the current knowledge and 
challenges on the dynamics of distribution of malaria vectors in sub-Saharan 
Africa, and advances on the innate immunity of the malaria mosquito 
towards the malaria parasites. It identifies research gaps and provides the 
aims of the thesis;  
 Chapter 2 reports development of a high throughput PCR-RFLP 
genotyping approach that can be used to sufficiently identify all TEP1 
alleles. It provides and discusses data on genetic diversity and 
biogeographic distribution ranges of TEP1 alleles/genotypes of local 
malaria vector populations in Mali, Burkina Faso, Cameroon and Kenya; 
 Chapter 3 provides insights into the genetic and phenotypic variation of 
TEP1 alleles or genotypes and their impact on development of human- and 
murine-malaria parasites. It highlights challenges encountered in breeding 
mosquitoes bearing the TEP1*R1 alleles, and suggests future breeding 
strategies that may be explored in a bid to enhance successful routine 
rearing of such mosquitoes under the laboratory and/or field conditions; and  
 Further, Chapter 4 gives the general discussions and proposes hypotheses 
based on the results of this thesis. It suggests open questions that remain to 
be addressed by future studies and further wraps up with the perspective of 
the study, implications/conclusion of the key findings.  
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Biotope-specific factors shape TEP1 genetic variation in the populations of 
Anopheles gambiae across sub-Saharan Africa 
2.1 Summary 
Species of the principal malaria vector A. gambiae s.l. have adapted to a wide range 
of ecological niches (biotopes or habitats) across Africa (112). Many studies based on 
mtDNA, paracentric chromosomal inversions and microsatellite markers have described 
genetic differentiation, local adaptation and gene flow in vector populations in sub-
Saharan Africa, (113-117). Indeed, putting in place effective vector control measures to 
curb malaria transmission requires a wider understanding of genetic variation and 
selective pressures underlying structuring of vector populations, and malaria 
transmission. Here, TEP1 locus was used to examine genetic architecture of field vector 
populations. The study developed and used a PCR-RFLP genotyping method to identify 
TEP1 genotypes and allelic subclasses. We identified generalist (*R2/R2, *R2/S1 and 
*S1/S1) and specialist (*R1/R1, *R3/R3, *R3/S1, *S2/S2 and *S1/S2) TEP1 genotypes. 
We show that *R2 and *S2 are the most conserved alleles suggesting that they may 
represent ancestral alleles that have been maintained over generations. The contribution 
of intronic polymorphism to the evolution of TEP1 alleles and genotypes is discussed. 
These findings suggest a trade-off between intrinsic forces maintaining ancestral genetic 
polymorphism and extrinsic factors that drive vector adaptation to local ecological 
ecotypes.  
2.2 Introduction 
Physical isolation and premating reproductive barriers limit reproductive 
interactions between malaria populations breeding in distinct habitats (118, 119). An 
example of geographic separation is the Great Rift Valley (GRV), a massive trench that 
stretches from North to South of Kenya separating it into three ecological strata: (i) 
West; (ii) along the GRV trench; and (i) East of the GRV. The GRV acts as a gene flow 
barrier in the geographical locations between the western, within the valley and the 
eastern populations leading to genetic and reproductive isolation (113, 120-122). 
Changes in ecological circumstances due to human activities and climate change affect 
ecological abundance of vector populations such as constriction or expansion of 
ecological niches (105, 123). Climate change is predicted to result in rise of sea water 
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levels forcing the mosquito species living in the salty habitats to move and colonize new 
fresh-water habitats, and this may have consequences for malaria transmission (124). 
Sympatric mosquito species have reproductive restrictions such as premating and 
post-mating barriers between them (34, 125-127). Ecological factors driving these 
reproductive restrictions vary from one habitat to another, thus relaxing the gene flow 
barriers between divergent species leading to incomplete reproductive restrictions (99). 
For instance in West Africa, natural hybrids between A. coluzzii and A. gambiae s.s. in 
sympatric populations (8, 35, 99) do occur mostly in low frequencies (<20%) suggesting 
porous reproductive restrictions (8, 39, 115, 128-131). Similar observations on 
hybridization have been reported for A. gambiae s.s. and A. arabiensis (36).  
Genetic structure of a population can be described based on chromosomal 
arrangement, microsatellites and mtDNA. There is a correlation between local 
adaptation to different climatic zones and paracentric chromosome inversions in 
mosquito populations (32, 119, 132, 133). As such, higher and lower inversion 
frequencies correlate with arid/dry and wet ecotypes, respectively. Moreover, peaks and 
troughs match dry and rainy seasons, respectively (32, 132). On an exploded geographic 
picture, Lehmann et al. (134) described population structure of mosquitoes across ten 
African countries using 11 microsatellite markers and observed genetic differentiation 
into two substructures; Northwest and Southeast population groups.   
The A. gambiae thioester-containing protein 1 (TEP1) encoded by a polymorphic 
gene (i.e. bearing different alleles-*R1, *R2, *S1 and *S2), plays a role in antimicrobial 
and anti-malarial immune responses, and in male fertility (4, 5, 18, 77, 80, 135). Trade-
off between reproduction and immunity could have a direct consequence on mosquito 
population abundances and malaria transmissions. This makes TEP1 locus a promising 
target for new malaria control interventions (6-8, 78). TEP1 locus is under selective 
pressure for adaptive divergence in West and far-West Africa leading to geographic 
differences in TEP1 allele frequencies (6, 8, 35). However, TEP1 genotyping methods 
used did not distinguish between *S1 and *S2 alleles, thus biogeographic distribution 
ranges of these alleles remains unknown (6, 8, 35, 80). Largely, due to lack of high 
throughput TEP1 genotyping methods, it is unclear how TEP1 genetic diversity 
influences the genetic structure and local adaptation of natural vector populations, and 
development of human malaria parasites (6-8). 
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In this chapter, I explored the suitability of the TEP1 locus for genotyping the main 
malaria vector A. gambiae to dissect patterns of distribution of malaria vector species 
and TEP1 genetic diversity. A. gambiae s.l. species were sampled across sub-Saharan 
Africa, namely West (Mali, Burkina Faso), Central (Cameroon) and East (Kenya) 
Africa. I examined the hypothesis that TEP1 polymorphism shapes structures of local 
mosquito populations. Specifically, the following objectives were addressed: i) whether 
single nucleotide polymorphisms (SNPs) within the TEP1 locus could be harnessed as a 
genetic marker for high throughput TEP1 genotyping; ii) patterns of distribution of 
TEP1 genotypes and alleles across Africa; and iii) structuring of TEP1 genotypes and 
alleles according to ecological and geographic regions. 
All known TEP1 genotypes and alleles were identified using a simple high-
throughput PCR-RFLP genotyping approach (80). I identified interesting signatures of 
natural selection on both intronic and exonic TEP1 sequences. Further, I identified a 
new TEP1 allele, hereafter named *R3, which was maintained as *R3/R3 and *R3/S1 
genotypes in A. merus population along the coastal region of Kenya. Patterns of 
distribution of TEP1 genotypes and alleles suggested new biogeographic distribution. In 
brief, genotypes were categorized into four groups, proposed as follows: generalist 
(*R2/R2, *R2/S1 and *S1/S1) due to wide distribution in relatively high frequencies in 
all species and most countries, specialist (*R1/R1, *R3/R3, *R3/S1, *S1/S2 and *S2/S2) 
since they were found restricted to specific species and locations, rare (*R1/S1, *R1/S2 
and *R2/S2) as they were in very low frequencies in some species in West Africa, and 
undetected (*R1/R2, *R1/R3, *R2/R3 and *R3/S2) genotypes which were not found in 
any mosquito samples. On the other hand, alleles were grouped into two biogeographic 
groups; generalist (*R2 and *S1) found in almost all species across Africa, and 
specialist (*R1, *R3 and *S2) alleles which were found or restricted to species and 
locations in Africa.  
The specialist *R1 allele and *R1/R1 genotype were identified in Mali and Burkina 
Faso. The A. coluzzii *R1 allele correlated with arid conditions, suggesting a link to 
resistance to desiccation and ability to withstand harsh breeding conditions of the Sahel 
zone in Mali and Burkina Faso. In Kenya, the emergence of new *R3 private allele may 
be beneficial to A. merus in confronting certain biotic and/or abiotic ecological 
constraints specific to their ecological niches.  
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In Cameroon, both A. coluzzii and A. gambiae s.s. had inverse proportions between 
*R2/S1 and *S1/S2 genotype frequencies, and between *R2 and *S2 allelic frequencies, 
suggesting a competition between the *R2 and *S2 alleles. The most predominant 
alleles and genotypes in most species were *S1 and *S1/S1 respectively, except A. 
coluzzii in Mali and in some habitats in Burkina Faso which had *R1/R1 genotypes. The 
heterozygote *R2/S1 genotypes were the most widespread across Africa in all species 
except in A. coluzzii in Mali and in Burkina Faso, suggesting that both *R2/S1 and 
*S1/S1 genotypes have the highest fitness advantage.  In addition, haplotype clustering 
of alleles showed that the*R2 and *S1 haplotypes were the most shared between species 
across Africa suggesting that these alleles in the vector populations are the most 
conserved.  
Collectively, these findings suggest that local selection factors drive vector 
adaptation to ecological biotopes according to mosquito species. As the distribution of 
TEP1 genetic diversity matches African climatic zones, I propose that TEP1 locus 
contributes to the local adaption of mosquitoes to the prevailing environmental 
conditions. Based on the above findings, I conclude that the genetic variation at the 
TEP1 locus shapes the population genetic structure of local malaria populations. For the 
first time, this study mapped TEP1 alleles and genotypes in four malaria vector species 
from four African countries. Accordingly, new biogeographic distribution ranges of the 
TEP1 alleles and genotypes have been proposed. Therefore, structure of mosquito 
populations at the TEP1 locus offers an important tool in assessing gene flow radiation 
and genetic dispersal of malaria vectors. I propose that the SNPs that were used for 
TEP1 genotyping in this study could be harnessed as genetic markers for high 
throughput TEP1 genotyping as they provide a robust approach for dissecting genetic 
population structure of A. gambiae s.l.. Policy makers may incorporate these approaches 
into vector-control programs for surveying, monitoring and documenting the 
conjectures of population dynamics in local malaria vectors, as they come in handy in 
forecasting future demographic circumstances that bring severe epidemiological 
consequences. 
2.3 Material and Methods 
Materials, equipment and software that were used in this chapter are listed in 
Appendix 1A-D. 
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2.3.1 Fieldwork samples and sample origin  
Four sub-Saharan African countries (Burkina Faso, Cameroon, Kenya and Mali) 
were chosen for sample collections due to diverse geographical locations and climatic 
zones, as well as availability of collaborators (Fig. 2-1A). Larvae (Mali, Burkina Faso, 
Cameroon, and Kenya), and adults [mating swarms (Burkina Faso) and indoor resting 
mosquitoes (Kenya)] were sampled between 2009 and 2016 (Fig. 2-1; Table 2-1). 
 
Fig. 2-1. Sampling sites investigated in this study.  
(A) Overview of sampling sites in the context of the African climatic zones. Mali (ML) and Burkina 
Faso (BF) lie in warm savanna with a single dry season. Cameroon (CM) is in humid equatorial 
climate. Kenya (KE) is in warm equatorial and savanna climate zones. Locations of sampling sites in: 
(B) ML and BF;  
(C) CM; and 
(D) KE.  
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Table 2-1. Information on the sampling sites. 
Country Site 
Geographic 
coordinates Year 
Ecological 
domain Landscape Bioclimate 
ML NK 12.17 N, 8.29W 2009 Sahel farmland very hot semi 
dry 
BF VK5 11.3N, 4.4W 2009 Sahel farmland hot semi dry 
BF VK7 11.4N, 4.4W 2009 Sahel farmland hot semi dry 
BF SM 11.02N, 4.06W 2009 Savanna savanna very hot moist 
CM MF 3.97N, 11.94E 2009 Savanna rainforest very hot wet 
CM MV 3.82N, 11.53E 2009 Savanna urban very hot wet 
CM NS 3.88N, 11.46E 2009 Savanna urban very hot wet 
CM NM 3.87N, 11.4E 2009 Savanna rainforest hot wet 
CM ND 3.95N, 11.5E 2009 Savanna rainforest hot wet 
KE AH 0.17S, 34.93E 2009, 2012, 
2016 
Equatorial farmland hot moist 
KE BT 0.46N, 34.12E 2009 Equatorial farmland hot wet 
KE KK 0.31N, 34.79E 2009 Equatorial farmland hot wet 
KE KL 3.89S, 39.91E 2009, 2011 Savanna coastal hot wet 
KE KW 4.17S, 39.47E 2009 Savanna coastal hot wet 
KE MD 3.25S, 40.11E 2009, 2016 Savanna coastal hot semi dry 
Countries: ML-Mali; BF-Burkina Faso; CM-Cameroon; KE-Kenya. Sites: NK-Nankilabougou; 
VK5-Vale de Kou 5; VD7-Vale de Kou 7; SM-Somoussou;  MF-Mfou;  MV-Mvan;  NS-
Nkolbisson;  NM-Nkolkoumo;  ND-Nkolodom; AH-Ahero; BT-Busia/Teso; KK-Kakamega; KL-
Kilifi; KW-Kwale; MD-Malindi. 
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 In Mali, Nankilabogou (NK) sampling site featured sympatric population of A. 
coluzzii and A. gambiae s.s.. This sampling site is about 66 km Southwest of Bamako in 
proximity to the river Niger. (Fig. 2-1B). Two main sites in Burkina Faso, Vale de Kou 
(VK5 and VK7 villages) and Somousso village, are located approximately 400 km 
southwest of Ouagadougou (Fig. 2-1B). In Vale de Kou and Somousso, A. coluzzii and 
A. gambiae s.s. populations coexisted in allopatry and sympatry, respectively. Unlike 
Somousso with temporary breeding habitats, Vale de Kou District is an agricultural rice 
field sourcing water for irrigation that provided permanent long-term large breeding 
sites for mosquitoes. In Cameroon, mosquito samples of sympatric A. coluzzii and A. 
gambiae s.s. mosquitoes were collected from five districts: Mfou - about 60 km 
Northwest of Yaounde, Mvan - 10 km South of Yaounde; Nkolondom - Southeast of 
Yaounde;  Nkolkoumou - South of Yaounde and Nkolbisson - about 10 km Northwest 
of Yaounde (Fig. 2-1C). In Kenya, sampling was performed in two regions, western and 
coastal Kenya, which are separated by the GRV (Fig. 2-1D). In western Kenya, there 
were three local sampling locations: Ahero (native irrigated rice farms), Kakamega 
(agricultural land with tall vegetation including the forests) and Busia/Teso (a grassland 
in the savanna zone). Along the coastal Kenya, three locations were chosen: Kwale on 
South coast, Malindi and Kilifi on the North coast. 
2.3.2 Species identification 
The genomic DNA (gDNA) was extracted from larvae or adult legs using DNeasy 
kit (Qiagen, USA). The gDNA (10 ng/µl) was used in PCR standard methods to identify 
mosquito samples into sibling Anopheles species according to the published protocols 
(136, 137). Briefly, A. gambiae molecular forms in Mali, Burkina Faso and Cameroon 
were identified by a short interspersed-PCR (SINE-PCR) approach, which amplifies a 
200 bp insertion polymorphism at locus S200 X6.1 located in chromosomes X (137). 
The following primers were used; forward primer 5´-TCGCCTTAGACCTTGCGTTA-3´ 
and reverse primer 5´-CGCTTCAAGAATTCGAGATAC-3´ which amplifies a 479 bp 
fragment in A. coluzzii (former M form) and 249 bp in A. gambiae s.s. (former S form) 
(137). In Kenya, A. arabiensis, A. gambiae s.s. and A. merus sibling species were 
identified using a multiplex ribosomal DNA-PCR method, which distinguishes the 
species based on species-specific sequence variation in the ribosomal DNA intergenic 
spacers (136). This method utilizes one universal primer-UN 5´- 
GTGTGCCCCTTCCTCGATGT-3´ and four species–specific primers; A. arabiensis-AR 
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5´-AAGTGTCCTTCTCCATCCTA-3´, A. gambiae s.s.-AG 5´-
AAGTGTCCTTCTCCATCCTA-3´, A. melas/A. merus-ME 5´- 
TGACCAACCCACTCCCTTGA-3´, and A. quadrianulatus-QD 5`- 
CAGACCAAGATGGTTAGTAT-3´. The primers amplify 315 bp for A. arabiensis, 390 
bp for A. gambiae s.s., 464/466 bp for A. melas/A. merus, and 153 bp for A. 
quadrianulatus (136). 
 3.3.3 Sequencing of the full-length TEP1 genomic sequence 
Six primer pairs: VB928/9, 932/33, 936/7, 940/1, 230/1, and 944/5 spanning the 
whole region (4.8 kb) of the TEP1 locus were designed to amplify six overlapping 
fragments (Fig. 2-2). The primers were designed using online platforms in 
http://www.justbio.com/hosted-tools.html and http://www.bioinformatics.org/sms2/. 
PCR reaction to amplify each fragment, constituted the following components:  
0.25 µl (0.2 mM) deoxyribonucleotide triphosphate (dNTP) mix (2 mM each); 
2.5 µl (1 ×) 10 × buffer with MgCl2 (1.5 mM); 
0.5 µl (5 pmol) each primer (10 pmol/µl); 
0.25 µl (0.05 U) Phusion DNA polymerase (2 U/µl); and 
 21 µl of nuclease free water (NFW) to top up to a total volume of 25 µl. 
PCR thermocycling parameters were carried as follows: 
 98 °C for 30 s; 
35 cycles of 98 °C for 15 s, 62 °C for 30 s, and 72 °C for 40 s; and 
72 °C for 3 min.  
Fig. 2-2. TEP1 full-length amplification strategy. 
(A) Schematic representations of coding TEP1
sequences highlighting the position of exons and
introns. Primers for the TEP1 alleles were
designed using the coding regions in order to
amplify six overlapping fragments. Primer detail
are provided in Table 2-2.
(B) Expected PCR results of TEP1 full-length
amplification from genomic DNA. Each primer
pair was used independently to amplify a specific
DNA fragment for each allele from TEP1
homozygote mosquitoes. The PCR products were
purified and cloned for sequencing. Sequence
chromatograms were curated in Bioedit and DNA
star SeqMan Pro. BLAST searches for each
fragment confirmed that all sequences matched
the TEP1 locus.
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Table 2-2. Primer used for TEP1 PCR amplification. 
Pair 
5´-3´ forward primer 
(VB number) 
5´-3´ reverse primer 
(VB number) 
Specificity/ Taq polymerase annealing 
temperature/Applicon (size in bp) Reference 
1 ATGTGGCAGTTCATA
AGGTCAC (VB928) 
ATCCTGCTGATCCG
CATCC (VB929) 
Universal/58°C/exon 1-3#1 (1042-7 bp) This study 
2 GTCAACGTTCGACG
TGCAG (VB932) 
CGGAATCATCTTTTC
TGTTGCGT (VB933) 
Universal/58°C/exon 3-6#2 (993 bp) This study 
3 GAAGATGTGAATAA
GGTAGAAACGG 
(VB936) 
TCGGTCTGGTTGGC
CACAT (VB937) 
Universal/58°C/exon 5-8#3 (1160 bp) This study 
4 GTAGTACCGGACAC
GACCA (VB940) 
TCGTAGCTTTGTCGA
TTAGATGC (VB941) 
Universal/58°C/exon 8-10#4 (857±2 bp) This study 
5 TTGGACATCAACAAG
AAGGC (VB230) 
ACTTCAGTTGAACG
GTGTAGT (VB231) 
Universal/55°C/exon 9-10#5 (1034±1 bp) This study 
6 CATACGACCTATCGA
TAGCAAC (VB944) 
GCACTCTGCAGGAC
AGTCT (VB945) 
Universal/58°C/exon 10-12#6 (1093-6 bp) This study 
7 GATGTGGTGAGCAG
AATATGG (VB003) 
ACATCAATTTGCTCC
GAGTT (VB004) 
Universal/57°C/Generate primary PCR 
(892 bp) 
Modified from 
(80) 
8 ATCTAATCGACAAAG
CTACGAATTT 
(VB001) 
CTTCAGTTGAACGGT
GTAGTCGTT (VB002) 
Universal/56°C/Generate (TEP1-TED) 
secondary PCR (758 bp) 
Modified from 
(80) 
9 TCAACTTGGACATCA
ACAAGAAG (VB229) 
ACATCAATTTGCTCC
GAGTT (VB004) 
Universal/53°C/Generate primary PCR 
(1088±1 bp) 
Modified from 
(80, 138) 
10 TTGGACATCAACAAG
AAGGC (VB230) 
ACTTCAGTTGAACG
GTGTAGT (VB231) 
Universal/55°C/Generate secondary PCR 
(1034±1 bp) 
This study 
11 TTGCATGCCATCGG
GTCGAAA (VB221) 
CGGTGAGAAACACG
CTACCATT  (VB222) 
*R1-specific/59°C/*R1 detection (148 bp) Modified from 
(80, 138) 
12 TTGCATGCCATCGG
GTCGAAA (VB221) 
AACCGTTCGTTTTTA
TCAGCATCAATGAA  
(VB224) 
*R-specific/59°C/*R detection (560 bp)
This study 
13 TTGCATGCCATCGG
GTCGAAA (VB221) 
CTATTGGATTCGTTG
TGTTCCAGA (VB228) 
*R-specific/59°C/*R detection (583 bp) This study 
14 TTGCATGCCATCGG
GTCGAAA (VB221) 
CTATTTGATTCTTTG
TTCTCCAAAACC 
(VB232) 
*R3-specific/58°C/*R3 detection (583 bp) This study 
15 GGTTTGTGGGAGAC
TACTGG  (VB223) 
AACCGTTCGTTTTTA
TCAGCATCAATGAA 
(VB224) 
*R2-specific/59°C/*R2 detection (452 bp) Modified from 
(80, 138) 
16 GGTTTGTGGGAGAC
TACTGG (VB223) 
CTATTGGATTCGTTG
TGTTCCAGA  
(VB228) 
*R2-specific/59°C/*R2 detection (475 bp) This study 
17 CGGTAAAGTGTGGC
ACAAAGAT  (VB225) 
AACCGTTCGTTTTTA
TCAGCATCAATGAA 
(VB224) 
*S2-specific/58°C/*S2 detection (288 bp) This study 
18 CGGTAAAGTGTGGC
ACAAAGAT (VB225) 
CTATTGGATTCGTTG
TGTTCCAGA (VB228) 
*S2-specific/58°C/*S2 detection (311 bp) This study 
19 CGGTAAAGTGTGGC
ACAAAGAT (VB225) 
CAATTTGGTCAGCG
CTTTAAGG  (VB227) 
*S-specific/58°C/*S detection (466 bp) This study 
20 TCAGTGATAATAATA
AAAAAGAACGGTAC  
(VB226) 
CAATTTGGTCAGCG
CTTTAAGG (VB227) 
*S1-specific/58°C/*S1 detection (206 bp) This study 
VB stands for Vector Biology, MPI laboratory in Berlin where the thesis work was done. The VB number was assigned to each 
primer. All the sequenced TEP1 genomic sequences are available in the NCBI GenBank under accession numbers MF098568 to 
MF098592 (full-length sequences) and MF035727 to MF035924 (TEP1-TED sequences). 
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 PCR fragments were visualized on 1.5% Tris-acetate EDTA (TAE) ethidium-
bromide stained agarose gel. The PCR products were cloned into pJet1.2 blunt cloning 
vector (Thermo Fisher Scientific).  
 Recombinant plasmids were purified using the miniprep kit (Qiagen) and sent for 
Sanger sequencing (Eurofins, Germany). Sequence chromatograms were curated 
manually by visual inspection using Bioedit software (139) and Seqman Pro (DNAStar). 
Sequence fragments amplified from an individual mosquito sample, were further 
crosschecked by BLAST search in the VectorBase database to confirm the absence of 
co-amplification with other TEP genes. Curated fragments and quality chromatograms 
were assembled to form a complete TEP1 full-length contig using Seqman Pro 
(DNAStar). The full-length sequences are available in the NCBI GenBank under 
accession numbers MF098568 to MF098592. 
2.3.3 TEP1 genotyping methods 
 Most genetic markers that are used in the population studies are highly 
polymorphic and some are neutral i.e. should not be adaptive to the environment (140). 
For example, microsatellites are largely considered neutral and so are under no 
influence of natural selections because they are located in non-coding regions (140). 
The exceptional polymorphism in TEP1 locus is characterized by allele-specific amino 
acid residues within the thioester domain (TED) (5, 7, 8, 76, 77). 
To explore whether the SNPs coding for these amino acid residues could be 
harnessed as genetic markers for high throughput TEP1 genotyping, five SNPs 
matching restriction sites for BamHI, HindIII, BseNI and NcoI enzymes were chosen 
and validated using a nested-Polymerase Chain Reaction-restriction fragment length 
polymorphism (PCR-RFLP) approach. To confirm that the restriction sites for the SNPs 
were not subject to natural selection (negative or positive) within each allelic subclass, 
the restriction sites were tested (using selection tools hosted by the Datamonkey server 
at http://www.datamonkey.org/). Reliably, the restriction sites were only polymorphic 
between allele groups and fixed per each allele classes or subclasses. In addition, only 
with exception of a nucleotide (codon S1105) for the HindIII sites in >10% of TEP1 
*S1/S1 in A. merus populations in Kenya, all the restriction sites were under no
selection (Table 2-3), suggesting their suitability as markers for typing all TEP1 alleles. 
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 Fig. 2-3A shows schematic representation of TEP1 genotyping using the PCR-
RFLP at the TED region. The PCR product is a 758 bp exon that corresponds to 
positions 2573 to 3390 in reference to TEP1 full-length coding DNA sequences. 
Polymorphism at positions 3055-3060 (α7 loop at G1019) carries a BamHI site fixed for 
*R alleles that was used to detect the presence of only *R1, *R2 and *R3 alleles, that 
gives two bands of 399 bp and 365 bp fragments in RFLP digestions. Polymorphism at 
position 3312-3317 (pre-α12 at G1104) has a HindIII site in *S alleles for detecting both 
*S1 and *S2 alleles by RFLP, resulting in two 656 bp and 102 bp bands. In *S1 alleles, 
polymorphism at positions 3193-3198 (β-hairpin at Y1063) introduces a BseNI site for 
detection of the *S1 alleles via RFLP, resulting in two fragments of 537 bp and 221 bp. 
Table 2-3. Codons of the SNP genetic markers used in the PCR-RFLP for TEP1 
genotyping, and whether or not the codons are under forces of natural selection.  
Type of codon position *R1 *R2 *S1 *S2 
BamHI SNP sites for *R G1019, 
S1020 
G1019, 
S1020 
- - 
     
HindIII SNP sites for *S   G1104, 
S1105, 
F1106 
G1104, 
S1105, 
F1106 
     
NcoI SNP sites for *S and *R3   T843, 
M844, 
V845 
T843, 
M844, 
V845 
     
BseNI SNP sites for *R2 - T918, 
G919 
- - 
     
BseNI SNP sites for *S1 - - Y1063, 
W1064 
- 
     
a) Negatively selected sites I998 - Q897, 
H959, 
G962, 
G982, 
L1036, 
G1065, 
T1072, 
S1105 
F927, 
G962, 
N1068, 
P1107, 
G1115 
     
b) Positively selected sites - - AV1004, 
PA1024 
DNR1065 
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The *R2 alleles bear a different BseNI site at positions 2757-2762 (pre-α4 at G919) that 
produces 102 bp and 656 bp RFLP fragments.  
I used the leg of a single mosquito to extract gDNA for use as a template in primary
PCR (PCRI) reaction using primers VB003 and VB004 (Fig. 2-3A; Table 2-2). The 
PCRI was done (Fermentas, USA) in total volume of 20 µl containing: 
2 µl (0.2 mM) dNTP mix (2 mM each); 
2 µl (1×) 10× buffer with 1.5 mM MgCl2; 
0.4 µl (0.2 pmol) each primer (10 pmol/µl); 
0.4 µl (0.05 U) Taq DNA polymerase (5 U/µl); 
1 µl (>10 ng/µl) template (gDNA or one mosquito leg); and 
14.2 µl of NFW to top up to a total volume of 20 µl. 
PCR was carried as follows: 
95 °C for 5 min;  
20 cycles of 94 °C for 30 s, 57 °C for 30 s, 72 °C for 55 s; and 
72 °C for 3 min.  
Fig. 2-3. Schematic representation of TEP1 genotyping methods. 
(A) Schematic representation of TEP1 nested PCR-RFLP genotyping principle (Pompon and Levashina,
2015). It amplifies a final product of 758 bp of the TED region using universal primers that can amplify any
of the all the four TEP1 alleles), and the digestions of RFLP on the 758 bp PCRII products. The name and
color codes of the primers are indicated on the primers.
(B) Schematic representation of TEP1 nested PCR-RFLP genotyping method (based on the 1034±1 bp
fragment) with the modified primers and the use of the NcoI restriction site to complement the HindIII site.
By using the NcoI restriction digestion can genotype TEP1*S1m (in Mut6 mutant strain) and TEP1*R3
alleles.
(C) Schematic representation of TEP1 PCR-based allele-specific genotyping method.
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 For the secondary or the second nested PCR (PCRII) reaction, 2 µl of primary PCR 
product was used as a DNA template. Primers VB001 and VB002 (Table 2-2) were 
used in a total PCR reaction (Fermentas, USA) volume of 25 µl containing: 
2.5 µl (0.2 mM) dNTP mix (2 mM each); 
2.5 µl (1×) 10× buffer with MgCl2 (1.5 mM); 
0.4 µl (0.2 pmol) primers (10 pmol/µl); 
0.25 µl (0.05 U) Taq DNA polymerase (5 U/µl); 
2 µl (~10 ng/µl) of primary PCR product; and 
16.95 µl of NFW to top up to a total volume of 25 µl. 
PCR thermocycling parameters were as follows:  
95 °C for 5 min;  
40 cycles of 94 °C for 30 s, 56 °C for 30 s, 72 °C for 50 s; and 
72 °C for 3 min. 
Alternatively, the above PCR amplifications were performed with GO Taq kit, 
which has ready-to-use PCR master mix with a premixed buffer containing dNTP mix, 
MgCl2 and Taq DNA polymerase (Promega, USA).  
PCRII products were digested with two sets of restriction enzymes (Table 2-4). 
Set 1 - a double digestion with BamHI and HindIII (Thermo Fisher Scientific, Germany) 
in 37 °C for 1 h in 25 µl reaction volume containing: 
2.5 µl (1×) 10 × buffer; 
1 µl (10 U) BamHI (10 U/µl); 
1 µl (10 U) HindIII (10 U/µl); 
5 µl PCRII product; and 
15.5 µl NFW to top the volume to 25 µl. 
Set 2 - a single digestion reaction with BseNI (Thermo Fisher Scientific, Germany) at 
65 °C for 2 h containing: 
2.5 µl (1 ×) 10 × buffer; 
1 µl (10 U) BseNI (10 U/µl); 
5 µl PCRII product; and 
16.5 µl NFW to top the volume to 25 µl.  
Digestion products were resolved on 2% agarose gel stained with ethidium bromide 
run at 10 V/cm length of the gel for 45 min. Patterns of electrophoretic separation were 
visualized and photographed under ultraviolet (UV) light (Fig. 2-4A; Table 2-4). 
Alternatively, the RFLP products were resolved by capillary electrophoresis on a 
fragment analyzer (Advance Analytical Technical, USA). ProSize software version 2.0 
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(Advance Analytical Technical, USA). Further analyses on the RFLP fragments were 
done using an R script (141) customized for expected fragments of the PCR-RFLP 
genotyping (Table 2-4).  
To identify A. merus TEP1*S1 alleles that lacked HindIII site, a 1034±1 bp PCRII 
fragments were amplified and subjected to a double BamHI and NcoI digest (Fig. 2-3B; 
Fig. 2-4B; Table 2-5). Similar to *S, the *R3 allele also had an NcoI site at the same 
positions 2605-2610 (α0 loop M844).  
For samples that could not be genotyped by the PCR-RFLP genotyping methods, I 
designed a PCR-based genotyping (Fig. 2-3A; Table 2-6). To this end, published TEP1 
allele-specific PCR primers were modified (7, 8) to allow genotyping of all the known 
alleles.  
Fig. 2-4. Expected PCR results for TEP1 genotyping of *R1, *R2, *S1 and *S2 alleles. 
(A) Fragments of expected sizes produced as a result of digest of the amplified region of TEP1
were used for allele determination. Digest with BamHI identifies *R alleles at the α7 loop, while
digest with HindIII only cuts *S amplicons at pre-α12 loop. Digestion with BseNI cuts only *R2
and *S1 amplicons at the pre-α4 and β-hairpin loops respectively. The last panel shows
representative results of TEP1*S1/S1 A. merus from Kenya.
(B) Results of TEP1 nested PCR-RFLP genotyping using modified primers and the NcoI
restriction site at α0 loop M844 instead of the HindIII digestion. Sequencing and the NcoI
restriction pattern confirmed the identity of TEP1*S1/S1 samples. The same method was used to
genotype *R3 allele.
(C) TEP1 PCR-based allele-specific genotyping strategy was used to confirm the results of PCR-
RFLP if necessary. The results are from the multiplex PCR with all 7 primers, NC is a negative
control. The name and color codes on the gel correspond to each allele. Note that the best results
were achieved by using primer pairs for 1 to 2 alleles at a time.
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Table 2-4. Expected RFLP fragment sizes (bp) of TEP1 genotypes 
resulting from a digest of the 758-bp TEP1 amplicon. 
 Restriction enzyme and expected fragment sizes 
TEP1 genotype BamHI+HindIII BseNI 
S1/S1 656, 102 537, 221 
S1/S2 656, 102 758, 537, 221 
S2/S2 656, 102 758 
R1/R1 399, 359 758 
R1/S1 399, 359, 656, 102 758, 537, 221 
R1/S2 399, 359, 656, 102 758 
R2/R2 399, 359 657, 101 
R2/S1 399, 359, 656, 102 537, 221, 657, 101 
R2/S2 399, 359, 656, 102 758, 657, 101 
R2/R1 399, 359 758, 657, 101 
R3/R3 399, 359 758 
R3/S1 399, 359, 656, 102 758, 537, 221 
R3/S2 399, 359, 656, 102 758 
R3/R1 399, 359 758 
R3/R2 399, 359 758, 657, 101 
Table 2-5.  Expected RFLP fragment sizes (bp) of TEP1 genotypes resulting from a 
digest of the 1034±1 bp TEP1 amplicon. 
 Restriction enzyme and expected fragment sizes 
TEP1 genotype BamHI+HindIII BamHI+NcoI BseNI 
S1/S1 930, 103 146, 887 811, 222 
S2/S1 930, 103 146, 887 1033, 811, 222 
S2/S2 930, 103 146, 887 1033 
R1/R1 674, 360 674, 360 1034 
R1/S1 674, 360, 930, 103 674, 360, 146, 887 1034, 811, 222 
R1/S2 674, 360, 930, 103 674, 360, 146, 887 1034*, 1033* 
R2/R2 674, 360 674, 360 376, 658 
R2/S1 674, 360, 930, 103 674, 360, 146, 887 811, 222, 376, 658 
R2/S2 674, 360, 930, 103 674, 360, 146, 887 1033, 376, 658 
R2/R1 674, 360 674, 360 1034, 376, 658 
R3/R3 675, 360 527, 360, 148 1035 
R3/S1 675, 360, 930, 103 887, 527, 360, 146*, 148* 1035, 811, 222 
R3/S2 675, 360, 930, 103 887, 527, 360, 146*, 148* 1035*, 1033* 
R3/R1 675*, 674*, 360 674, 527, 360, 148 1035*, 1034* 
R3/R2 675*, 674*, 360 674, 527, 360, 148 1035, 376, 658 
*
Fragments have close size ranges and would appear as one overlapped fragment.
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2.3.4 TEP1 sequencing and sequence analyses 
The TEP1-TED 758 bp amplicons were cloned either into pGEM-T Easy (Promega, 
USA) vector or pjet1.2 vector (Thermo Fischer Scientific, USA). The clones were 
sequenced from both orientations (Eurofins, Germany). Sequence chromatograms were 
curated and aligned using the Bioedit version (139). Various sequence manipulation 
free-hosted tools in justbio.com and http://www.bioinformatics.org/sms2/ were used for 
in silico translation of the sequences into amino acids as well as digestions with BamHI, 
HindIII and BseNI restriction enzymes. DnaSP version 5.0 (142, 143) was used to 
analyze DNA polymorphism and neutrality tests such as Tajima’s D tests, Fu & Li's D 
to infer selection pressures. TEP1 DNA sequences were collapsed into network of allele 
haplotypes using TCS1.21 (144). The TCS1.21 software uses a statistical parsimony to 
infer gene genealogies. It generates genealogy network based on mutational steps that 
separate or connect the haplotypes and is able to detect back mutations. 
Both TEP1-TED nucleotide and amino acid sequence alignments were used for 
phylogenetic analyses. Jmodeltest (145) was used to choose the most optimal nucleotide 
substitution model for the DNA sequence data sets (145, 146). The Jmodeltest analyses 
suggested parameters of K80 (147) with invariable sites and gamma rate of evolution. 
DNA sequences were translated into amino acid sequences as done above. Distance-
Table 2-6. Expected fragment sizes (bp) from TEP1 PCR-based genotyping. 
Allele-specificity of the primer and expected fragment sizes 
TEP1 genotype *R *R1 *R2 *R3 *S *S1 *S2
R1/R1 583$ 148 - - - - - 
R1/R2 583$ 148 475$ - - - - 
R1/R3 583$ 148 - 583 - - - 
R1/S1 583$ 148 - - 466 206 - 
R1/S2 583$ 148 - - 466 - 311$
R2/R2 583$ - 475$ - - - - 
R2/R3 583$ - 475$ 583 - - -
R2/S1 583$ - 475$ - 466 206 - 
R2/S2 583$ - 475$ - 466 - 311$
R3/R3 583$ - - 583 - - - 
R3/S1 583$ - - 583 466 206 - 
R3/S2 583$ - - 583 466 - 311$
S1/S1 - - - - 466 206 - 
S1/S2 - - - - 466 206 311$ 
S2/S2 - - - - 466 - 311$ 
$
When VB228 (*S2 - and *R- specific) primer is used in PCR instead of VB224.
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based neighbor-joining and maximum likelihood-based phylogenetic algorithms on the 
sequences were performed using MEGA6 (148), PhyML 3.0 (149) and BEAST (150) 
and produced similar tree topologies. The reliability of these analyses was evaluated by 
bootstrap tests with 1000 replications. All the positions with gaps and missing data were 
eliminated from the dataset. Phylogenetic trees were annotated in MEGA6 (148), and 
adobe illustrator CS5 and Photoshop CS5 (Adobe Systems, California USA). Full-
length multiple sequence alignments presented in the Appendix 5 and Appendix 6 were 
done with Kalign in http://www.ebi.ac.uk/Tools/msa/ and Boxshade in 
http://www.ch.embnet.org/software/BOX_form.html online platforms. 
2.3.5 Statistical analyses 
The data on alleles and genotypes were analyzed in R. version 3.1.3 (2015) (141). 
Customized R scripts and R-packages: r genetic package and standard graphical 
packages such as plyr, ggplot2, reshape2, gridExtra, cowplot for data manipulation and 
plotting of graphs (Appendix 1D). Chi-Square tests were used to analyse for deviations 
from expectations of the Hardy Weinberg Equilibrium. Part of the R scripts is provided 
in the Appendix 2 and Appendix 3. 
2.4 Results 
 2.4.1 Overview of study countries and A. gambiae s.l. samples 
 A total of 1556 of Anopheles s.l. mosquitoes were sampled from Mali, Burkina 
Faso both in West Africa, Cameroon in Central Africa, and Kenya in East Africa, and 
were molecularly identified to species level (Fig. 2-5A). 
Fig. 2-5. Composition of A. gambiae 
s.l. samples from sub-Saharan African
countries.
The samples that were collected in
Mali, Burkina Faso, and Cameroon
were A. coluzii and A. gambiae s.s.. In
Kenya, A. arabiensis, A. gambiae s.s.
and A. merus were collected. The
stacked bar charts show species
distribution and the numbers in them
represent the number of samples
collected in each country per species.
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This constituted the following mosquito species: A. coluzzii (n = 116) and A. 
gambiae s.s. (n = 150) in Mali; A. coluzzii (n = 112) and A. gambiae s.s. (n = 47) in 
Burkina Faso; A. coluzzii (n = 210) and A. gambiae s.s. (n = 643) in Cameroon; and A. 
arabiensis (n = 84), A. gambiae s.s. (n = 139) and A. merus (n = 49) in Kenya. 
 2.4.2 TED region resolves natural TEP1 variation into distinct allelic 
subclasses 
 To characterize TEP1 genetic variation in the field-sampled malaria vectors, first a 
robust high-throughput TEP1 genotyping approach was developed. To do this, mosquito 
samples from Cameroon (n = 21) and Mali (n = 2) were used to amplify and sequence 
full-length TEP1 genomic sequences, representing *R1, *R2, *S1 and *S2 allelic 
subclasses.  
The sequences were curated to correct ambiguous base calls, and subsequently, all 
the 11 introns were trimmed off leaving only 4014 bp DNA coding sequences for 
analyses. Allele-specific SNPs located at the TED region were used to categorize TEP1 
sequences into *R1, *R2, *S1 and *S2 allelic subclasses. The full-length TEP1 
sequences of field collected samples were aligned together with those from four 
laboratory strains; L3-5 (*R1), 4Arr (*R2), G3S3 (*S1) and 4Arr (*S2) bearing *R1, 
*R2, *S1 and *S2 alleles, respectively. 
To characterize distribution of synonymous (dS) and non-synonymous (dN) 
mutations in TEP1 full-length sequences, cumulative behaviour of dS and dN 
substitutions was calculated. Results reveal unique differences in the substitution and 
selective pressure regimes (Fig. 2-6). Specifically, *R1 alleles had excess of dN 
compared to dS substitutions (0 - 10), *R2 alleles had the most balanced dS and dN (0 - 
3), *S1 alleles featured excess of dS compared to dN substitutions (0 - 20) with the 
widest allele diversity, and *S2 alleles also had excess of dS compared to dN 
substitutions (0 - 5) but it remained fairly constant over the gene locus.  
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Analysis of DNA polymorphism was carried out using the DnaSP version 5 (142, 
143) within and between allele classes. No significant differences were observed with 
the neutrality tests; Tajima’s D, Fu and Li's D and Fu and Li's F statistics (Table 2-7).  
However, sliding window analyses revealed highest levels of nucleotide diversity 
(Pi) scores at the TED region (0.01 - 0.09) as compared to other domains (0 - 0.03) (Fig. 
2-7A).  
 
Fig. 2-6. Codon diversity and variability in behavior of dN and dS substitutions reveals allele-specific 
selective forces acting on TEP1 locus. Full-length coding DNA sequences *R1 (n = 2), *R2 (n = 4), *S1 (n 
= 8) and *S2 (n = 13) were used to calculate codon-based cumulative synonymous (dS) and non-
synonymous (dN) substitutions using SNAP online platform (151, 152) . Codon data were exported to R 
for plotting (141). 
 
Table 2-7. Neutrality test on TEP1 full-length coding sequences. 
 
Statistics 
Allele  
All alleles *S1 *S2 *R1 *R2 
Tajima's D -0.02 0.44 -1.00 NA -0.79 
Fu and Li's D -0.07 0.65 -1.45 NA -0.79 
Fu and Li's F -0.07 0.67 -1.52 NA -0.84 
Sequences No. 26 8 12 2 4 
Haplotypes No. 20 7 7 2 4 
Haplotype diversity 0.98 0.96 0.89 1.000 1.000 
Variable sites No. 367 65 35 15 78 
Total mutations 375 67 35 15 78 
Nucleotide diversity/site 0.024 0.007 0.002 0.004 0.010 
NA = Not applicable      
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To validate whether variability at the TED region mirrors that of the full-length 
TEP1, I performed neighbor joining sequence comparison of TEP1 full-length and TED 
sequences (highlighted with a dotted window in Fig. 2-7A). Phylogenetic trees based on 
the alignment of full-length (left) and TED region (right) showed similar topologies 
(Fig. 2-7B, left panel; Fig. 2-7B, right panel), although full-length sequences contained 
more information for fine resolution of the *S2 allele cluster. Therefore, this study 
entirely focused on the TED region and used it to develop a high throughput nested 
TEP1 PCR-RFLP genotyping approach. Five genetic markers corresponding to BamHI, 
HindIII, NcoI and BseNI restriction sites were identified and validated in the PCR-
RFLP method for typing all the alleles used in this study (see Materials and Methods). 
2.4.3 TEP1 genotypes across Africa 
 To identify distribution of TEP1 genotypes in the selected mosquito populations, a 
total of 1556 mosquitoes were genotyped. Overall, 11 (five homozygous and six 
heterozygous) TEP1 genotypes with varied frequencies were identified across Africa 
(Fig. 2-8; Fig. 2-9; Fig. 2-10A-C). An R-script used to generate Fig. 2-9 and Fig. 2-10 
is provided in the Appendix 2B-C. 
Fig. 2-7. Genetic diversity of TEP1 locus. 
(A) Sliding window plot of nucleotide diversity of full-length coding sequences over TEP1
protein coding sequence. In total, 27 sequences as used in Fig. 2-6; Cameroon (n = 21),
Mali (n = 2) and laboratory strains (n = 4) representing four allelic subclasses were used.
Highlighted in dotted window is the 758 bp TED region that was used to develop high
throughput TEP1 genotyping approach.
(B) Comparative topology of two neighbor-joining (NJ) trees (50% cut-off values, 1000
bootstrap replicates, number of differences) for 4014 bp full-length (left) and 758 bp TED
(right) sequences.
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Fig. 2-8. Global distribution of TEP1 genotypes in Africa.  
Overview of TEP1 genotypes per country across Africa. The 
numbers below each column represent the number of genotyped 
individuals. Abbreviations of countries are as follows: ML, Mali; BF, 
Burkina Faso; CM, Cameroon; and KE, Kenya. 
 TEP1*S1/S1 genotype was the most common genotype present in all the countries. 
TEP1*R2/S1 and *R2/R2 were also found in all countries but at lower frequencies. The 
*R1/R1 genotype was only found in Mali and Burkina Faso. In Mali, Cameroon and 
Kenya, *S2/S2 genotypes were detected albeit at low frequencies. Interestingly, high 
number of *S1/S2 genotypes was observed in Cameroon. Interestingly, a new *R-type 
allele, hereafter named *R3, was found in A. merus populations along the coastal Kenya 
(Fig. 2-8).  
Comparison between the observed and the expected genotypes using the data set for 
all the countries showed departures from the HWE (Table 2-8; Table 2-9; Appendix 3; 
Appendix 4). To quantify these deviations, population F statistics for subpopulations 
and global population i.e. all combined mosquito subpopulations were calculated using 
Wright´s F statistics (see the R-script in Appendix 3 and the statistical output in 
Appendix 4). Variation was observed in inbreeding coefficients (FS) and/or 
homozygosities (FS <0) between species and sampling sites. A. gambiae s.s. in Mali (FS 
= -0.1) and in some Cameroonian sites (FS = -0.06) has deficiency in homozygotes 
suggesting that they were outbred. In contrast, A. gambiae s.s. populations in Burkina 
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Faso (FS = 0.27) and Kenya (FS > 0) showed excess homozygosity or inbreeding. 
Similarly, in Kenya, A. arabiensis populations had high inbreeding coefficient (FS = 
0.65, -0.58, 0.3).  
2.4.4 Species-specific distribution of TEP1 genotypes 
Does TEP1 genotype distribution vary between species? Fig. 2-9 summarizes 
distribution of TEP1 genotypes in the vector species per country samples in this study. 
Interestingly, moderate frequency of *R1/S1 genotypes were detected in A. coluzzii 
from Mali, whereas in Burkina Faso and in A. gambiae s.s. from Mali these genotypes 
were very rare. Strikingly, we confirm that the divergence between sympatric 
populations of A. coluzzii and A. gambiae s.s. is higher in Mali (FST = 0.47) than in 
Burkina Faso (FST = 0.003) (Table 2-9; Appendix 4), suggesting genetic differentiation. 
I propose that degree of segregation in sympatric species at the TEP1 locus is dependent 
on local breeding habitats. 
Table 2-8. Inbreeding coefficient (Fs). 
Country Site Species Hom HETObs HETExp Fs χ2cal Statistic 
ML NK A. col 10 0.19 0.27 0.30 df = 3, χ2cal = 10.07* 
ML NK A. gam -5.3 0.37 0.34 -0.10 df = 3, χ2cal = 2.09
BF SM A. col -2.7 0.5 0.49 -0.03 df = 1, χ2cal = 0.01
BF SM A. gam 24.3 0.34 0.47 0.27 df = 3, χ2cal = 4.51 
CM MV A. col 2.7 0.48 0.49 0.03 df = 3, χ2cal = 0.90 
CM MV A. gam 3.1 0.44 0.46 0.04 df = 3, χ2cal = 9.46* 
CM NS A. col -0.46 0.50 0.50 0.00 df = 3, χ2cal = 0.53 
CM NS A. gam -3.7 0.39 0.36 -0.06 df = 3, χ2cal = 48.69*
CM MF+ND+NM A. col -12.0 0.5 0.43 -0.16 df = 3, χ2cal = 1.88
CM MF+ND+NM A. gam -3.5 0.38 0.35 -0.06 df = 3, χ2cal = 31.52*
KE AH A. ara 0.6 0.17 0.48 0.65 df = 1, χ2cal = 25.57* 
KE AH A. gam 0.82 0.08 0.50 0.83 df = 1, χ2cal = 8.31* 
KE BT A. gam 0.07 0.23 0.28 0.19 df = 3, χ2cal = 7.62 
KE KK A. ara 0.53 0.20 0.48 0.58 df = 1, χ2cal = 4.31* 
KE KK A. gam 0.15 0.07 0.20 0.63 df = 1, χ2cal = 10.55* 
KE MD A. ara 20.7 0.29 0.41 0.3 df = 1, χ2cal = 0.63 
KE MD A. mer 32.2 0.34 0.50 0.32 df = 6, χ2cal = 56.46* 
Hom = Homozygosity; HETObs = Observed heterozgosity;  HETExp = Expected heterozgosity; 
Fs = Local inbreeding coefficient; Asterisk (*) indicates χ2 significant deviation from the HWE at p<0.05. 
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Higher numbers of TEP1*S1/S2 mosquitoes were identified for A. coluzzii in 
Cameroon (Fig. 2-9). In addition, *S2/S2 homozygotes were predominantly found in A. 
coluzzii in Cameroon, whereas this genotype was very rare in other countries and 
species. 
 
Fig. 2-9. Global view of mosquito vector population species and TEP1 genotypes. 
Overview of TEP1 genotypes per species in Mali (ML), Burkina Faso (BF), 
Cameroon (CM), Kenya (KE). The numbers below each column indicate the 
number of genotyped individuals.  Asterisk (*) indicates significant deviation from 
the HWE expection. 
Table 2-9. Population Wright´s F-statistics in sympatric mosquito populations. 
Country Site Species Hi Hs Ht FIS FIT FST 
ML NK Col-gam 0.29 0.31 0.59 0.05 0.50 0.47 
BF SM Col-gam 0.37 0.47 0.47 0.21 0.21 0.003 
CM MV Col-gam 0.47 0.46 0.49 -0.02 0.04 0.06 
CM NS Col-gam 0.42 0.36 0.42 -0.16 -0.01 0.13 
CM MF+ND+NM Col-gam 0.38 0.35 0.36 -0.08 -0.07 0.01 
KE AH Ara-gam 0.15 0.48 0.49 0.68 0.69 0.01 
KE KK Ara-gam 0.09 0.24 0.26 0.61 0.64 0.08 
KE MD Ara-mer 0.33 0.49 0.55 0.32 0.12 0.40 
Hi = Observed heterozygosity; Hs = Sum of expected heterozygosity within one subpopulation; 
Ht = Sum of expected heterozygosity in all populations; Fis = Inbreeding coefficient; FST = 
Wright´s standard variance (population differentiation index) between demes; and FIT = Deviation 
from the expected HWE proportions. 
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In Kenya, TEP1*R3/R3 and *R3/S1 genotypes were only found in A. merus. A. 
arabiensis species were enriched for *R2/R2 and *S1/S1 homozygotes with 
proportionally low number of *R2/S1 heterozygotes. Interestingly, similar enrichment 
of *R2/R2 and *R2/S1 genotypes was observed in A. merus, whereas very low 
frequencies of *R2/R2 and *R2/S2 heterozygotes were detected in Cameroon. In Kenya 
and to the least extent in Mali, the *S2/S2 genotypes appeared at low frequencies. 
2.4.5 Local-specific biotope factors determine TEP1 genotype distribution 
How are TEP1 genotypes stratified at the species and habitat level across Africa? In 
Mali, A. coluzzii and A. gambiae s.s. populations breed in sympatry (Fig. 2-10A). We 
detected A. gambiae s.s. *R1/S1 individuals as well as low number (1%) of A. coluzzii / 
A. gambiae s.s. hybrids with *R1/R1 (n = 2) and *R1/S1 (n = 1) genotypes (Fig. 2-10A)
but no hybrids were found in Burkina Faso. 
In Cameroon, sympatric A. coluzzii and A. gambiae s.s. mosquitoes from the five 
different districts (Mfou, Mvan, Nkolondom, Nkolkoumou and Nkolbisson) were 
collected (Fig. 2-10B). Across all the Cameroon sampling sites, an average ratio of 
*S1/S2 to *R2/S1 individuals in sympatric A. coluzzii and A. gambiae s.s. populations
was 2:1. In addition, this ratio was switched in A. gambiae s.s. to A. coluzzii species to 
1:2. Further, the Cameroon-restricted *S1/S2 genotypes (~30%) showed a negative 
correlation with *R2/S1 genotypes (>15%). The few A. coluzzii / A. gambiae s.s. hybrids 
in Cameroon (1.5%) featured *R2/S1 (n = 4) and *S1/S1 (n = 2) genotypes (Fig. 2-10C). 
To calculate the inbreeding coefficient and F-statistics, Cameroon’s sympatric 
populations in Mfou, Nkolondom and Nkolkoumou were merged since proportions of 
A. gambiae s.s. were similar (>90%), compared with Mvan (25%) and Nkolbisson
(69%). In breeding coefficients (Fs >0.19, FST >0.3) were higher in Kenya than those in 
Mali, Burkina Faso and Cameroon (Table 2-8; Table 2-9; Fig. 2-10). In addition, the 
Wright´s fixation indices (Table 2-9) showed marked variation in species pairwise 
comparisons across Africa suggesting existence of population structure at the TEP1 
locus. These analyses were not done for Kilifi and Kwale sites due to low sample sizes. 
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Fig. 2-10. Sampling sites and distribution of TEP1 genotypes per species per site. 
(A) Sampling sites and distribution of TEP1 genotypes in Mali and Burkina Faso. Abbreviations of 
mosquito vector species are as follows: A. col, A coluzzii and A. gam, A. gambiae s.s.. Hybrid refers 
to rare offspring resulting from natural crossbreeding between A. coluzzii and A. gambiae s.s. 
species.  The numbers shown below each stacked bar chart in A-C, represent the sample sizes of 
the genotyped individuals per species per site.   
(B) Sampling sites and distribution of TEP1 genotypes in Cameroon.  Abbreviation of mosquito 
vector species A. col and A. gam are as in A.  
(C) Sampling sites and distribution of TEP1 genotypes in Kenya: Abbreviation of mosquito vector 
species A. ara, A. arabiensis; A. gam, A. gambiae s.s. and A. mer, A. merus.  Asterisk (*) indicates 
significant deviation from HWE tests using a conservative χ2 that corrects for small size sample 
numbers. See page 23 and the statistical output in Appendix 5. 
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2.4.6 Allelic frequencies and inference of genetic relationship 
Allelic frequencies were calculated for the merged sites from the TEP1 genotype 
data (Fig. 2-11). An R-script used to generate this figure is provided in Appendix 3D. 
Some alleles were either completely absent or very rare in certain species and in certain 
sampling locations (Fig. 2-10A-C; Fig. 2-11). TEP1*S2 was mostly common in 
Cameroon, less abundant in Mali and Kenya but absent in Burkina Faso. Significant 
deviation from the HWE was observed for *R2, *S1 and *S2 alleles in sympatric A. 
coluzzii and A. gambiae s.s. population in Cameroon and in A. coluzzii populations in 
Mali. Significant deviations from the HWE expectations were also evident among 
populations of A. merus and A. gambiae s.s. in coastal Kenya, and A. gambiae s.s. and 
A. arabiensis in western Kenya (Fig. 2-11).
Fig. 2-11. Global TEP1 allele frequencies across Africa. 
Overview of distribution of allele frequencies across African countries. Abbreviations of sampling 
locations and sites are as follows, ML, Mali; VK5, Vale de kou 5; VK7, Vale de kou 7; SM, Somousso in 
Burkina Faso; CM, Cameroon (MF, Mfou; MV, Mvan; ND, Nkolondom; NM, Nkolkoumou and NS, 
Nkolbisson were merged); WK, western Kenya (AH, Ahero; KK, Kakamega and BT, Busia Teso were 
merged), and CK, coastal Kenya (KW, Kwale; KL, Kilifi and MD, Malindi were merged).  The numbers 
along the x-axes represent the number of sampled alleles. Asterisk (*) indicates significant deviation from 
the HWE expectations. 
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While the *R2 and the *S1, and to a lesser extent the *S2 alleles were conserved 
across Africa, the private *R1 in A. coluzzii and *R3 in A. merus were not only the most 
diverse, but also showed geographical- and species-specific patterns. In overall, *S1 
allele appears to be the most compatible allele with all the others as confirmed by the 
occurrence of the *R1/S1, *R2/S1 and *S1/S2 homozygotes. Therefore, our results 
uncovered marked differences in the distribution of TEP1 alleles and/or genotypes 
between and within the sampling sites as well as between the species.  
2.4.7 Sequence analyses 
To interrogate the genetic relationship and diversity of the alleles, the TED region 
of 195 (including 3 more from our G3 laboratory strains, to make 198 in total) 
representative alleles from different species across all the surveyed countries was 
sequenced and subjected to phylogenetic analyses using various amino acid substitution 
models, and all showed similar allele clustering (Fig. 2-12). The 198 TED nucleotide 
sequences were deposited in the NCBI GenBank under the accession numbers 
MF035727 to MF035924. A few of published sequences representing different TEP1 
alleles from field-caught (6) and laboratory mosquitoes were included in the analyses.  
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The Neighbor Joining (NJ) phylogenetic analyses confirmed a clear separation of 
TEP1 alleles into *S and *R clades. TEP1*S further splits to form two clusters of *S1 
and *S2 subclasses. For *S1 alleles, no clear pattern of species-species or geographic 
clustering was evident. The majority of *S2 alleles originated from Cameroon samples, 
and showed apparent divergence from the only one *S2 from western Kenya and from 
the laboratory G3 strain. TEP1*R segregated into three clusters of *R1, *R2 and *R3, 
with *R3 at the root of the clade. 
Fig. 2-12. Geodiversity of surveyed species stratified by TEP1 alleles across Africa. 
A. gambiae s.l sampled across four geographically diverse sub-Saharan countries. TEP5 and TEP6 were
used as outgroup taxa.  The 198 TED nucleotide sequences from our data set were deposited in the NCBI
GenBank under accession numbers MF035727 to MF035924. Sequences of other published TEP1*S1, *R1
and *R2 alleles; laboratory (n = 5), and field-caught mosquitoes (6) (n = 9) indicated by countries and
accession numbers were included in the alignment.  In total, the analyses involved 212 amino acid
sequences in MEGA6 (p-distance parameters, 1000 replicates, 50% cut-off). Color codes of the tree
branch represent alleles as follows: Green, *S1; light green, *S2; blue; *R1; light blue, *R2; and pink, *R3.
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Next, TEP1 sequences were separated into haplotypes using TCS 1.21 software 
(144). The software infers gene genealogies based on statistical parsimony, and depicts 
mutational steps (nucleotide substitutions) that separate or connect different groups of 
haplotypes. Fig. 2-13A, left panel, highlights a simplified DNA nucleotide genealogy 
network (not to scale) of major haplotypes across Africa. The NJ tree in Fig. 2-13B, 
displays relatedness of all the haplotypes shown in Fig. 2-13A. 
The TED genealogy network and phylo-geography of TEP1 haplotypes led us to 
suggest that: 1) TEP1 alleles cluster independent of species and geography; 2) *R2 is 
the most conserved allele as revealed by the highest number (28) of shared haplotypes 
across the countries and species; 3) *R2 and *S1 are the most widespread haplotypes in 
all countries and in all species; 4) the major *R and the *S alleles groups are separated 
by the highest number of mutational steps (57), whereas the lowest number of 
mutational steps (>10) was observed within allelic subclass haplotypes; 5) based on the 
TED, the newly identified *R3 allele is closer to *R2 (33 steps) than is to *R1 (35 steps).  
 
Fig. 2-13. Genealogy network and geodiversity of TEP1 haplotypes.  
(A) Schematic representation (not to scale) of genealogical network (left panel) of major haplotypes of the 
TED sequenced alleles that were inferred by the TCS software. Each oval shapes groups represent a 
haplotype composed of the species/strain and/or country of origin. The numbers in the left panel between 
each haplotype cluster represent number of nucleotide mutational steps or SNPs separating them.  
(B) Neighbor joining tree (right panel) of the same haplotypes. The numbers in the right panel shown in 
brackets represent the actual number of individual alleles sharing the same haplotype. Abbreviations of the 
sampling sites or countries are as before. In both panels, different laboratory mosquito strains whose allele 
sequences were included are G3 (*R1, *R2 and *S2), G3S3 (*S1), Suakoko (*S1), 4Arr (*R2 and *S2), and 
L3-5 (*R1). 
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2.4.8 TEP1*R3 allele displays unique amino acid substitutions 
To assess the features of TEP1*R3 allele, its sequences was translated in silico to 
amino acid residues. Amino acid substitutions within the TED were compared against 
the sequences from this study and those from other reports (5, 8, 35, 76, 77) (Fig. 2-14). 
Strikingly, *R3 substitutions were localized in the hypervariable loops i.e. loop before 
α-helix 4 (pre-α4 loop), catalytic loop and ß-hairpin loop (Fig. 2-14A). 
Amino acid residues E1043 and D1058 in the ß-hairpin loop and K966, E970 and 
E974 in the catalytic loop were conserved in *R1, *R2 and *R3. The *R1 and *R2 forms 
shared the same amino acid residues with *R3 except three *R1 to *R3 substitutions at 
N919G, N937K and V946M, and two *R2 to *R3 substitutions at T918S and A936S. 
Indeed, TEP1*R1, *R2 and *R3 also shared conserved residues at the pre-α4 loops 
L914, T917, T918 and G920. Moreover, TEP1*R3 shared conserved residues with *S 
forms at positions S918, N936, S940, S960, T991, A1005, and N1012. However, it 
featured private amino acid substitutions outside the catalytic loop. These are M1021 at 
pre-α8 and positions R1065 and K1067 at α-helix 10. 
Relatedness of *R3 to both the *R and *S forms at the TED region was unexpected, 
therefore I extended the analyses to introns and exons of the full-length gene (Fig. 2-
14B). For this, allele full-length genomic sequences were amplified and sequenced from 
*R3/R3 (n = 2), *R1/R1 from Mali (n = 1), *R2/R2 from Mali (n = 1), *R2/R2 from
Kenya (n = 2) and *S1/S1 Kenya (n = 2). 
In this analysis of homozygote mosquitoes, I used six primer pairs to amplify the 
full-length gene in overlapping PCR fragments (see Materials and Methods). While all 
fragments from *R3 from Kenya, *R2 from Mali and *R1 from Mali were successfully 
amplified and sequenced (Appendix 5; Appendix 6), I failed to amplify *R2 from Kenya 
using the pair of primers for the third fragment. 
TEP1 gene has 11 intronic segments (Appendix 5), which were trimmed off for 
analysis of the coding sequence. To visualize sequence alignments, NJ trees of the full-
length nucleotide and amino acid sequences were constructed, similar tree topologies of 
allele segregation to those in Fig. 2-12 and Fig. 2-13, were obtained (Fig. 2-14C). 
Amino acid modifications outside the TED region were assessed by aligning the 
full-length coding sequences of the *R3 form together with those of *R1, *R2, *S1 and 
*S2 (Appendix 6). Additional *R3 private amino acid modifications were found in
MG3, MG5, MG7 and MG8 domains (Table 2-10; Appendix 5; Appendix 6). 
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Next, polymorphism in the introns was evaluated by joining all the trimmed 11 
intronic sequences to form a continuous contig of 807 bp sequence, which was used for 
the NJ alignment. Sliding window analyzes showed a marked variation in nucleotide 
diversity along the gene sequence. The diversity was low in introns 1 to 7 (0-0.05) and 
higher in the introns 8 to 11 (0.05-0.23), suggesting that high levels of genetic diversity 
around TED in the coding regions are in concert with high levels of genetic diversity in 
the noncoding sequences (Fig. 2-14B). In addition, the *R3 allele has nucleotide 
substitutions that decorate the introns 1-6 and 8-9, substitutions and insertions in the 
intron 7, only insertions in intron 11, but intron 10, which was allele-specific, did not 
have any modifications compared to *R1, *R2, *S1 and *S2 alleles (Fig. 2-14C).  
 
 
 
Table 2-10. TEP1*R3 full-length amino acid modification.  
  Amino acid substitution 
Position Domain *R/*S *R3 
266 MG3 D E 
289 MG3 D N 
489 MG5 R/K M 
742 MG7 Y C 
759 MG7 L F 
760 MG7 I V 
1005 TED E/N A 
1021 TED I M 
1065 TED G/N R 
1067 TED T K 
1223 MG8 Q/E K 
    
Chapter 2 TEP1 genetic diversity 
60 
Fig. 2-14. Overview of unique TEP1*R3 amino acid and nucleotide sequence variability. 
(A) Comparison of TEP1*R3 amino acid residues with those of other alleles at the TED. TEP1*R3
private SNPs are mapped on TEP1*R1 structure. The conserved catalytic histidine (H972) and
TEP1*R3-specific substitutions are shown as colored sticks. The TED peptide is shown as a cartoon
in grey and TE (thioester) as a red bubble. Hypervariable pre-α4, catalytic and β-hairpin loops are
shown in green, blue and light yellow colors respectively.  Amino acid alignment displays
comparison of TEP1*R3 residues with that of other alleles in pre-α4 (913-920), catalytic (966-972)
and ß-hairpin (1054-1067) loops. The pink asterisks below the alignment indicate four positions of
TEP1*R3 amino acid substitutions (A1005 and M1021 found in most *R3 haplotypes, and R1065
and K1067 found in all *R3 haplotypes). Amino acid residue groups are colored as follows; AVLIM
(gray), G (yellow), FY (purple), N (green), ST (Turquoise), DE (red), KR (Blue). The TEP1*R1
structure was adapted from Le et al., 2012 (76).
(B) Sliding window plots compare nucleotide polymorphism between the sequences of exons (left
panel) and introns (right panel). Below the plots are the corresponding TEP1 domain map and 11
introns respectively. Higher intronic nucleotide diversity occurs in the last four introns found in
regions flanking the TED. Higher nucleotide diversity in exons at these parts within and in
neighborhood of the TED that correspond to the C-terminus of the protein. Sequences include two
*R3 full-length sequences. See Appendix 5 and Appendix 6.
(C) Visualization of the alignment showing TEP1 allele separation between coding and intronic
sequences. A neighbor-joining tree (first tree) using amino acid full-length sequences and nucleotide
maximum likelihood (second tree) based on only intronic sequences. The NCBI Genbank accession
numbers of TEP1 full-length sequences are MF098568 to MF098592. The table highlights *R3
modifications in the introns. Below it, is a schematic map depicting the positions of the 11 introns in
the genomic TEP1 sequence. For details, see Appendix 5 for complete sequence alignment.
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2.5 Discussion 
Evolution of immune genes is functionally constrained by predominantly purifying 
selection in order to conserve their role in immunity, hence detecting evidence of sites 
under positive selection is very rare (100). Fixed TEP1 allele-specific SNPs at the TED 
region provide clear inter-allelic differences (5, 76, 77). The TED allele-specific SNPs 
that were used in PCR-RFLP to genotype TEP1 in mosquito populations were robust in 
resolving all the TEP1 alleles (80). Importantly, the method may become a useful tool 
for high throughput TEP1 genotyping that can be easily performed in the field.  
All the four TEP1 alleles (*R1, *R2, *S1 and *S2) previously identified in 
laboratory strains are also found in the natural A. gambiae s.l. complex malaria vector in 
Africa (5, 8, 35). Taking into account the newly identified A. merus *R3 allele, a full 
panmixia scenario predicts 15 possible TEP1 genotypes. However, our data identified a 
restricted number of genotypes across Africa. This is partially due to geographical 
separation between the species that carry geographically restricted alleles (for example, 
*R1 in Mali, *R3 in A. merus in coastal Kenya, and *S2 in Cameroon). Therefore, we 
identified only 11 (5 homozygous and 6 heterozygous) TEP1 genotypes across Africa. 
The observed variation in the biogeographic distribution of TEP1 alleles and 
genotypes allowed categorization of genotypes into generalists and specialists. Thus, 
*S1/S1 and *R2/S1 as generalist genotypes since they were identified in all the countries 
and in all species, whereas *R1/R1, *R3/R3, *R3/S1, *S1/S2 and *S2/S2 were 
categorized as specialist (or restricted) genotypes as they show either geographical- or 
species-specific restriction. Note that *R1/S1, *R1/S2 and *R2/S2 were found at very 
low frequencies (<0.05) in regions where specialist alleles exist. Some TEP1 genotypes, 
such as *R1/R2, *R1/R3, *R2/R3 and *R3/S2 were absent in the mosquito populations, 
and therefore were categorized as undetected genotypes. Surprisingly, *R alleles were 
only found in homozygosity or in heterozygosity with *S, suggesting potential 
functional incompatibility between *R alleles. 
In line with the previous reports (8, 35), the *R1/R1 genotype was only found in 
Mali and Burkina Faso. This could result from genetic restriction and adaptation to arid 
habitats in the Sahel region, or some drier Savanna ecotypes. The *S2/S2 genotype 
which was recently associated with higher male reproductive fitness (80), was found 
only in low frequencies in Mali and Kenya. Enrichment of *S2 allele in Cameroon 
indicates that some selection factors may be at work, however, the nature of these 
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factors remains to be investigated. Interestingly, the generalist *S1/S1 and specialist 
*S2/S2 mosquitoes present in Cameroon both contribute to the maintenance of the 
*S1/S2 genotype, as suggested by a high number of Cameroon-restricted *S1/S2 
heterozygotes.  
Although, the frequency (~0.1) of *R3/R3 and *R3/S1 genotypes was very low in 
Kenya, these mosquitoes were sampled inside residential homes using manual 
aspiration method. It is important to highlight here that the reason for the low mosquito 
numbers in Kenya was due to the nature of the sampling plan designed to catch blood 
fed adult mosquitoes in human dwellings. Getting at least one mosquito in a given 
household was precious!  
This study uncovered a well-refined architecture of geographic- and species-TEP1 
genotype variation. The departure of TEP1 genotypes from the HWE expectation 
suggests that one or more of the HWE assumptions are violated, and indicates action of 
some selection forces that drive ecological adaptations in A. gambiae s.l.. High values 
of FST, global fixation indices are indicative of genetic differentiation in all populations, 
suggesting presence of defined local genetic structures at the TEP1 locus. Moreover, 
high inbreeding coefficients in some mosquito populations are indicative of extensive 
inbreeding between the mosquitoes. The *R1/R1 genotypes are present at near-fixation 
in A. coluzzii mosquitoes in Mali and Burkina Faso but absent from Cameroon (8, 35). 
This observation may suggest that as a result of adaptation to different ecological 
niches, A. coluzzii has undergone significant diversification due to geographical and 
reproductive isolation (8, 35). Another important factor may be inter-species 
competition in the breeding sites, for example competitive exclusion of A. coluzzii has 
been observed in wet areas in the absence of A. arabiensis and A. gambiae s.s. (46).  
The presence of rare *R1/S1 genotypes in A. coluzzii and in A. gambiae s.s. and of 
*R1/S2 in A. coluzzii populations may suggest a moderate reciprocal gene flow between 
the species. Alternatively, *R1 might have been selectively eliminated from A. gambiae 
s.s. and the few examples represent some vestigial evidence. Importantly, the absence of 
*R1/R1 genotypes in A. gambiae s.s. populations may be an indication of fitness cost 
associated with this *R1 allele in A. gambiae s.s. By extension, the occurrence of 
*R1/R1 genotypes in natural hybrids between the A. coluzzii and A. gambiae s.s. 
species, suggests that genetic background of A. coluzzii species benefits *R1/R1 
genotype.  
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Most A. merus species were found in salty-water environments in Malindi in 
coastal Kenya, where no A. gambiae s.s. was found likely due to competitive exclusion. 
Therefore, diverse ecological settings provide core niches for diversification and 
adaptation of anopheline species (43). In the salty-water biotopes, the generalist *S1/S1 
genotype is predominant, suggesting that it is not subject to demographic and ecological 
effects in most species, and is under strong purifying selection driving its conservation.  
Cameroon-restricted *S1/S2 genotypes were found both in A. coluzzii and A. 
gambiae s.s., implying that the environmental conditions prevailing in Cameroon drive 
selection for *S1/S2 genotypes. Yet, another consistent observation in Cameroon was 
the higher frequency of *S1/S2 genotypes in A. coluzzii relative to *S1/S2 genotypes in 
A. gambiae s.s., which may imply that functional species-specific differential selection 
for *S1/S2 genotype occurs. This raised the question whether *R2/S1 genotype in A. 
gambiae s.s. could be more competitive than *S1/S2, since the relative frequency 
*R2/S1 genotype was higher in A. gambiae s.s. than in A. coluzzii populations. This 
apparent negative correlation between *R2/S1 and *S1/S2 genotypes and between the 
two species may be interpreted as a signature of competition between the two genotypes 
at the habitat level. Moreover, it appears that this trade-off between *R2/S1 and *S1/S2 
genotypes is species-specific. In contrast, the specialist *S2/S2 genotypes were 
identified in all species at low frequencies in Cameroon, Mali and Kenya. This suggests 
that *S2/S2 is more widespread than *S1/S2 genotypes. 
Mainly, the generalist *R2/R2, *R2/S1 and *S1/S1 genotypes maintain *R2 and *S1 
alleles observed across all countries and in all species. Since all A. gambiae s.l. species 
feature *S1/S1 and *R2/S1 across African ecological ranges, this may be indicative of 
some advantages offered by *R2 and *S1 alleles. Importantly, this allelic combination 
may point to conserved but yet unknown biological functions intrinsic to the *R2/R2, 
*R2/S1 and *S1/S1 genotypes, and hence the *R2 and *S1 alleles. 
The generalist *R2/R2, specialist *S2/S2 and *S1/S2, and rare *R2/S2 genotypes 
maintain *R2 and *S2 alleles in most species. Strikingly, the unique switched pattern in 
genotype frequency in *S1/S2 and *R2/S1 genotypes between A. coluzzii and A. 
gambiae s.s. in Cameroon may suggest that *R2 and *S2 alleles compete with each 
other to confer competitive fitness and/or advantage to the species. It is inferable from 
the data that the generalist *S1 allele is compatible with all the other alleles as 
exemplified by the presence *S1 carriers i.e. *R1/S1, *R2/S1, *R3/S1 and *S1/S2 
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genotypes, hence underpins unknown functional fitness advantage underlying this 
compatibility. 
Studies have suggested that about 5000 years ago, gene flow and recent expansion 
in malaria vectors may be due to active migration including passive transportation 
through human activity (32, 119, 153). Yawson et al. (2007) (99), observed absence of 
hybrids in Ghanaian A. coluzzii and A. gambiae s.s. populations and no species-specific 
genetic differentiation but implicated strong genetic differentiation among diverse 
ecological areas. In far-West Africa, especially in Guinea Bissau, extensive 
hybridization between the two species suggests that this region is a central hybridization 
zone (8, 39, 115, 130). Our study found evidence of low gene flow rate, as exemplified 
by the paucity of observed hybrids between A. coluzzii and A. gambiae s.s.. Due to low 
frequency of hybrids, it will be challenging to determine the natural mating potential of 
these hybrids and their competence for malaria transmission.  
Most generally, striking differences were observed between A. coluzzii genotypes in 
Mali, Burkina Faso and Cameroon, strongly suggesting environmental factors that drive 
the selection of these genotypes. Previous studies suggested that differences in 
ecological niches of the malarial vector karyotypes are particularly important drivers of 
genetic differentiation (102). Variation in ecological niches pushes species to adapt by 
developing special discrete phenotypes as seen in genetic structuring of A. arabiensis 
based on mtDNA ND locus (154). In another study, it was observed that local A. 
arabiensis populating in more arid or hottest ecotypes have darker or melanic skin color 
and bigger body size as compared to A. arabiensis from more humid or cooler regions. 
Moreover, these melanic forms are more frequent and persistent throughout seasons of 
dry spell (154, 155). However, their study did not interrogate the TEP1 genotypes of 
these species. 
Taken together, our data suggest that the distribution of generalist (wide spread) 
and specialist (restricted) genotypes may be associated with ecological adaptation to 
diverse selective constraints such as hosts, pathogens, and climatic stress. (8, 35).  The 
*R1/R1 genotype in A. coluzzii in hybridization zones in far-West is characterized by
extensive outbreeding with other A. gambiae s.s. genotypes, thus, demonstrates a 
correlation between TEP1 locus and eco-geographical partitioning of A. coluzzii. 
Previous studies using chromosomal inversions or microsatellite markers had reported 
separation of A. coluzzii into subpopulations. For instance, arrangements on the 2R 
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chromosome had revealed three A. gambiae reproductive units, called Bamako, Mopti 
and Savanna, where complete reproductive isolation was observed between Bamako 
and Mopti but incomplete isolation between Bamako/Mopti and Savanna (46). 
Interestingly, TEP1 localization on chromosome 3L suggests that it is not linked to the 
inversions that separate Bamako, Mopti and Savanna forms. The correspondence 
between TEP1 polymorphism and these forms remains to be elucidated. 
Deviations from the HWE expectations suggest existence of environmental forces 
(such as climatic or local factors) that operate at the TEP1 locus. As TEP1*S1 and 
*R2 are the most widespread alleles present today across the African countries, they
likely are representing the most conserved ancestral forms spanning over many million 
mosquito generations. The male fertility-associated TEP1*S2 alleles (80) are mostly 
selected in Cameroon but are kept at very low frequencies in Mali and Kenya. 
While the *R2 and the *S1, and to a lesser extent the *S2 alleles are conserved 
across Africa, the A. coluzzii *R1 and the A. merus *R3 private alleles are not only the 
most diverse, but also show geographical- and species-specific pattern. It can be 
inferred that strong directional selection is a driver of this geographical- and species-
specific selection pressures, hence this pattern of local adaptation. 
Moreover, TEP1*R1 and *R3 and, to some extent, *S2 alleles suggest divergent 
evolutionary paths that A. gambiae s.l. developed to confront certain biotic and/or 
abiotic ecological constraints specific to their ecological niches. These differences in 
allele and genotype selections in nature may be, in part, due to differences in the choice 
and stability of breeding habitats (118) or prevailing ecological climates of which local 
factors and geographical isolation significantly render differences in the breeding 
ecology, hence speciation, diversification and selection of fitter genotypes (98, 118). 
The genealogy network and phylo-geographic analyses confirm that TEP1 alleles 
have been maintained in the populations of malaria vector throughout Africa (6, 8, 35), 
with substantially shared polymorphism among species. Although there are more 
haplotypes within the TEP1*S1 alleles (partly due to the oversampling of the sequenced 
*S1 alleles), *S1 haplotypes cluster discretely from the haplotypes of other alleles. This
may be a result of differences in accumulation of diverse ecotype-specific mutations 
that do not switch allele classes, hence the conservation in all countries in all mosquito 
species. The majority of *R2 sequences share a single haplotype, highlighting the 
highly-conserved nature of this allele. According to the coalescence theory (156), the 
Chapter 2 TEP1 genetic diversity 
66 
striking conserved nature of *R2 and, to a lesser degree of *S1 haplotypes, and the 
propensity of both to form heterozygotes, further suggests that they represent the most 
maintained ancestral alleles whose polymorphism in African A. gambiae s.l. populations 
is functionally constrained. 
The striking similarity of TEP1*R3 amino substitutions with those of both TEP1*R 
and TEP1*S forms, led us to suggest that the new allele may be or is closely related to 
an ancestral form of both *R2 and *S alleles. Analyses of the full-length *R3 genomic 
sequences revealed the extent of conservation of this new allele. First, uneven 
nucleotide substitutions and/or indels were identified in all the introns. Uniquely, the 
intron 10 appeared to be allele-specific and did not have any nucleotide modifications 
compared with the *R1, *R2, *S1 and *S2 alleles. Secondly, high nucleotide diversity 
was detected in the introns 8 and before TED and introns 10 and 11 in MG8 suggesting 
functional contrains in both the introns and the exons. Thirdly, seven additional private 
amino acid substitutions in other domains may indicate that they evolve together and 
likely to be important for TEP1*R3 function, which is currently unknown. 
2.6 Conclusion 
The marked divergence between A. coluzzii in Mali and Burkina Faso from A. 
coluzzii in Cameroon suggests partitioning of this species into ecotypes directly or 
indirectly linked to TEP1 locus. Therefore, structure of mosquito populations at the 
TEP1 locus offers an important tool in assessing gene flow radiation and genetic 
dispersal of malaria vectors. This study has successfully used evolutionary genetics and 
molecular tools to understand TEP1 genetic diversity and population genetic structure 
of malaria vector populations in field ecological surveys in West Africa, Central Africa, 
and East Africa. For the first time, this study mapped TEP1 alleles and genotypes in 
four malaria vector species from the four African countries. The SNPs used for TEP1 
genotyping were robust and may be harnessed as genetic or molecular markers for high 
throughput TEP1 genotyping. The data discussed here demonstrate that the genetic 
variation in TEP1 locus shape the population genetic structure in local malaria 
populations. The TEP1 alleles and genotypes are structured according to geography and 
local vector species. The TEP1 genetic diversity that was observed matches different 
African climatic zones suggesting that it enables the mosquitoes to adapt to the 
prevailing environmental conditions. 
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Impact of TEP1 variation on development of P. falciparum 
3.1 Summary 
Little is known about the impact of TEP1 allelic variation on P. falciparum. The 
aim of the project described in this chapter was to examine the impact of TEP1 variation 
on P. falciparum development. To this end, I established a mosquito line that contained 
three TEP1 alleles: *R1, *S1 and *S2. I compared the outcomes of infections with 
human P. falciparum and murine P. berghei between TEP1 genotypes. Interestingly, 
TEP1*S1/S1 and TEP1*S2/S2 appear to be equally susceptible to Plasmodium 
infections. Rearing of the TEP1*R1/R1 homozygous mosquitoes was challenging. Due 
to the high mortality rates, only few mosquitoes homozygous for *R1/R1 were used, 
preventing meaningful statistical analyses. Nevertheless, these preliminary results 
indicate a trend in resistance of TEP1*R1/R1 to P. falciparum infections as compared to 
TEP1*S mosquitoes. High mortality of *R1/R1 mosquitoes suggests that TEP1*R1 may 
be conditional lethal allele, and therefore, future functional experiments with the 
*R1/R1 mosquitoes should be done in their natural ecology in Africa. 
3.2 Introduction 
The highly polymorphic nature of thioester-containing protein 1 (TEP1) in the A. 
gambiae mosquito mediates a powerful immune response against Plasmodium parasites 
during midgut invasion (4, 135, 157). Mosquitoes bearing different TEP1 genotypes 
have distinct phenotype variation in the mode of clearance of P. berghei ookinetes (5). 
In TEP1*R1 mosquitoes, the ookinetes are bound with faster kinetics and dead parasites 
are cleared by both lysis and melanization, compared to TEP1*S alleles which mediate 
killing by lysis only (135). TEP1*R1 mosquitoes display relatively lower P. falciparum 
(3D7 strain) infection rates than TEP1*S (35). However, in TEP1*R1 homozygous 
strains, the Brazilian 7G8 and the African NF54 (the parental strain of 3D7) P. 
falciparum differ greatly in the parasite killing and clearance, suggesting that P. 
falciparum infectivity is dependent on the genetic background of the parasites (158). 
Notably, P. falciparum parasites express P. falciparum surface protein (Pfs47) on the 
ookinetes to enable them to efficiently evade the immune system of the mosquito and 
mature into the oocysts in the midgut (159). Recently, Pfs47 protein was shown to 
mediate the survival of the ookinetes by disrupting the mosquito JNK signaling 
pathways against the parasite (160, 161). Conversely, efficiency of Pfs47 in mediating 
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immune evasion varies between African parasites and other parasites suggesting that 
genetic adaptation of the parasites, genetic differences between the mosquitoes and 
parasite-vector compatibility may play a role (159, 162). Sequencing of P. falciparum 
isolates in Africa and of culture lines failed to detect a correlation between susceptibility 
to TEP1-mediated killing and Pfs47 genotypes (104). These observations suggest that 
TEP1 is an important anti-plasmodial factor for P. falciparum transmission, and that 
genetic variation at Pfs47 locus is not the sole mediator of P. falciparum evasion of 
TEP1 immune responses (104). However, their study did not address the impact of 
TEP1 polymorphism on P. falciparum development. 
In this project, I examined whether TEP1 polymorphism impacts Plasmodium 
development. To this end, parasite loads and prevalence of P. berghei and NF54 P. 
falciparum infections in laboratory mosquitoes bearing TEP1*R1, *S1 and *S2 alleles 
were determined. First, mosquito line, herein named H3T1, bearing TEP1*R1, *S1 and 
*S2 alleles was established. Next, the line was infected with murine P. berghei and 
human P. falciparum parasites to assess the impact of TEP1 genotypes on the 
infections. Results show that TEP1*S1/S1 and TEP1*S2/S2 mosquitoes appear to be 
equally susceptible to Plasmodium infections. Interestingly, a trend for TEP1*R1/R1 
genotype showing resistance to P. falciparum infections was observed. However, the 
TEP1*R1/R1 mosquitoes suffered high mortality rates from one generation to the next, 
therefore, only low numbers of *R1/R1 homozygotes were tested in the infection 
experiments.  
3.3 Materials and Methods 
All the materials (consumables and biological), equipment and software that were 
used in this chapter are listed in Appendix 1. 
3.3.1 Plasmodium berghei strain and maintenance 
P. berghei ANKA (PbGFPcon) (163), murine parasite strain that constitutively 
expresses a green fluorescent protein (GFP) was maintained in vivo using CD1 mice. 
Parasitaemia of the infected mouse was assessed by FACS. 
3.3.2 Plasmodium falciparum strains and maintenance 
All the Standard Operating Procedures of culturing P. falciparum strains were 
followed according to the standard settings of security level 2 (S2) laboratories as per 
the German national regulations of the Landesamt for Gesundheit und Soziales 
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(LAGESO).  The standard P. falciparum strain NF54 (164) and strains; HBC (165), 
NF54HT-GFP-luc (166) , NF165 (104) and 7G8 (158, 167) were routinely cultured. 
3.3.3 Mosquito strains and maintenance 
A. gambiae mosquitoes, Mut6 (TEP1*S1/S1 mutant) (138), Ngousso (TEP1*S1/S1) 
(168), 7b (TEP1*S1/S1 knockdown line)  (78), 4Arr (MR4) (5), L3-5 (TEP1*R1/R1, 
refractory strain to P. berghei) (167, 169) and G3 
(https://www.beiresources.org/Catalog/livingMosquitoes/MRA-112.aspx) were used in 
this study. The G3, is herein referred to as “H3T1” or ‘H3T1 WT’, had three TEP1 
alleles: *R1, *S2 and *S1. Both 7b and Mut6 were used as TEP1-deficient control 
strains. Mut6 strain is TEP1*S1/S1 homozygous for a premature stop mutation at the 
alpha helix region connecting the CUB and TED that rendered the mosquito hyper-
susceptible to infections by P. berghei (138). Mutations in TEP1 were generated by 
TALENS technology resulting in the deletion of 3 endogenous amino acids and the 
insertion of 6 exogenous amino acids (138). Importantly, Mut6 was used in intercrosses 
with the H3T1 strain to introduce a mutant allele in order to develop TEP1*S1 
hemizygous mosquitoes.  
Adult mosquitoes were fed daily on 10% sucrose solution and maintained under 
standard insectary conditions at 28 ± 2 °C and 75-80% relative humidity in a 12 h 
day/night cycle. For oviposition, female mosquitoes were blood fed for 15 min on 
human type O+ blood (HAEMA, Berlin) using a standard membrane feeder (SMF). 
After 48 h, an egg dish (a damp funnel-shaped filter paper placed over a jar filled with 
sterile water) was placed in the cage for egg-laying. Eggs were collected 24 h later and 
floated in plastic pans containing sterile water supplemented with 0.1% NaCl. Upon 
hatching, larvae were fed on ground Tetrafin Flake Fish food (Tetra, Germany). Pupae 
were collected in water-containing jars and transferred into standard cages (30×30×30 
cm) (http://bugdorm.megaview.com.tw/bugdorm-43030f-insect-rearing-cage-32-5x32-
5x32-5-cm-pack-of-one-p-241.html) and allowed for adults to emerge. 
3.3.4 Breeding of the H3T1 mosquito strain and balancing TEP1 allelic 
composition and genotype frequencies  
The original H3T1 colony was genotyped for TEP1 to assess the TEP1 genotype 
frequencies. Of the three alleles, TEP1*R1 had the lowest allele frequency. Therefore, a 
selection procedure was set in place to establish a H3T1 colony with equal TEP1 allelic 
frequencies. For this, TEP1*R1 males (n = 28) were selected and allowed to freely mate 
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with 7-day-old virgin females (n = 165). The F1 offspring were maintained to adulthood 
and self-crossed to produce F2 progeny. The F2 offspring were genotyped for TEP1, 
and then male and female mosquitoes with desired TEP1 genotypes were allowed to 
mate and give rise to F3 progeny. The subsequent generations were assessed for TEP1 
genotype and allelic frequencies. The colony was enriched accordingly for the TEP1*R1 
alleles whenever a declining shift was observed in its frequencies (35). However, the 
original *R1 allele was not successfully stabilized, thus an alternative *R1 allele from 
L3-5 refractory mosquitoes was introgressed into the H3T1 strain. I also tried to 
introgress TEP1*R2 allele from the 4Arr strain obtained from MR4 into the H3T1 
colony. However, both the introgression experiments were unsuccessful. 
3.3.5 MH3T1 reciprocal crosses 
To carry out reciprocal crosses between the mut6 and H3T1 mosquito lines, pupae 
from each line were sexed under a microscope by the examination of terminalia. Males 
of mut6 and females of H3T1 were merged as pupae into a mosquito cage and allowed 
to emerge to adulthood. Similarly, males of H3T1 and females of mut6 pupae were 
merged into another mosquito cage and allowed to emerge to adulthood. Female adults 
were blood-fed between 5- and 7-d-post-emergence. The mosquitoes were provided 
with egg dishes for oviposition on 48 h post blood-meal acquisition. The resulting egg 
dishes were merged into one floating pan and allowed to hatch to larvae. Mosquitoes 
were reared to adulthood and used for P. berghei infection experiments. 
3.3.6 DNA extraction 
Mosquito genomic DNA for PCR analyses was extracted from mosquito legs by 
lysis in 40 µl of squashing buffer (200 µg/ml proteinase K, 10 mM Tris-Cl pH 8.2, 1 
mM EDTA and 25 mM NaCl) and followed by 1 h incubation with proteinase K at 37 
°C with subsequent 5 min inactivation at 95 °C. The lysates were cleared by high-speed 
centrifugation to pellet the proteins and tissues that may inhibit the PCR. Alternatively, 
a leg was used directly as the DNA template in the PCR reaction. 
3.3.7 TEP1 genotyping 
Nested-PCR RFLP and PCR-based genotyping strategies (Chapter 2) were used to 
genotype TEP1. The reciprocal crosses between the mut6 and H3T1 strains were 
genotyped using the 1034±1 bp PCR-RFLP genotyping method. See Table 3-1 for the 
expected sizes of RFLP fragments.  
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3.3.8 Experimental infections 
3.3.8.1 P. berghei infections 
Female mosquitoes (3- to 5-d-old) were infected with the GFP-expressing rodent 
malaria parasite (P. berghei ANKA, PbGFPcon) (163). The mosquitoes were starved for 
6 h prior to a 20 min blood feeding on an anaesthetized P. berghei-infected CD1 mouse 
by injection of the mice with a mix (120 µl) of xylazine and ketamine in line with the 
national regulations by the LAGESO. Fully blood-fed mosquitoes were selected and 
maintained by feeding daily on 10% sucrose solution in S2 incubator set at 20 °C and 
75-80% relative humidity in a 12 h day/night cycle for 10 d post-infection. Midguts 
were dissected in sterile PBS under a stereomicroscope. For oocysts counting, midguts 
were fixed in 4% paraformaldehyde for 30 min and washed 3 times in PBS. Midguts 
were mounted on a slide, stained with DAPI (Vector Laboratories, USA). The images 
were documented under an Inverted Fluorescence Microscope (Zeiss Axio Observer 
Z1). 
3.3.8.2. P. falciparum infections 
All infectious work on the human malaria P. falciparum parasite cultures and 
infection of mosquitoes was performed under controlled security level 3 (S3) laboratory 
conditions according to the standard regulations by the LAGESO, project number 
411/08. In order to infect mosquitoes with the P. falciparum, the SMF system was used. 
Here, ~ 1-5% stage V gametocyte cultures of routinely maintained P. falciparum NF54 
incubated with human blood cells (HAEMA, Berlin) were fed to the 3 to 5-d-old 
Table 3-1. RFLP fragment (bp) expected from genotyping the Mut6-H3T1 genetic crosses. 
 Restriction enzyme and expected fragment sizes 
TEP1 genotype BamHI+NcoI BseNI 
S1/S1 146, 887 811, 222 
S1/S2 146, 887 1033, 811, 222 
S2/S2 146, 887 1033 
R1/R1 674, 360 1034 
R1/S1 674, 360, 146, 887 1034, 811, 222 
R1/S2 674, 360, 146, 887 1034*, 1033* 
S1m/S1m 1043$ 821$, 222 
R1/S1m 674, 360, 1043$ 1034, 821$, 222 
S1/S1m 146, 887, 1043$ 811*, 821*$, 222 
S2/S1m 146, 887, 1043$ 1033, 821$, 222 
*
Fragments have close size ranges and would appear as one overlapped fragment. 
$ The expected size of S1m allele is 9 bp more due to the targeted deletion of 8 endogenous bases and subsequent 
insertion of 17 exogenous bases at the NcoI site (138).
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females using the SMF stystem for 20 min at 37 °C. Unfed and partially engorged 
mosquitoes were removed from the cage and killed immediately using a vacuum 
aspirator into 70% ethanol. Fully engorged mosquitoes were maintained in the S3 
conditions for 10 d at 26 °C and 75-80% relative humidity in a 12 h day/night cycle.  
After 10 d post infection, mosquitoes were killed in 70% ethanol and washed 3 
times in 1 PBS. Mosquitoes were dissected in sterile PBS under a stereomicroscope to 
remove the midguts for assessment of P. falciparum oocyst loads. To visualize and 
count the developed oocysts, the midguts were stained with 1% mercurochrome for 10 
min, and observed under a bright field upright microscope (Leica DM2000 LED) 
equipped with a CCD color camera.  
3.3.9 Analyses 
R version 3.1.3 (2015) customized scripts and R-packages as in Chapter 2 were 
used to analyze the genotype and allele frequencies from the TEP1 genotyping data 
(Appendix 2). All statistical analyses were carried out in R statistical package version 
3.1.3 (2015) (141). These include the assessment of normality of the data using Q-Q 
plots and Shapiro tests, analyses of oocyst numbers using the non-parametric Kruskal-
Wallis test with pairwise Wilcox test and Bonferroni correction. Analyses of means of 
Plasmodium prevalence by one-way ANOVA on log-transformed data followed by the 
Tukey’s HSD test. A sample of an R script is given in Appendix 7. Figures were edited 
in Adobe Illustrator C5 and Adobe Photoshop C5.  
 3.4 Results  
3.4.1 Establishment of the mosquito colony with balanced TEP1 allelic and 
genotype frequencies 
My aim was to examine the impact of TEP1 alleles on P. falciparum development. 
However, the attempts to introgress *R2 allele from 4Arr strain (obtained from MR4) 
were unsuccessful.  
Nonetheless, the availability of the H3T1 A. gambiae mosquito colony bearing 
TEP1*R1, *S1 and *S2 alleles was used for Plasmodium infection experiments. First, 
original H3T1 strain was genotyped for TEP1 to assess allelic frequencies and 
genotypes (Fig. 3-1, experiment 1). Strikingly, I did not detect any homozygous 
TEP1*R1/R1 (n = 96), although *R1 allele was maintained by the heterozygote *R1/S1 
and *R1/S2 genotypes (2% each) (Fig. 3-1A). *R1 showed the lowest frequency (2%), 
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while frequencies of *S2 (41%) and *S1 (57%) were similar (Fig. 3-1B). Therefore, it 
was important to increase the frequency of *R1 allele in H3T1 before performing 
Plasmodium infections. 
All mosquitoes carrying *R1 alleles were self-crossed to generate F1 progeny with 
enriched *R1 alleles. The F1 progeny were reared to adulthood and self-crossed to 
produce F2 generation (Fig. 3-1, experiment 2). The F2 progeny was genotyped and 
*R1 individuals were used for crosses to further enrich the frequency of *R1 and of
*R1/R1 genotypes. The colony was maintained with regular genotyping to assess
frequencies of genotypes and alelles and accordingly enrich it with *R1 alleles (Fig. 3-
1, experiments 3-7). 
All my attempts to establish the H3T1 colony with equilibrated genotype 
frequencies were unsuccessful (Fig. 3-1). The homozygous *R1/R1 mosquitoes always 
displayed the lowest frequencies, resisting my selection strategy. Interestingly, self-
crossing of *R1 individuals increased allelic frequencies of *R1, but not the proportion 
of *R1/R1 individuals, suggesting some degree of homozygote lethality of *R1 allele. 
To counteract this challenge, a strategy of a continuous boosting of the colony with 
*R1 mosquitoes was adopted. However, this strategy required an extremely high
Fig. 3-1. Equilibration of TEP1 
allelic and genotype frequencies in 
the H3T1 strain. 
(A) Overview of TEP1 genotype
frequencies of the H3T1 upon with
TEP1*R1 enrichment in the colony.
The x-axes represent the number of
experiment. Experiment 1 depicts
genotype and allelic frequencies in
the original colony.
(B) TEP1 allelic frequencies with
constant enrichment of TEP1*R1
allele in the H3T1 colony. Numbers
below indicate the number of the
genotyped individuals in each
experiment. Below each experiment
number is a specific date (enclosed
in brackets) when the genotyping of
each colony was done.
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number of total mosquitoes (>600) to analyze per experiment. This high number of 
mosquitoes was not achievable and sustainable hence required a continuous 
optimization during the breeding cycles.  
To avoid potential competition between *R1/R1 and other genotypes, I established 
homozygous lines of *R1/R1, *S1/S1 and *S2/S2 mosquitoes. Note that establishment of 
homozygous *R1/R1 took longer time than *S1/S1 or *S2/S2 homozygote colonies.  
Moreover, the *R1 homozygous colony experienced frequent crushing due to poor adult 
blood feeding and low numbers of laid eggs.  
I tested another option to enrich the frequencies of *R1 alleles by introgressing *R1 
allele of refractory strain L3-5 into the H3T1 colony bearing *S1 and *S2 alleles. This 
strategy needed a considerably high number of generations (>6) involving the 
intercrosses to synchronize and equilibrate genetic background and to avoid the 
confounding impacts of founder effect. However regardless of the *R1 origin, *R1/R1 
homozygotes were challenging to breed. Therefore, the H3T1 colony with very low 
frequency of *R1/R1 genotypes (around the frequencies of Fig. 3-1, experiment 5 and 6) 
was used to perform P. berghei and P. falciparum infection experiments.  
3.4.2 MH3T1 mosquito colony establishment 
To obtain hemizygote mosquitoes for assessing the impact of single copies of 
TEP1*R1 or *S1 or *S2 on Plasmodium development, I set up reciprocal crosses 
between H3T1 and mut6 mosquito cohorts. The mutant TEP1 allele is referred to as 
*S1m. In principle, the F1 progeny should inherit one copy of TEP1 allele from the 
H3T1 WT (wild type) and one from the Mut6 (mutant). This allelic combination offered 
an opportunity to directly compare the impact of single TEP1 alleles on Plasmodium 
development. 
3.4.3 P. berghei infections of the MH3T1 mosquito reciprocal crosses 
To dissect the contribution of a single TEP1 allele to resistance to Plasmodium 
infection (and to resolve the synergistic effects of two alleles in the mosquito), F1 
generations of the MH3T1 mosquitoes were infected with the PbGFPcon parasites (Fig. 
3-2). Briefly, mosquitoes were allowed to feed on anaesthetized PbANKA-infected mice 
for 20 min, and only fully engorged mosquitoes were maintained for 10 d. To assess the 
number of oocysts that developed in the midgut, the mosquitoes were dissected at 10 d 
post-infection. The TEP1*R1/S1m (i.e. *R1 allele), *S2/S1m (*S2) and *S1/S1m (*S1) 
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alleles carried the lowest, intermediate and highest number of parasites respectively 
(Fig. 3-2A).  
 
Interestingly, *S1 mosquitoes had higher oocyst loads than *S2 mosquitoes (Fig. 3-
2A). In contrast, at the level of infection prevalence, more *S2 mosquitoes were 
infected than *S1 mosquitoes (Fig. 3-2B). However, in both cases the differences 
between *S1 and *S2 alleles were not statistically significant. The order of increasing 
parasite load; TEP1*R1<*S2<*S1 was evident (Fig. 3-2A). I observed an increasing 
prevalence of infection (that is the proportion of infected mosquitoes relative to the total 
number of mosquitoes) in the following order TEP1*R1<*S1<*S2 (Fig. 3-2B). The 
results obtained was similar to the published data on reciprocal allele-specific RNAi that 
linked TEP1 *R1/R1 genotype to lower P. berghei development than TEP1*S2 (5).  
3.4.4 TEP1*R1/R1 mosquitoes are more resistant to Plasmodium infections  
In a control experiment, H3T1 mosquito line was infected with P. berghei strain as 
previously described (5) (Fig. 3-3).  
 
Fig. 3-2. Influence of TEP1 alleles on P. berghei infection in MH3T1 mosquitoes. 
(A) P.b GFPcon ANKA strain infection loads in the MH3T1 progeny in F1 generation.  Each dot 
represents the number of oocysts per midgut.  The red-colored line represents the median of the 
oocysts. Statistical significance between the groups was calculated using non-parametric Kruskal-
Wallis with pairwise Wilcox test and Bonferroni correction. Results from two independent 
experiments were pooled. Statistically significant differences are indicated by **p<0.01.   
(B) Corresponding percentage prevalence per each genotype group in the same F1 generation in 
Fig. 3-2A. Statistical significance between the groups was calculated using ANOVA test on 
normalized data, and Tukey’s HSD test. Error bars show the mean ± SEM from the two 
independent experiments. Statistically significant differences are indicated by *p<0.05.  
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A statistically significant difference in the parasite oocyst loads was observed 
between *R1/S2 and *S2/S2 (p<0.01) (Fig. 3-3A). The TEP1*R1/R1 genotype had the 
lowest prevalence of infection (27%), followed by *R1/S2 (46%), *R1/S1 (40%), *S2/S2 
(54%), *S1/S2 (59%) and *S1/S1 (62%) in order of increasing susceptibility. 
 Similar infection experiments with human malaria parasite, P. falciparum (NF54) 
strain were performed on the same H3T1 mosquito lines (Fig. 3-4).  
 
Fig. 3-3. Phenotype differences in H3T1 
mosquitoes upon P. berghei infection. 
(A) P. berghei oocyst loads per midgut. 
Each dot represents the number of 
oocysts per midgut. The red lines 
represent the median of the oocysts. 
Statistical significant differences are 
indicated by **p<0.01. Statistical 
significance between the groups was 
calculated using non-parametric Kruskal-
Wallis with pairwise Wilcox test and   
Bonferroni correction. The numbers 
below the data points represent the 
sample size of the infected mosquitoes 
per genotype. 
(B) P. berghei infection prevalence. The 
horizontal axes show TEP1 genotype. 
The numbers below each bar represent 
the sample sizes per genotype. Results 
from 4 independent experiments were 
combined. Error bars show the mean ± 
SEM.  Statistical significance between 
the groups was calculated using ANOVA 
test on normalized data, and Tukey’s 
HSD test. 
 
Fig. 3-4. Phenotype differences in H3T1 
mosquitoes upon P. falciparum infection. 
(A) P. falciparum oocyst loads per midgut. 
Each dot represents the number of oocysts per 
midgut. The red bars represent medians of 
oocysts per midgut.  Statistical significance 
between the groups was calculated from non-
parametric Kruskal-Wallis with pairwise 
Wilcox test and Bonferroni correction. Results 
of 5 independent experiments were pooled.   
The numbers below the data points represent 
the sample size of the infected mosquitoes per 
genotype. 
(B) P. falciparum prevalence of infection. 
Results of 5 independent experiments were 
pooled.  The numbers below each bar 
represent the total sample sizes for each 
genotype. Error bars show the mean ± SEM. 
Statistical significance between the groups 
was calculated using ANOVA test on 
normalized data, and Tukey’s HSD test.   
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A marked decrease in oocyst loads in the *R1/R1 genotype was not statistically 
significant as compared with the parasite loads of the TEP1 genotype groups, probably 
because of the small sample size (Fig. 3-4A). All other TEP1 genotypes were equally 
infected. In addition, the prevalence of the infection was considerably high (>80%) for 
all TEP1 genotypes (Fig. 3-4B) and significantly higher than in infections with P. 
berghei. As these results show no statistically significant differences in the NF54 P. 
falciparum oocyst loads or prevalence of infection between the TEP1 genotypes, it 
suggests that the NF54 P. falciparum isolate was largely resistant to TEP1-mediated 
killing in H3T1 mosquitoes. To assess the same phenotypes in P. falciparum isolates 
that have been associated with a high degree of susceptibility to TEP1-mediated 
immune responses, I established cultures of TEP1-susceptible P. falciparum isolates. 
3.4.5 Establishment of TEP1-sensitive P. falciparum cultures was unsuccessful 
In order to evaluate the role of TEP1 polymorphism in infection with different P. 
falciparum parasites, efforts were made to establish cultures of parasites known to be 
TEP1-sensitive; HB3 (165), 7G8 (158, 167), NF54 GFP-Luc (166) carrying a disrupted 
Pfs47 locus and NF165 (104). To test the infectivity of the gametocyte cultures on the 
3- to 5-d-old mosquitoes, mosquito strains of H3T1, Mut6 (138), TEP1 S1/S1 subset of 
Ngousso (168) and 7b (78) were bred and infected separately with the parasites. The 7b 
lines were used as positive TEP1-deficient mosquitoes. P. falciparum NF54 strain was 
used as a positive control for infections. 
 
.  
Fig. 3-5. Assessment of infectivity of TEP1-
sensitive P. falciparum isolates. 
Top panel shows P. falciparum oocyst loads 
per parasite strain to check whether they can 
infect mosquitoes.  The red bars represent 
medians of oocysts per midgut. The numbers 
below the data points represent the sample 
size of the total mosquitoes that were 
dissected.  Except for the NF54, multiple 
independent experiments were pooled. 
Bottom panel displays corresponding 
summary comparison of gametocytaemiae, 
exflagellation and prevalence in infections 
with NF54, 7G8, NF54HT-GFP-luc and 
NF165 P. falciparum isolates in mosquitoes. 
In general, the 7G8, NF54HT-GFP-luc and 
NF165 parasites were not infectious to the 
TEP1-deficient mosquitoes; therefore, they 
were not be used for infection experiments 
with the wild-type H3T1 mosquitoes.  
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To gauge the general performance of the cultures, profiles of three parameters; 
gametocytaemia, exflagellation/15 fields and infection prevalence were assessed in the 
infected mosquitoes. Establishment of the cultures of TEP1-sensitive parasites posed a 
number of challenges. First, repeated attempts to establish HB3 gametocyte cultures 
failed to produce infectious gametocytes (data not shown). Second, the 7G8, NF54 
GFP-Luc and NF165 parasites produced gametocytes, which did not generally infect the 
mosquitoes (Fig. 3-5). Although the 7G8 cultures showed high gametocytemia, repeated 
infections of the mosquito strains showed poor exflagellation and infection prevalence 
levels (Fig. 3-5). The 7G8 cultures were therefore discarded. Both NF54 GFP-Luc and 
NF165 cultures showed good exflagellation levels but failed to infect mosquitoes. The 
NF165 asexual cultures were highly susceptible to stress, such as slight changes in 
culture conditions. In addition, despite good gametocytaemia and high exflagellation 
rates, the NF165 parasites were generally not infectious to mosquitoes. Therefore, the 
NF165 cultures were also discarded. The difficulties in culturing these TEP1-
susceptible parasite strains than the TEP1-resistant NF54, prevented us from evaluating 
the impact of TEP1 alleles on P. falciparum development. 
3.5 Discussion 
Our understanding of functional influence of TEP1 polymorphism on phenotypic 
traits during malaria infections provides important progress towards development 
control strategies of malaria transmission (4, 5, 35, 77, 78). These studies are facilitated 
by breeding and maintenance of the A. gambiae mosquito colonies, of which TEP1 
susceptible mosquitoes are easier to breed while refractory ones may be challenging 
(35). In this thesis, difficulties with the establishment of A. gambiae H3T1 strain with 
equal frequencies of TEP1*R1 or *S1 or *S2 alleles suggested high lethality rates of 
*R1/R1 genotypes. This study did not determine the optimal conditions and factors that 
benefit the survival of *R1/R1 homozygotes. Interestingly, similar difficulties were 
encountered with rearing mosquitoes with TEP1*R2 allele, as the introgression of *R2 
allele into H3T1 strain was unsuccessful. Selection strategies were effective in 
increasing the frequencies of *R1 alleles but did not significantly improve the 
proportion of *R1 homozygotes. Nevertheless, modest numbers of *R1/R1 mosquitoes 
offered an opportunity to perform P. berghei and P. falciparum infections in H3T1 and 
MH3T1 lines. 
Chapter 3 Impact of TEP1 variation 
80 
Blandin et al. (5) compared resistance of TEP1*R1/R1, *R2/R2 and *S2/S2 
mosquitoes to P. berghei parasites, but did not examine the phenotype of *S1/S1 
mosquitoes. Our results of Plasmodium infections of MH3T1 indicated lower infection 
rates of the TEP1*R1 hemizygotes as compared to *S2 and *S1, where *S1 mosquitoes 
had higher oocyst numbers than *S2. In contrast, at the level of infection prevalence, 
more *S2 mosquitoes were infected than *S1. But since I could perform only two 
independent experiments, differences between *S1 and *S2 were not statistically 
significant. Therefore, I concluded that TEP1*S alleles are equally susceptible to P. 
berghei infections. These results are in line with the previous reports that showed that 
TEP1*R1 is more resistant to P. berghei infections than the TEP1*S2 (5).  
Low numbers of *R1/R1 mosquitoes reduced the significance of our results with P. 
berghei infections, though I observed a trend towards higher refractoriness of *R1/R1 
mosquitoes, whereas *S1/S1 mosquitoes showed higher susceptibility as compared to 
*S2/S2 homozygotes and other heterozygotes with intermediate phenotypes.
Interestingly, P. berghei infections yielded lower prevalence than infections with P. 
falciparum. These observations are consistent with previous report that the P. 
falciparum NF54 used in this study is resistant to TEP1 (159). Recent reports suggested 
that some African parasites, such as NF54 strain, have developed strategies to evade 
TEP1-mediated immune responses (158, 160). Unfortunately, I was unable to assess the 
impact of TEP1 polymorphism on the development of TEP1-sensitive P. falciparum 
parasites due to difficulties with the maintenance of in vitro cultures. 
3.6 Conclusion 
My results support the previous reports demonstrating TEP1-mediated mosquito 
resistance to rodent malaria parasites and extend these observations to *S1 allele. 
Unexpectedly, the challenges associated with the establishment of mosquito line with 
equal representation of TEP1 alleles suggest higher lethality rates of *R1 homozygote 
mosquitoes in the conditions of insectary. However, the observation that *R1 
homozygotes are only found exclusively in A. coluzzii species in West Africa region 
(Chapter 2) suggests that the maintenance of this allele is driven by unknown 
environmental and A. coluzzii-specific conditions unique to specific locations in West 
Africa.  
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General Discussion 
4.1 Summary 
The aim of this thesis was to: 1) elucidate how TEP1 locus contributes to genetic 
structure of local A. gambiae s.l. species across four sub-Saharan Africa countries 
(Chapter 2); and 2) assess the impact of TEP1 alleles and genotypes on P. berghei and 
P. falciparum development (Chapter 3). The main conclusions of my study are that: i)
the TED region is sufficient for TEP1 genotyping, including clear identification of 
TEP1*S1 and *S2 alleles; ii) the high throughput PCR-RFLP genotyping approach 
offers a robust and affordable strategy for both small and large scale TEP1 genotyping; 
iii) a novel TEP1*R3 allele was identified in A. merus population in coastal Kenya; iv)
ecotype partitioning of local malaria vectors across Africa was described using TEP1 
genotyping; v) a ‘conditional lethality’ of TEP1*R1 allele in *R1 individuals, occurs 
under the standard laboratory breeding conditions suggesting specific natural factors 
that promote fixation of the allele in A. coluzzii in West Africa; and vi) TEP1*S1 and 
TEP1*S2 alleles are equally susceptible to malaria parasite infections. 
4.2 TED region identifies all the TEP1 allele subclasses 
The TED region offers a genetic marker for TEP1 genotyping as it can be used to 
identify all the TEP1 alleles with the ability to provide clear distinction between 
TEP1*S1 and *S2 alleles, which were previously unresolved (6, 8, 35). The developed 
method is also affordable for TEP1 genotyping in the field laboratories. By combining 
species-specific markers with TEP1 genotyping, we identified partitioning of local 
malaria vectors into ecotypes across African environments. Since TEP1 locus shows 
clear geographic and species-specific patterns, it can be potentially used to monitor the 
on-going speciation events caused by climate change, dispersal and colonization of new 
ecological niches, local adaptation, and gene flow between vector species. 
4.3 Natural selection drives biogeographic genetic diversity at TEP1 locus 
Natural selection drives the global distribution of species and of TEP1 alleles across 
Africa (6, 8, 35). Local (habitats) selection forces which form the hallmark of local 
adaptation in A. gambiae mosquitoes, allow the mosquitoes to accumulate local alleles 
that make them adapt to local pathogen and environments (32, 129, 132, 154). This 
study has biogeographically categorized the TEP1 alleles and genotypes into specialist 
and generalist groups (Fig. 4-1).  
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In Africa, TEP1*R1/R1 genotypes inhabit sahelian ecosystem, arid zones and in 
Mali and Burkina Faso (8, 35). This thesis upholds evidence from these previous reports 
that TEP1*R1 alleles are locally selected in West Africa. Unknown environmental and 
species-specific conditions prevailing only in West Africa drive enrichment of 
TEP1*R1 allele (or TEP1*R1/R1 genotype) in A. coluzzii at near-fixation (6, 8, 35). In 
addition, our study uncovered high lethality of homozygous *R1/R1 mosquitoes under 
laboratory conditions. Therefore, from the challenges of breeding the *R1/R1 
mosquitoes in the laboratory (35) and in our study, I propose that the *R1 allele is a 
conditional lethal. In homozygote individuals, a conditional lethal allele may be 
maintained by some special unknown circumstances without which they selected 
against or are rarely selected for and/or is permitted more at heterozygous (*R1/S1 and 
*R1/S2) genotypes.
Our study has extended this observation on local selection to TEP1*R3 alleles 
among A. merus population in coastal Kenya, and *S2 alleles mainly in Cameroon by A. 
coluzzii and A. gambiae s.s.. As the TEP1*R3 allele portrays unique polymorphism, it 
Fig. 4-1.  Hypothesis underlying natural forces acting on TEP1 locus. 
The TEP1 alleles and genotypes were categorized according to their geographical and species 
distribution; generalist and specialist alleles. This study hypothesizes that prime selective agents are 
specific to their ecological biotopes and species, and highlights the most likely agents for selections as a 
proxy for future field studies seeking to identify actual potent selective agents. 
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suggests that these modifications may be particularly important for certain fitness of 
these species in harsh salty-water environment. Furthermore, it may reflect the impact 
of evolution and natural selection on TEP1 locus towards local adaptation. Further, 
TEP1*S1 and *R2 alleles, and genotypes they form, have a generalist nature, where they 
are selected almost in all sites and species. Of note, the *R2/S1 genotype (with the 
exception of A. coluzzii in Mali and Vale de Kou in Burkina Faso) is maintained in all 
the studied species across Africa suggesting that it competitively outperforms other 
heterozygotes, however, selection forces that benefit this genotype and *R2/*S1 allele 
compatibility remain unknown.  
Importantly, P. berghei infection experiments showed that both *R2 and *S2 alleles 
render the mosquitoes susceptible to infections as compared to *R1 alleles (5). The 
cooler and humid climate prevailing in Cameroon apprears to promote selection for the 
specialist *S2 alleles. Here, our data have shown further that *S2 and *S1 mosquitoes 
are equally susceptible to both P. berghei and P. falciparum infections, suggesting that 
these alleles confer higher vector competence to A. gambiae in local populations, hence 
have a direct consequence of malaria transmission. 
4.4 Open questions and future directions 
Our study opens new research avenues (Fig. 4-1) that should address the following 
questions;  
First, what determines restricted selection patterns of TEP1*R1 and *S2 mosquitoes 
across African biotopes? What drives the ‘conditional lethality’ of the TEP1*R1 allele? 
Second, the structured genotype diversity revealed in this study, in particular the 
enrichment of A. coluzzii *R1/R1 genotypes in Mali and Burkina Faso, *R2/S1 across 
Africa, *S1/S2 in Cameroon, and *R3/R3 and *R3/S1 coastal Kenya needs further 
investigation to establish their biological regimes and functional constraints underlying 
this polymorphism. 
Third, could there be natural beneficial roles or selective advantages of *R2/S1, 
*R3/S1 and *S1/S2 heterozygotes over homozygote counterparts resulting in traits that
influence malaria transmission? 
Fourth, future studies should examine the role of the *R3 allele in A. merus 
mosquito resistance to Plasmodium, or identify its role in other biological processes or 
whether it has a risen as a result of local adaptation to salty water biotopes in 
comparison to A. melas counterpart in West Africa. Is the *R3 allele undergoing 
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fixation in A. merus larval populations? Genotyping of TEP1 in a cross sectional larval 
collections spanning dry and rainy seasons may be a good starting point. Towards this 
end, a short preliminary fieldwork was conducted in the same sampling sites in Malindi, 
coastal Kenya, where the *R3 allele was identified. Larval populations from two 
discrete larval habitats have been collected (data not shown) and TEP1 analyses are 
underway. These data are expected to inform the design and the direction of a bigger 
study. 
Fifth, sequence similarity in SNPs and amino acid substitutions between *R3 allele 
and *R2/*S alleles suggest novelty in derivation of the *R3 allele, and point towards 
inter-allele genetic exchange resulting in extensive shared polymorphism. Whether there 
are high mutational constrains (salinity and water chemistry or nature of predators, 
pathogens or vegetation) in the saline breeding environments, which may have triggered 
the emergence of this novel allele and its maintenance in the population, remains to be 
addressed (Fig. 4-1). In particular, the specific *R3 nucleotide and amino acid 
modifications discussed here, may potentially confer some fitness advantage to A. 
merus mosquito populating in these saline biotopes that could impact significantly on 
malaria epidemiology. To understand molecular events underlying this fitness, 
characterization of genetic recombination events or mutation pressures acting on the 
entire genome especially on the chromosome 3 in A. merus populations may provide 
some light.  Interrogation of the published data on the sequences, the genome assembly 
and transcriptomes of A. merus, one of the 16 recently published genomes of A. 
gambiae, may offer an insightful basis (24).  
And sixth, the challenge is to identify natural selection forces that cause the 
geographic- and species variation in TEP1 polymorphism in the African mosquito 
populations.  
4.5 Conclusion 
In the A. gambiae s.l. populations, TEP1 polymorphism has been maintained 
throughout Africa (6, 8, 35). This thesis has shown that polymorphism (TEP1*R2 and 
*S1) is substantially shared among species, while (TEP1*R1, *R3 and *S2) are locally 
selected by specific Anopheles species. Particularly, the TEP1*R2 and *S1 are the most 
shared alleles across Africa. As they were found in all the four countries, it suggests that 
the species in the A. gambiae s.l. complex may have had these alleles before they 
expanded to colonize new ecological niches and speciate to sibling species.  
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The generalist *S1 allele suggests compatibility with all the other alleles as 
exemplified by presence of *R1/S1, *R2/S1, *R3/S1 and *S1/S2 heterozygotes, a 
phenomenon underpinning unknown functional fitness advantage driving this 
compatibility. This geographic variation in allele and genotype selections may be, in 
part, due to differences in the choice and stability of breeding habitats (118) or 
prevailing ecological climates of which local factors and geographical isolation 
significantly drive speciation, diversification and selection of fitter genotypes (98, 118). 
Collectively, the findings from this study suggest a trade-off between intrinsic 
(vectorial) forces and extrinsic (ecological) factors that drive the vector adaptation to 
local ecological ecotypes through strict maintenance of the TEP1 polymorphism and 
microevolution (i.e. evolution in within the population leading to change in allele and 
genotype) at the habitat level. Additionally, it suggests local selection for specialist 
alleles is advanced by specialist species while global dispersal of generalist alleles is 
driven by generalist species. These data suggest that TEP1 locus experiences distinct 
local selective pressures in mosquito natural populations, in agreement with the 
proposed pleiotropic functions of TEP1 (80) i.e. influence of TEP1 gene on more than 
one phenotypic traits such as in reproduction (80) and immune responses (4, 5, 18, 71). 
Further, this study proposes a ‘conditional lethality’ of TEP1*R1 allele in the laboratory 
conditions, which is promoted by unknown conditions; and demonstrates that TEP1*S1 
and TEP1*S2 alleles are equally susceptible to malaria parasite infections. 
The development of novel vector control measures requires in-depth documentation 
and prediction of demographic vis-à-vis ecological events underpinning local 
adaptation, speciation, extinction, colonization of new niches in malaria vectors, like 
those driven by the climate change and human activities (48, 108-111). Using TEP1 as a 
marker, revealed the partitioning of A. gambiae s.l. species into generalist and specialist 
genotypes. Therefore, it offers clear geographic and species-specific patterns, and can 
be potentially used to monitor the on-going speciation events dispersal and colonization 
of new ecological niches, local adaptation, and gene flow between vector species. 
Importantly, this study has contributed molecular tools for high throughput TEP1 
genotyping that can be used to complement species identification methods in surveying 
and monitoring the population dynamics of local malaria vectors over time and space. It 
has provided phylogeny and sequence information needed to improve the understanding 
on TEP1 diversity. Incorporating these informative ecological genetic markers in 
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malaria control programs and in other vector-borne diseases should help in forecasting 
future demographic population dynamics that come with severe epidemiological 
consequences.
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Appendices 
Appendix 1. Materials, Equipment and Software used in this study 
Materials, Equipment and Software 
A Biological Materials and where the Resources were obtained from. 
No.: Material Source 
1 A coluzzii (Ngousso colony) 
mosquito strains 
Institut de Biologie Moléculaire et 
Cellulaire (IMBC), Strasbourg, 
France (168). 
2 A. coluzzii L3-5 refractory
mosquito trains
Dr. Stéphanie Blandin, IMBC, 
Strasbourg, France (167, 169). 
3 G3 mosquito stains Dr. Flaminia Catteruccia. 
Department of Immunology and 
Infectious Diseases, Harvard T.H. 
Chan School of Public Health, 
Boston, Massachusetts 02115, USA. 
2 Center for Communicable Disease 
Dynamics, Harvard T.H. Chan 
School of Public Health, Boston, 
Massachusetts 02115, USA. 
4 4Arr mosquito strain MR4 (5). 
5 7b TEP1 knockdown mosquito 
strain 
IMBC, Strasbourg, France (78). 
6 Mut6 - TEP1 mutant mosquito 
strain 
Dr. Erick Marois, IMBC, Strasbourg, 
France (138). 
7 P. berghei ANKA (163). 
8 P. falciparum NF54 Prof. Dr. Robert W. Sauerwein at 
Department of Medical 
Microbiology, Radboud University 
Medical Centre, Nijmegen, The 
Netherlands (104, 164). 
9 P. falciparum NF54HT-GFP-luc
malaria parasites
Prof. Dr. Robert W. Sauerwein (166) 
10 P. falciparum HBC malaria
parasites
MR4 (165) 
11 P. falciparum NF165 malaria
parasites
Prof. Dr. Robert W. Sauerwein (104) 
12 P. falciparum 7G8 malaria
parasites
MR4 (158, 167) 
13 DH5α and 10βeta chemically
competent E. coli cells
New England Biolabs, UK 
B Consumable Materials 
No.: Material Supplier (Manufacturer), Country 
14 1 kb DNA Ladder Thermo Fisher Scientific, Germany 
15 1 kb Plus DNA Ladder Thermo Fisher Scientific, Germany 
16 100 bp Plus DNA Ladder Thermo Fisher Scientific, Germany 
17 2-Propanol Carl Roth, Germany 
18 Agarose Invitrogen, Germany 
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No.: Material Supplier (Manufacturer), Country 
19 Ammonium Acetate Ambion, Germany 
20 Ampicillin Sigma-Aldrich, Germany 
21 Ampicillin (stock solution 1000×) 100 mg/ml in ddH2O, sterile filtered 
22 Bacto-Agar Invitrogen, Germany 
23 Calcium Chloride Merck, Germany 
24 Coffee-Cup Exclusiv 120 ml and 
300mL 
IGEFA, Germany 
25 Coverslips Carl Roth, Germany 
26 CryoTubes, 1.8 ml 
(cryopreservation of bacteria) 
Greiner Bio-One, Germany 
27 Dimethyl Sulphoxide (DMSO) Sigma-Aldrich, Germany 
28 dNTP-mix Thermo Fisher Scientific, Germany 
29 Electrophoresis buffer TAE 50 × Thermo Fisher Scientific, Germany 
30 Electrophoresis buffer TBE 50 × Thermo Fisher Scientific, Germany 
31 Eppendorf tubes, 1.5 ml and 2 ml Eppendorf, Germany 
32 Ethanol, molecular grade Carl Roth, Germany 
33 Ethidium Bromide Sigma-Aldrich, Germany 
34 Ethylenediamine tetraacetic acid 
(EDTA) 
Carl Roth, Germany 
35 Falcon tubes, 15 ml and 50 ml Sarstedt, Germany 
36 Gel Loading Dye, Blue (6 ×) Thermo Fisher Scientific, Germany 
37 Gentamycin Sigma-Aldrich, Germany 
38 Giemsa concentrate (10 ×) VWR, Germany 
39 Giemsa staining buffer (1 ×) VWR, Germany 
40 Giemsa staining solution (1 ×) Giemsa staining buffer, Giemsa 
concentrate 
41 Glass beads Sigma-Aldrich, Germany 
42 Glycerol Carl Roth, Germany 
43 Golden Fish Tetra, Germany 
44 Human A+ serum (pool from > 20 
donors) 
HAEMA, Blood Bank, Germany 
45 Human red blood cells (O 
positive, pool from > 8 donors) 
HAEMA, Blood Bank, Germany 
46 Hypoxantine liquid Neustadt, Germany 
47 Inoculation loops, plastic, 
disposable 
VWR International, Germany 
48 Kanamycin Sigma-Aldrich, Germany 
49 Ketamine Arzneimittelvertrieb, Germany 
50 LB-Agar Invitrogen, Germany 
51 Luria Broth (LB) base Invitrogen, Germany 
52 Magnesium Chloride Merck, Germany 
53 Magnesium Sulphate Merck, Germany 
54 MicroAmp Fast Optical 96-Well 
Reaction Plates 
Applied Biosystems, Germany 
55 MicroAmp Optical Adhesive Film Applied Biosystems, Germany 
56 Microscope slides Menzel, Germany 
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Materials, Equipment and Software 
No.: Material Supplier (Manufacturer), Country 
57 P. falciparum complete medium 
(asexual cultures) (RPMI 1641, 
10% Human A+ serum, 2% 
hypoxantine liquid, 20 μg/ml 
gentamycin, sterile filtered (0.22 
μm) and stored at 4 °C for max. 3 
weeks, or -20 °C for long term 
storage) 
Gibco Invitrogen, Germany 
58 P. falciparum complete medium 
(gametocyte cultures) (RPMI 
1641, 10% Human A+ serum, 2% 
hypoxantine liquid, sterile filtered 
(0.22 μm) and stored at 4 °C for 
max. 2 weeks, or -20 °C for long 
term storage) 
Gibco Invitrogen, Germany 
59 Parafilm Bemis, USA 
60 Pasteur pipettes Carl Roth, Germany 
61 PBS, sterile solution Gibco Invitrogen, Germany 
62 PCR tubes Greiner Bio-One, Germany 
63 Petri dishes Greiner, Germany 
64 pGEM-T Easy Promega, USA 
65 Phosphate-buffered saline (PBS), 
tablets 
Gibco Invitrogen, Germany 
66 Phusion High-Fidelity DNA 
Polymerase 
New England Biolabs, Germany 
67 Pipette tips, 10-1000 μl Sarstedt, Germany 
68 Proteinase K Invitrogen, Germany 
69 QIAprep Spin Miniprep Kit Qiagen, Germany 
70 QIAquick PCR Purification Kit Qiagen, Germany 
71 Restriction enzyme, FastDigest kit 
(BamHI, HindIII, BseNI  and 
NcoI) 
Thermo Fisher Scientific, Germany 
And Fermentas, USA 
72 Restriction enzymes kit (BamHI, 
HindIII, BseNI  and NcoI) 
New England, UK 
73 RPMI 1641, with L-glutamine and 
25mM HEPES 
Gibco Invitrogen, Germany 
74 Salt, table salt LIDL, Germany 
75 Sea salt Alnatura, Germany 
76 Super Optimal Culture (SOC) 
medium 
Thermo Scientific, Germany 
77 Sodium Acetate Carl Roth, Germany 
78 Sodium Chloride Carl Roth, Germany 
79 Sodium dodecyl sulphate (SDS) Sigma-Aldrich, Germany 
80 Sugar, table sugar LIDL, Germany 
81 Go Taq DNA polymerase kit Promega, USA 
82 Tris-Base Carl Roth, Germany 
83 Triton X-100 Carl Roth, Germany 
84 Tween-20 Sigma-Aldrich, Germany 
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No.: Material Supplier (Manufacturer), Country 
85 Xylazine Bayer Vital, Germany 
   
C Equipment 
No.: Material Supplier (Manufacturer), place 
86 Aspirator, mechanical Clarke, USA 
87 Bunsenburner LABOGAZ 470 Carl Roth, Germany 
88 Centrifuge 5804, for bacterial 
cultures 
Eppendorf, Germany 
89 Centrifuge, 96-well plates, 
benchtop 
Thermo Fisher Scientific, Germany 
90 Desktop office computer DELL, USA 
91 Fragment Analyser Advance Analytical, USA 
92 Freezer -20 °C Liebherr, Germany 
93 Freezer -80 °C Liebherr, Germany 
94 Fridge 4 °C Siemens, Germany 
95 Gel casting system VWR International, Germany 
96 Gel documentation system Gel 
Doc 2000 
BioRad, Germany 
97 Glass Midi-feeder 1.5 ml (for 
mosquito blood feeding) 
Coelen Glas, Germany 
98 Glassware Schott, Germany 
99 Ice machine AF200 Scotsman, Germany 
100 Incubator and shaker Innova 40 
(for liquid bacterial cultures) 
Eppendorf, Germany 
101 Incubator freezer BK 160 (for 
mosquitoes) 
Thermo Fisher Scientific, Germany 
102 Incubator Heraeus B6 (for plated 
bacterial cultures) 
Thermo Scientific, Germany 
103 Ipad Apple, USA 
104 Laminar flow, Herasfe KS12 Thermo Scientific, Germany 
105 MacBook Air laptop Apple, USA 
106 Microscope Leica DM2500 Leica, Germany 
107 Microscope Zeiss Axio 
Observer.Z1 
Zeiss, Germany 
108 Microscope Zeiss Stemi 2000-C 
Stereo 
Zeiss, Germany 
109 Mosquito cages Bugdorm, USA 
110 Nanodrop 2000c Thermo Scientific, Germany 
111 PCR Thermocycler MJ Mini Bio-Rad, Germany 
112 Pipette (2.5 μl , 20 μl , 200 μl, and 
1000 μl) 
Eppendorf, Germany 
113 Pipetting aid Pipetus Hirschmann Laborgeräte, Germany 
114 Portable Timer Carl Roth, Germany 
115 Sterile hood HERAsafe KS Thermo Scientific, Germany 
116 Thermo-mixer Mixmate Eppendorf, Germany 
117 TissueLyser LT Qiagen, Germany 
118 Vortex Vortex Genie, USA/ Scientific 
Industries, USA 
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No.: Material Supplier (Manufacturer), place 
119 Water bath, GFL 1002 GFL, Germany 
D Online Software and Software and database 
No.: Online server or 
software  
Purpose Link or Reference 
120 NCBI BLAST BLAST, Sequence retrival and 
alignment 
NCBI, USA 
121 Bioinformatics.org Primer design , Sequence in 
silico manipulations 
www.bioinformatics.o
rg/sms2 
122 Justbio Primer design , Sequence in 
silico manipulations 
www.justbio.com 
123 Datamonkey server exploring sequence alignments 
for evidence of selection forces 
acting the genes 
http://www.datamonk
ey.org/ 
124 Kalign Full-length multiple sequence 
alignments 
http://www.ebi.ac.uk/
Tools/msa/ 
125 Boxshade Full-length multiple sequence 
alignments 
http://www.ch.embnet
.org/software/BOX_fo
rm.html 
126 SNAP Calculate codon-based 
cumulative synonymous and 
non-synonymous substitutions 
references (151, 152) 
127 MEGA6 Phylogenetic sequence 
analyses 
Reference (148) 
128 PAML Phylogenetic sequence 
analyses and exploring 
sequence alignments for 
evidence of selection forces 
acting the genes 
Reference (170, 171) 
129 BEAST Phylogenetic sequence 
analyses 
Reference (150) 
130 DnaSP version 5.0 Sliding window analyses and 
neutrality tests; Tajima’s D, Fu 
and Li's D and Fu and Li's F 
statistics 
Reference (142, 143) 
131 ProSize software 
version 2.0 
Analyze PCR and RFLP 
fragments 
Advance Analytical 
Technical, USA 
132 TCS1.21 Estimating gene genealogies Reference (144) 
133 Pymol Molecular visualization and 
manipulation of TEP1 crystal 
structure 
www. pymol.org 
134 PhyML 3.0 Phylogenetic sequence 
analyses 
Reference (149) 
135 NCBI Primer-Blast Primer design NCBI, USA 
136 NCBI PubMed Search engine for scientific 
publications 
NCBI, USA 
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137 VectorBase Bioinformatics resource for 
invertebrate vectors of human 
pathogens 
NIAID, USA 
138 Adobe Photoshop CS5 Image editing Adobe Systems Inc., 
USA 
No.: Software/online server Purpose Link or Reference 
139 Adobe Illustrator CS5 Figure preparation Adobe Systems Inc., 
USA 
140 MS Office Preparation of Word 
/PowerPoint slides 
Microsoft, USA 
141 EndNote Bibliography Reference 
Manager 
ENDNOTE, 
Netherlands 
142 SeqMan Pro Sanger sequence assembly DNASTAR, USA 
143 Bioedit Editing, aligning sequences T. A. Hall (139) 
144 qGIS GIS, preparation of maps http://www.qgis.org/e
n/site/ 
145 FACS Checking parasitaemia in mice LSR Fortessa, USA 
146 R (version 3.3.2) Data analysis, statistics, and 
visualization 
R Core Team (2016) 
(141) 
147 RStudio (version 
0.99.893) 
Data analysis, statistics, and 
visualization 
RStudio Team (2015) 
148 r genetic package 
(version 1.3.8.1) 
Analyse population genetics R Repository (CRAN) 
149 dplyr R package 
(version 0.5.4) 
Data manipulation in R R Repository (CRAN) 
150 plyr R package (version 
1.8.4) 
Splitting, applying and 
combining data in R 
R Repository (CRAN) 
151 ggplot2 R package 
(version 2.2.1) 
Data visualizations in R R Repository (CRAN) 
152 cowplot R package 
(version 0.7.0) 
Streamline plot theme and plot 
annotations in ‘ggplot2’ 
R Repository (CRAN) 
153 reshape2 R package 
(version 1.4.2) 
Reshape data R Repository (CRAN) 
154 gridExtra R package 
(version 2.2.1) 
Apply functions for grid 
graphics 
R Repository (CRAN) 
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Appendix 2. Sample R scripts used to visualize the distribution of TEP1 variation 
Global and local distribution of TEP1 genotypes and alleles in Africa 
A Data description 
#R-Script to analyse the global and local levels (i.e. per country and sampling sites 
resüpectively) TEP1 genotypes. I stratified these TEP1 genotypes and allelic frequencies 
according to species, countries and sampling sites in Mali, Burkina Faso, Cameroon and 
Kenya, and specified color-blind friendly colors to be used in the graphs. 
cbbPalette <- c("#0072B2", "#999999", "#000000", "#56B4E9", "#D55E00","#9999CC", 
"#CC79A7", "#F0E442", "#009E73", "#E69F00", "#B2DF8A") 
#Respectively these colors were assigned to the following TEP1 genotypes and alleles: #1. 
"R1/R1" and "R1", #2. "R1/S1", #3. "R1/S2", #4. "R2/R2" and "R2", #5. "R2/S1", #6. 
"R2/S2", #7. "R3/R3" and "R3", #8. "R3/S1", #9. "S1/S1" and "S1"#10. "S1/S2", #11. 
"S2/S2"and "S2". 
#set default working directory (wdir) accordingly, where data files for analyses are stored 
and are fetched by R from. Put the data files in the wdir. 
getwd ()#check the current wdir 
rm(list = ls())#clear environment  
#MALVECBLOK data from our local data base (db) 
db <- read.csv ("mvb.1.csv",sep=",",dec=".")#load packages 
#library(genetics)# my known issue with the genetic R package is that it confuses the 
colors pellete assigned to the genotypes as some of its functions overlap/mask with 
functions from other loaded packages above. So I load it when I really need it. For now, I 
deactivate it. 
my_packages <- c("plyr", "ggplot2", " reshape2", " gridExtra", "cowplot") 
libraries(my_packages) 
#column names are "Individual.ID", "Country", "Sample.ID", "Site.Name", 
"SpeciesAbbr", "Species", "Genotype" 
#Abbreviation of countries by inserting a new column "CountryAbbr" 
db$CountryAbbr[as.factor(db$Country) == "Mali"] <- "ML" 
db$CountryAbbr[as.factor(db$Country) == "Burkina Faso"] <- "BF" 
db$CountryAbbr[as.factor(db$Country) == "Cameroon"] <- "CM" 
db$CountryAbbr[as.factor(db$Country) == "Kenya"] <- "KE" 
B Global TEP1 genotype distribution in Africa 
#Overview of TEP1 genotypes across Africa 
db1 <-subset(db, !SpeciesAbbr == "MS")#Omit the hybrids “MS”  
spp<-ggplot(db1, aes(x=factor(CountryAbbr, levels = c("ML", "BF", "CM", 
"KE")),fill=factor(Genotype)))+geom_bar(position="fill", 
width=0.62)+facet_wrap(~Species) 
spp<- spp+ggtitle ("Overview of TEP1 genotypes per species") + 
  xlab ("Country") + ylab("Genotype frequency") + 
  theme(legend.title = element_text(colour="black", size=10, face="bold")) + 
  theme(legend.text = element_text(colour="black", size=10, face="italic")) 
spp<-spp+ theme(legend.position="right") +scale_fill_manual(values=c("#0072B2", 
"#999999", "#000000", "#56B4E9", "#D55E00","#9999CC", "#CC79A7", "#F0E442", 
"#009E73", "#E69F00", "#B2DF8A"),name="Genotype",labels=c("R1/R1", "R1/S1", 
"R1/S2", "R2/R2", "R2/S1", "R2/S2","R3/R3", "R3/S1", "S1/S1", "S1/S2","S2/S2")) 
spp#Fig. 2-9 Overview of global TEP1 genotype distribution across Africa 
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 Global and local distribution of TEP1 genotypes and alleles in Africa 
C Local TEP1 genotype distribution 
 #Abbreviation of countries by inserting a new column "SiteAbbr2" to abbreviate the long 
sampling sites 
db$SiteAbbr2[as.factor(db$Site.Name) == "Nankilabougou"] <- "NK (Nankilabougou)" 
db$SiteAbbr2[as.factor(db$Site.Name) == "vk5"] <- "VK5 (Vale de Kou 5)" 
db$SiteAbbr2[as.factor(db$Site.Name) == "vk7"] <- "VK7 (Vale de Kou 7)" 
db$SiteAbbr2[as.factor(db$Site.Name) == "somousso"] <- "SM (Somousso)" 
db$SiteAbbr2[as.factor(db$Site.Name) == "Nkolbisson"] <- "NS (Nkolbisson)" 
db$SiteAbbr2[as.factor(db$Site.Name) == "Nkolkoumou"] <- "NM (Nkolkoumou)" 
db$SiteAbbr2[as.factor(db$Site.Name) == "Nkolondom"] <- "ND (Nkolondom)" 
db$SiteAbbr2[as.factor(db$Site.Name) == "Mfou"] <- "MF (Mfou)" 
db$SiteAbbr2[as.factor(db$Site.Name) == "Mvan"] <- "MV (Mvan)" 
db$SiteAbbr2[as.factor(db$Site.Name) == "Ahero"] <- "AH (Ahero)" 
db$SiteAbbr2[as.factor(db$Site.Name) == "Kakamega"] <- "KK (Kakamega)" 
db$SiteAbbr2[as.factor(db$Site.Name) == "Busia/Teso"] <- "BT (Busia Teso)" 
db$SiteAbbr2[as.factor(db$Site.Name) == "KWALE"] <- "KW (Kwale)" 
db$SiteAbbr2[as.factor(db$Site.Name) == "KILIFI"] <- "KL (Kilifi)" 
db$SiteAbbr2[as.factor(db$Site.Name) == "MALINDI"] <- "MD (Malindi)" 
#Abbreviation of species by inserting a new column "SpeciesAbbr2" and filling with 
respective 
#species abbreviations 
db$SpeciesAbbr2[as.factor(db$SpeciesAbbr) == "M"] <- "A. col" 
db$SpeciesAbbr2[as.factor(db$Species) == "A. gambiae s.s."] <- "A. gam" 
db$SpeciesAbbr2[as.factor(db$Species) == "MS"] <- "A.col/gam" 
db$SpeciesAbbr2[as.factor(db$Species) == "A. arabiensis"] <- "A. ara" 
db$SpeciesAbbr2[as.factor(db$Species) == "A. merus"] <- "A. mer" 
# ML: One site Nankilabogou site (NK) 
#In BF: Three ecological villages sites Vale de Kou (VK5 and VK7) and Somousso (SM) 
#combined graph of ML and BF with respect to species: A. coluzzii and A. gambiae s.s. in 
their respective sampling sites. I organize by site 
mlbf<-subset(db, CountryAbbr!= "CM") 
mlbf<-subset(mlbf, CountryAbbr!= "KE") 
#mlbf<-subset(mlbf, SpeciesAbbr!= "MS") 
#re-order the factors 
mlbf$SiteAbbr2_f = factor(mlbf$SiteAbbr2, levels=c('NK (Nankilabougou)','VK5 (Vale 
de Kou 5)', 'SM (Somousso)','VK7 (Vale de Kou 7)')) 
#ML and BF# 
MLBFsite<-ggplot(mlbf, aes(x=factor(SpeciesAbbr2),fill=factor(Genotype))) + 
  geom_bar(position="fill", width =0.5)+ facet_wrap(~SiteAbbr2_f) 
MLBFsite<- MLBFsite+scale_fill_manual(values=c("#0072B2", "#999999", "#000000", 
     "#56B4E9", "#D55E00", "#009E73"),name="Genotype",labels=c("R1/R1", "R1/S1", 
"R1/S2",  "R2/R2", "R2/S1", "S1/S1")) 
MLBFsite<-MLBFsite+ggtitle ("Sympatric and allopatric vector populations in ML and 
BF") +xlab ("Species") + ylab("Genotype frequency") +theme(legend.title = 
element_text(colour="black", size=10, face="bold")) +theme(legend.text = 
element_text(colour="black", size=10, face="italic")) 
#MLBFsite<-MLBFsite+ theme(legend.position="right") 
MLBFsite#Fig 2-10A 
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cm$SiteAbbr2_f = factor(cm$SiteAbbr2, levels=c('MF (Mfou)','MV (Mvan)', 'NS 
(Nkolbisson)', 'ND (Nkolondom)','NM (Nkolkoumou)')) # order the factor (sites) in CM 
CMsite<-ggplot(cm, aes(x=factor(SpeciesAbbr2),fill=factor(Genotype))) 
+geom_bar(position="fill", width=0.62)+  facet_wrap(~SiteAbbr2_f) 
CMsite<-CMsite+ggtitle ("Different vector populations in CM select for similar 
genotypes") +   xlab ("Species") + ylab("Genotype frequency") + 
  theme(legend.title = element_text(colour="black", size=10, face="bold")) + 
  theme(legend.text = element_text(colour="black", size=10, face="italic")) 
CMsite<-CMsite+ theme(legend.position="right") 
CMsite<- CMsite+scale_fill_manual(values=c("#56B4E9", "#D55E00","#9999CC", 
"#009E73", "#E69F00","#B2DF8A"),name="Genotype",labels=c("R2/R2", "R2/S1", 
"R2/S2", "S1/S1","S1/S2","S2/S2")) 
CMsite#Fig 2-10B 
ke<-subset(db, CountryAbbr=="KE")#KE 
KEsite<-ggplot(ke, aes(x=factor(SpeciesAbbr2),fill=factor(Genotype))) 
+geom_bar(position="fill", width=0.62)+  facet_wrap(~SiteAbbr2) 
KEsite<-KEsite+scale_fill_manual(values=c( "#56B4E9", "#D55E00","#9999CC", 
"#CC79A7", "#F0E442", "#009E73", "#B2DF8A"),name="Genotype",labels=c("R2/R2", 
"R2/S1", "R2/S2","R3/R3", "R3/S1", "S1/S1","S2/S2")) 
KEsite<-KEsite+ggtitle ("Different vector populations in KE select for similar 
genotypes") +   xlab ("Species") + ylab("Genotype frequency") + 
  theme(legend.title = element_text(colour="black", size=10, face="bold")) + 
  theme(legend.text = element_text(colour="black", size=10, face="italic")) 
KEsite<-KEsite+ theme(legend.position="right") 
KEsite#Fig. 2-10C 
D Local TEP1 allele frequency distribution 
 adb <- read.csv ("mvb.1.csv",sep=",",dec=".") 
#merging sites into sampling regions in BF (VK5 and VK7, and SM), CM (All sites 
together as CM), and KE (into western Kenya (WK) and coastal Kenya (CK)) into the 
column "MergedAbbr". Mali-Nankilabougou remains to be NK 
adb["MergedAbbr"] <- NA#Insert a new column to the data set file with NA values. 
Below codes replaces accorning the NA values with our desired Merged site names 
adb$MergedAbbr[as.factor(adb$Site.Name) == "Nankilabougou"] <- "NK"#Site 
Nakilabougou (NK) in Mali remains as NK 
adb$MergedAbbr[as.factor(adb$Site.Name) == "vk5"] <- "VK"#VK5 and VK7 are 
merged as VK 
adb$MergedAbbr[as.factor(adb$Site.Name) == "vk7"] <- "VK"#VK5 and VK7 are 
merged as VK 
adb$MergedAbbr[as.factor(adb$Site.Name) == "somousso"] <- "SM"#Somousso in BF 
remains as SM 
adb$MergedAbbr[as.factor(adb$Site.Name) == "Ahero"] <- "WK"#Ahero, Kakamega and 
Busia Teso are merged as WK 
adb$MergedAbbr[as.factor(adb$Site.Name) == "Kakamega"] <- "WK"#Ahero, 
Kakamega and Busia Teso are merged as WK 
adb$MergedAbbr[as.factor(adb$Site.Name) == "Busia/Teso"] <- "WK"#Ahero, 
Kakamega and Busia Teso are merged as WK 
adb$MergedAbbr[as.factor(adb$Site.Name) == "KILIFI"] <- "CK"#Kwale, Kilifi and 
Malindi are merged as CK 
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adb$MergedAbbr[as.factor(adb$Site.Name) == "KWALE"] <- "CK"#Kwale, Kilifi and 
Malindi are merged as CK 
adb$MergedAbbr[as.factor(adb$Site.Name) == "MALINDI"] <- "CK"#Kwale, Kilifi and 
Malindi are merged as CK 
adb$MergedAbbr[as.factor(adb$Site.Name) == "Nkolbisson"] <- "CM"#All CM sites are 
merged as CM 
adb$MergedAbbr[as.factor(adb$Site.Name) == "Nkolkoumou"] <- "CM"#All CM sites 
are merged as CM 
adb$MergedAbbr[as.factor(adb$Site.Name) == "Nkolondom"] <- "CM"#All CM sites are 
merged as CM 
adb$MergedAbbr[as.factor(adb$Site.Name) == "Mfou"] <- "CM"#All CM sites are 
merged as CM 
adb$MergedAbbr[as.factor(adb$Site.Name) == "Mvan"] <- "CM"#All CM sites are 
merged as CM 
# I use genetic R package or subsetting (TEP1 genotype splitting) approach. Here, I use 
the TEP1 genotype splitting approach. 
# First, I split up TEP1 genotype column into two other columns containing the respective 
alleles, and call the new data file adb.melt 
adb.alleles <- colsplit(adb$Genotype, "/", c("Allele1", "Allele2")) 
# Combine original and new data frame 
adb <- cbind(adb, adb.alleles) 
# In adb.melt file, melt variable columns Genotype, Allele1 and Allele2 together to form a 
new column called TEP1stutus, and another column called Allele 
adb.melt <- melt(adb, measure.vars = c("Genotype", "Allele1", "Allele2"), 
variable.name="TEP1status", value.name= "Allele") 
adb.melt<-subset (adb.melt, !TEP1status=="Genotype")#remove genotype class, because 
we only need to analyse Allele1 and Allele2 variables, which we need work with to 
calculate allele frequencies. This should be reproducible with genetic r package. 
adb.melt <- subset(adb.melt, !SpeciesAbbr=="MS")#omit hybrids 
AFsiteA<-ggplot(adb.melt, aes(x=factor(MergedAbbr,levels 
=c("NK","SM","VK","CM","WK","CK")),fill=factor(Allele))) 
+geom_bar(position="fill", width=0.62)+facet_wrap(~Species) 
#AFsiteEA 
AFsiteA<- AFsiteA+ggtitle ("Allele frequencies in all ssp. in Africa") + 
  xlab ("Country") + ylab("Allele frequency") + theme(legend.title = 
element_text(colour="black", size=10, face="bold")) + 
  theme(legend.text = element_text(colour="black", size=10, face="italic")) 
AFsiteA<-AFsiteA+ theme(legend.position="right") 
#AFsiteA 
AFsiteA<- AFsiteA+scale_fill_manual(values=c("#0072B2","#56B4E9", 
"#CC79A7","#009E73","#B2DF8A"), 
                                    name="Allele", 
                                    labels=c("R1","R2","R3", "S1","S2")) 
AFsiteA#Fig. 2-11 
 #End# 
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Appendix 3. Equations in population genetics and R script used in this study 
Equations and part of the R script that were used in population genetics 
A Hardy Weinberg Equilibrium (HWE), Inbreeding and inbreeding coefficient 
Assuming the Wrights Fisher model, an ideal panmictic diploid organisms, for example 
the mosquitoes, mate randomly such that haploid gametes fuse to form a zygote with 
equal chances to produce the progeny into the next population. Considering the example I 
used in the HWE introduction in chapter 1 of this thesis: 
TEP locus can have two alleles, say R and S;  
          their allele frequencies will given by p and q respectively; and  thus, 
q = 1- p. 
Genotype frequencies will be given by: 
p2 for the genotype of RR; 
2pq  for the genotype of RS; and 
 q2     for the genotype of RS.   
Knowing the counts of individual genotypes that are observed in the population, the p and 
q allele frequencies can be calculated, and expected genotypes can be predicted by 
multiplying the individual observed genotype counts by their respective p2, 2pq and q2 
genotype frequencies.  
In this context, inbreeding occurs when members of the same genotypes mate together, 
leading to higher probability (P) progeny of one observed genotype (G), say RR in this 
case, being identical by descent. 
Inbreeding coefficient (f) measures relative deviation from the HWE expectations. The f is 
calculated as; 
If the genotypes are not experiencing the inbreeding, but are instead mating preferentially 
(selectively) with other genotypes leading to high heterozygosities in the population, then 
the homozygote population is said to be breaking or undergoing the Wahlund effect. 
B Fixation indices 
Sewall Wright introduced three inbreeding coefficients that a structured population can 
have. These are called fixation indices or F-statistics namely: FIS, FIT and FST. FIS 
measures deficiency of heterozygote individuals considering the allele frequencies in the 
subpopulation. FIT measures deficiency of heterozygote individuals considering the allele 
frequencies in the total population. Therefore, both the FIS and FIT consider observed 
heterozygote individuals. The FST measures the difference between the expected and 
observed heterozygosity of subpopulations in comparison to the total population. The FST 
thus, takes into account allele frequency between demes (subpopulations), and may 
depend on species. Because it measures excess of homozygotes, its little value e.g. 0.2 in 
mosquito population may be considered huge and suggest that the population is structured. 
Generally; 
 = , where fx can be FIS, or FIT or FST. 
In this case, you can have two subpopulations, A and B. 
Will be given by  
HS = 2pq (Heterozygotes in A only), HT = 2pq (Sum of heterozygotes of A and B), and HI 
= p (Observed frequency of heterozygotes of A). 
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It follows that; 
 = ,   = ,   =   or  . 
Below is a part of the R script that was used to calculate the inbreeding coefficient and the 
F-statistics, using Mali’s two demes for sympatric A. coluzzii and A. gambiae s.s. 
populations. 
C A part of an R script that I used to calculate the Fixation indices 
 # load packages 
rm(list = ls())#clear environment 
my_packages2 <- c("plyr", " genetics", " reshape2") 
libraries(my_packages2) 
getwd()#check the current wdir, and set it if necessary 
# data set 
db <- read.csv ("mvb.1.csv",sep=",",dec=".")#The column names in the dataset are 
Individual.ID","Country","Sample.ID","Site.Name","SpeciesAbbr","Species","Genotype". 
#Abbreviation of countries by inserting a new column "CountryAbbr". The Country 
column has four levels: Mali, Burkina Faso, Cameroon and Kenya 
db$CountryAbbr[as.factor(db$Country) == "Mali"] <- "ML" 
db$CountryAbbr[as.factor(db$Country) == "Burkina Faso"] <- "BF" 
db$CountryAbbr[as.factor(db$Country) == "Cameroon"] <- "CM" 
db$CountryAbbr[as.factor(db$Country) == "Kenya"] <- "KE" 
#Calculation of Mali local F statistics on the A.coluzzii population 
ml<-subset(db, CountryAbbr =="ML")#Extract ML data only 
mlc<-subset(ml, SpeciesAbbr =="M")#Extract A. coluzzii only 
#Define Genotypes as objects using r-genetic package 
mlc$Genotype <- genotype(mlc$Genotype) 
#Step 1. Calculate allele frequencies using genetic package etc compare that you get these 
the figures. Compare that you get same figures as in Steps 6 and 7. 
summary(mlc$Genotype)#check mosquito counts, allele and genotype frequencies; 
Genotype = c("R1/R1", "R1/S1", "R1/S2", "S1/S1", "S1/S2","S2/S2"), observed genotype 
frequencies= c(87,21,1,7,0,0) 
R1f1<-(2*87+21+1)/(2*gc1)#[1] 0.8448276#Allele frequency of R1 
S1f1<-(21+2*7+0)/(2*gc1)#[1] 0.1508621#Allele frequency of S1 
S2f1<-(1+0+0)/(2*gc1)#[1] 0.004310345#Allele frequency of S1 
R1f1+S1f1+S2f1#[1] 0.8448276#Global gene frequency is CORRECT if it adds up to 1 
#Define those allele frequencies (p,q,r...) and total genotype counts (gc), 
#mannual calculation of allele frequencies to four significant numbers may be better than 
using r genetic package (two significant numbers). Be sure to cross check accurately. 
p1=0.8448#R1 allele frequency in 4 significant figures 
q1=0.1509#S1 allele frequency in 4 significant figures 
r1=0.0043#S2 allele frequency in 4 significant figures 
gc1=116#Total number of genotyped mosquitoes 
#Step 2 Calculate expected genotypic counts according to the Hardy Weinberg 
Equilibrium 
c(gc1*p1^2,gc1*2*p1*q1,gc1*2*p1*r1,gc1*q1^2,gc1*2*q1*r1,gc1*r1^2)#[1] 
82.78769664 29.57543424  0.84277248  2.64141396  0.15053784  0.00214484 
#Create a data frame (MLc) containing the observed and the expected genotype 
frequencies 
MLc <- data.frame(Country = "ML", Site ="NK", Population = "A. coluzzii",Genotype= 
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c("R1/R1", "R1/S1", "R1/S2", "S1/S1", "S1/S2","S2/S2"), 
Observed= c(87,21,1,7,0,0), Expected 
=c(gc1*p1^2,gc1*2*p1*q1,gc1*2*p1*r1,gc1*q1^2,gc1*2*q1*r1,gc1*r1^2)) 
#Calculate the HWE excess or deficiency of each genotype between the observed and the 
expected frequencies 
MLc["ObsExpDifference"]<-(MLc$Observed)-(MLc$Expected) 
#Calculate homozygote excess or deficiency in relation to HWE 
MLchm<-subset(MLc, !Genotype== "R1/S1")#Omit "R1/S1" 
MLchm<-subset(MLchm, !Genotype== "R1/S2")#Omit "R1/S2" 
MLchm<-subset(MLchm, !Genotype== "S1/S2")#Omit "S1/S2" 
sum(MLchm$ObsExpDifference) 
#[1] 8.568745 
#Percentage Homozygote excess or deficiency# excess means its inbred and 
#deficiency means its outbred or under Wahlund effect therefore the isolate is breaking 
sum(MLchm$ObsExpDifference)/sum(MLchm$Expected)*100#Percentage Homozygote 
excess 
#[1] 10.02999 shows that there is excess of homozygotes hence inbreeding occurs 
#Step 3 Calculate the local observed heterozgosities, Hobs. The genotypes are Counted 
MLcht<-subset(MLc, !Genotype== "R1/R1")#Exclude "R1/R1" 
MLcht<-subset(MLcht, !Genotype== "S1/S1")#Exclude "S1/S1" 
MLcht<-subset(MLcht, !Genotype== "S2/S2")#Exclude "S2/S2" 
HobsMLc<-sum(MLcht$Observed)/gc1#frequency of local observed heterozgosities 
HobsMLc#[1] 0.1896552 
#Step 4 Calculate local expected heterozygosity or gene diversity 
HexpMLc<-1-(p1^2+q1^2+r1^2)#Frequency of local expected heterozygosity method2 
HexpMLc#[1] 0.2635237 ie 26% 
#Step 5 Calculate local (or global) inbreeding coefficient, Fs using step 3 and step 4 
FsMLc<-(HexpMLc-HobsMLc)/HexpMLc 
FsMLc#[1] 0.2803106 i.e. 28% 
#Zero value means that the observed genotypes are according to HWE expectations 
#positive Fs (fewer heterozygotes than expected)indicates inbreeding# 
#negative Fs (more heteroyzgote than expected) shows excess out breeding 
#Step 6 and 7 Calculate p-bar the frequency of R1 over the total population 
R1f1<-(2*87+21+1)/(2*gc1)#[1] 0.8448276#Allele frequency of R1 
S1f1<-(21+2*7+0)/(2*gc1)#[1] 0.1508621#Allele frequency of S1 
S2f1<-(1+0+0)/(2*gc1)#[1] 0.004310345#Allele frequency of S1 
R1f1+S1f1+S2f1#[1] 0.8448276#Global gene frequency is CORRECT if it adds up to 1 
#Step 8 calculate global hererozygosity indices 
#Calculation of Mali local F statistics on the A. gambiae s.s. subpopulation (The second 
species in sympatry with the A. coluzzii) 
mlg<-subset(ml, SpeciesAbbr =="S")#Extract A. gambiae s.s. subset 
mlg$Genotype<-genotype(mlg$Genotype)#define "Genotype" column to be genotypes of 
A. gambiae s.s. mosquitoes using the r-genetic package 
summary(mlg$Genotype)#Check frequencies of mosquitoes, alleles and genotypes 
#Step 1. Calculate allele frequencies using r genetic package etc and 
#Define those allele frequencies(p,q,r...) and total genotypeCounts (gc) 
#Define #Genotype = c("R1/R1", "R1/S1", "R1/R2","R2/R2", "R2/S1", "S1/S1") 
#Define observed genotype frequencies#Observed= c(0,2,0,4,54,0,90,0,0) 
gc2=150#total mosquitoes genotyped for this species 
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#calculation of allele frequencies. Cross check accurately. 
p2=R1f<-(1*2)/(2*gc2)#[1] 0.006666667#Allele frequency of R1 
q2=R2f<-((2*4)+(1*54))/(2*gc2)#[1] 0.2066667#Allele frequency of R2 
r2=S1f<-((2*90)+(1*54)+(1*2))/(2*gc2)#[1] 0.7866667#Allele frequency of S1 
p2+q2+r2#=1 Global gene frequency is CORRECT when it adds up to 1 
#Step 2 #Calculate expected genotypic counts 
c(gc2*p2^2,gc2*2*p2*q2,gc2*2*p2*r2,gc2*q2^2,gc2*2*q2*r2,gc2*r2^2)#[1]  
0.006666667  0.413333333  1.573333333  6.406666667 48.773333333 92.826666667 
#Create a data frame containing the observed and the expected genotype frequencies 
MLg <- data.frame(Country = "ML", Site ="NK", Population = "A. gambiae s.s.", 
Genotype= c("R1/R1", "R1/R2", "R1/S1","R2/R2", "R2/S1", "S1/S1"), 
Observed= c(0,0,2,4,54,90), Expected 
=c(gc2*p2^2,gc2*2*p2*q2,gc2*2*p2*r2,gc2*q2^2,gc2*2*q2*r2,gc2*r2^2)) 
#Calculate the HWE excess or deficiency of each genotype between the observed and the 
expected frequencies 
MLg["ObsExpDifference"]<-(MLg$Observed)-(MLg$Expected) 
#Calculate homozygote excess or defieciency in relation to HWE 
MLghm2<-subset(MLg, !Genotype == "R1/R2")#Exclude "R1/R2" 
MLghm2<-subset(MLghm2, !Genotype == "R1/S1")#Exclude "R1/S1" 
MLghm2<-subset(MLghm2, !Genotype == "R2/S1")#Exclude "R2/S1" 
sum(MLghm2$ObsExpDifference)#[1] -5.24 
#Percentage Hom excess or defiecieny# excess means its inbred and 
#defeiciency means its outbred or under Wahlund effect therefore the isolate is breaking 
sum(MLghm2$ObsExpDifference)/sum(MLghm2$Expected)*100#[1] -
5.280129#Percentage Homozygote excess 
#Step 3 Calculate the local observed heterozgosities, Hobs. Count the genotypes 
MLght2<-subset(MLg, !Genotype == "R1/R1")#Omit "R1/R1" 
MLght2<-subset(MLght2, !Genotype == "R2/R2")#Omit "R2/R2" 
MLght2<-subset(MLght2, !Genotype == "S1/S1")#Omit "S1/S1" 
HobsMLg<-sum(MLght2$Observed)/gc2#frequency of local observed heterozgosities 
HobsMLg#[1] 0.3733333 
#Step 4 Calculate local expected heterozygosity or gene diversity 
HexpMLg<- 1-(p2^2+q2^2+r2^2)#Frequency of local expected heterozygosity method2 
HexpMLg#[1] 0.3384 
#Step 5 Calculate local (or global) inbreeding coefficient, Fs using step 3 and step 4 
Fs2MLg<-(HexpMLg-HobsMLg)/HexpMLg 
Fs2MLg#[1] -0.1032309 
#Zero means its according to HWE expectations 
#positive Fs (fewer heterozygotes than expected)indicates inbreeding# 
#negative Fs (more heteroyzgote than expected) shows excess out breeding 
#Step 6 and 7 Calculate p-bar the frequency of R1 over the total population 
R1f2<-(2*0+2+0)/(2*gc2)#[1] 0.006666667#Allele frequency of R1 
R2f2<-(2*4+54+0)/(2*gc2)#[1] 0.2066667#Allele frequency of R2 
S1f2<-(2+54+(2*90)+0)/(2*gc2)#[1] 0.7866667#Allele frequency of S1 
R1f2+R2f2+S1f2#[1] 1 
#Global gene frequency is CORRECT add upto 1 
#Step 8 calculate global hererozygosity indices( over individuals, subpopulations and 
Total population) 
#First two calculations employ a weighted average of the values in the whole set of 
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subpopulations 
#H1 based on observed heterozygosities in individuals in subpopulations 
H1MLcg<- (HobsMLc*116+HobsMLg*150)/(116+150) 
H1MLcg#[1] 0.2932331 
#Hs based on expected heterozygosities in subpopulations 
HsMLcg<- (HexpMLc*116+HexpMLg*150)/(116+150) 
HsMLcg#[1] 0.3384 
#Ht based on expected heterozygosities for overall total populations-using global allele 
frequencies 
MLR1bar = ((p1*232)+(p2*300))/532#[1] 0.3721684 
MLR2bar = ((q2*300))/532#[1] 0.1165414 
MLS1bar = ((q1*232)+(r2*300))/532#[1] 0.509415 
MLS2bar = ((r1*232))/532#[1] 0.001875188 
MLR1bar+MLR2bar+MLS1bar+MLS2bar#[1] 1 
HtMLcg<- 1-((MLR1bar)^2+(MLR2bar)^2+(MLS1bar)^2+(MLS2bar)^2) 
HtMLcg#[1] 0.5884016 
#Step 9 Calculate global F-statistics 
#Compare and contrast the global Fis below with the 'local inbreeding coefficient' Fs of 
step 5. 
#Here we are using a weighted average of the individual heterozygosities over all the 
subpopulations. 
#Both Fis and Fs are based on the observed heterozygosities, 
#where as Fst and Fit are based on the expected heterozygosities 
FisMLcg <- (HsMLcg-H1MLcg)/HsMLcg#[1] 0.133472#Fis 
FstMLcg <- (HtMLcg-HsMLcg)/HtMLcg#[1] 0.4248826#Fst 
FitMLcg <- (HtMLcg-H1MLcg)/HtMLcg#[1] 0.5016446#Fit 
#End# 
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 Statistical Tests for the Hardy Weinberg Equilibrium 
Chi-square tests on the HWE. Asterisk (*) indicates significant deviation from the HWE at χ20.05, p>0.05. 
χ2 Cal  (1) =  standard χ2, while χ2 Cal  (2) = conservative χ2 that corrects for small sample size. See pages 22-23. 
 Country Site Species Genotype Obs Exp Obs-Exp χ2 Cal  (1) χ2 Cal (2) χ20.05  
1 ML NK A. col R1/R1 87 82.788 4.212 0.214 0.17  
2 ML NK A. col R1/S1 21 29.575 -8.575 2.486 2.2  
3 ML NK A. col R1/S2 1 0.843 0.157 0.029 0.14  
4 ML NK A. col S1/S1 7 2.641 4.359 7.192 5.64  
5 ML NK A. col S1/S2 0 0.151 -0.151 0.151 0.81  
6 ML NK A. col S2/S2 0 0.002 -0.002 0.002 115.56  
       df = 3 ∑10.07* ∑124.52* 7.815 
7 ML NK A. gam R1/R1 0 0.007 -0.007 0.007 36.51  
8 ML NK A. gam R1/R2 0 0.413 -0.413 0.413 0.02  
9 ML NK A. gam R1/S1 2 1.573 0.427 0.116 0  
10 ML NK A. gam R2/R2 4 6.407 -2.407 0.904 0.57  
11 ML NK A. gam R2/S1 54 48.773 5.227 0.560 0.46  
12 ML NK A. gam S1/S1 90 92.827 -2.827 0.086 0.06  
       df = 3 ∑2.086 ∑37.61* 7.815 
13 BF SM A. col R2/R2 2 2.083 -0.083 0.003 0.08  
14 BF SM A. col R2/S1 6 5.833 0.167 0.005 0.02  
15 BF SM A. col S1/S1 4 4.083 -0.083 0.002 0.04  
       df = 1 ∑0.010 ∑0.14 3.841 
16 BF SM A. gam R1/R1 0 0.005 -0.005 0.005 46.01  
17 BF SM A. gam R1/R2 0 0.351 -0.351 0.351 0.06  
18 BF SM A. gam R1/S1 1 0.638 0.362 0.205 0.03  
19 BF SM A. gam R2/R2 9 5.793 3.207 1.776 1.27  
20 BF SM A. gam R2/S1 15 21.064 -6.064 1.746 1.47  
21 BF SM A. gam S1/S1 22 19.149 2.851 0.424 0.29  
       df = 3 ∑4.508 ∑49.12* 7.815 
22 CM MV A. col R2/R2 0 0.316 -0.316 0.316 0.11  
23 CM MV A. col R2/S1 6 6.456 -0.456 0.032 0  
24 CM MV A. col R2/S2 4 2.911 1.089 0.407 0.12  
25 CM MV A. col S1/S1 34 32.924 1.076 0.035 0.01  
26 CM MV A. col S1/S2 28 29.696 -1.696 0.097 0.05  
27 CM MV A. col S2/S2 7 6.696 0.304 0.014 0.01  
       df = 3 ∑0.901 ∑0.29 7.815 
28 CM MV A. gam R2/R2 0 0.593 -0.593 0.593 0.01  
29 CM MV A. gam R2/S1 8 5.630 2.370 0.998 0.62  
30 CM MV A. gam R2/S2 0 1.185 -1.185 1.185 0.4  
31 CM MV A. gam S1/S1 13 13,370 -0.370 0.010 0  
32 CM MV A. gam S1/S2 4 1.653 2.347 3.331 2.06  
33 CM MV A. gam S2/S2 2 0.593 1.407 3.343 1.39  
       df = 3 ∑9.459* ∑4.49 7.815 
34 CM NS A. col R2/R2 2 1.359 0.641 0.,303 0.01  
35 CM NS A. col R2/S1 16 16.413 -0.413 0.010 0  
36 CM NS A. col R2/S2 5 5.870 -0.870 0.129 0.02  
37 CM NS A. col S1/S1 49 49.567 -0.567 0.006 0  
38 CM NS A. col S1/S2 37 35.452 1.548 0,068 0.03  
39 CM NS A. col S2/S2 6 6.339 -0.339 0.018 0  
       df = 3 ∑0.534 ∑0.07 7.815 
40 CM NS A. gam R2/R2 6 8.975 -2.975 0.986 0.68  
41 CM NS A. gam R2/S1 86 76.698 9.302 1.128 1.01  
42 CM NS A. gam R2/S2 1 4.352 -3.352 2.581 1.87  
43 CM NS A. gam S1/S1 159 163.85 -4.854 0.144 0.12  
44 CM NS A. gam S1/S2 19 4.960 14.040 39.74 36.96  
45 CM NS A. gam S2/S2 2 0.527 1.473 4.111 1.79  
       df = 3 ∑48.69* ∑42.43* 7.815 
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 Statistical Tests for the Hardy Weinberg Equilibrium 
Chi-square tests on the HWE. Asterisk (*) indicates significant deviation from the HWE at χ20.05, p>0.05. 
χ2 Cal  (1) =  standard χ2, while χ2 Cal  (2) = conservative χ2 that corrects for small sample size. See pages 22-23. 
 Country Site Species Genotype Obs Exp Obs-Exp χ2 Cal  (1) χ2 Cal (2) χ20.05  
46 CM MF+ 
ND+ 
NM 
A. col R2/R2 0 0.766 -0.766 0.766 
0.09 
 
47 CM MF+ 
ND+ 
NM 
A. col R2/S1 6 5.031 0.969 0.187 
0.04 
 
48 CM MF+ 
ND+ 
NM 
A. col R2/S2 1 0,438 0,563 0.723 
0.01 
 
49 CM MF+ 
ND+ 
NM 
A. col S1/S1 8 8.266 -0.266 0.009 
0.01 
 
50 CM MF+ 
ND+ 
NM 
A. col S1/S2 1 1.438 -0.438 0.133 
0 
 
51 CM MF+ 
ND+ 
NM 
A. col S2/S2 0 0.063 -0.063 0.063 
3.06 
 
       df = 3 ∑1.880 ∑3.22 7.815 
52 CM MF+ 
ND+ 
NM 
A. gam R2/R2 6 11.207 -5.207 2.419 
1.98 
 
53 CM MF+ 
ND+ 
NM 
A. gam R2/S1 106 97.067 8.933 0.822 
0.73 
 
54 CM MF+ 
ND+ 
NM 
A. gam R2/S2 6 4.519 1.481 0.485 
0.21 
 
55 CM MF+ 
ND+ 
NM 
A. gam S1/S1 207 210.181 -3.181 0.048 
0.03 
 
56 CM MF+ 
ND+ 
NM 
A. gam S1/S2 17 5.167 11.833 27.102 
24.86 
 
57 CM MF+ 
ND+ 
NM 
A. gam S2/S2 1 0.456 0.544 0.651 
0 
 
       df = 3 ∑31.52* ∑27.82* 7.815 
58 KE AH A. ara R2/R2 19 9.600 9.400 9.204 8.25  
59 KE AH A. ara R2/S1 10 28.800 -18.800 12.27 11.63  
60 KE AH A. ara S1/S1 31 21.600 9.400 4.091 3.67  
       df = 1 ∑25.56* ∑23.55* 3.841 
61 KE AH A. gam R2/R2 6 3.521 2.479 1.746 1.11  
62 KE AH A. gam R2/S1 1 5.958 -4.958 4.126 3.34  
63 KE AH A. gam S1/S1 5 2.521 2.479 2.438 1.55  
       df = 1 ∑8.310* ∑6* 7.815 
64 KE BT A. gam R2/R2 4 2.196 1.804 1.482 0.77  
65 KE BT A. gam R2/S1 18 22.446 -4.446 0.881 0.69  
66 KE BT A. gam R2/S2 1 0.163 0.837 4.311 0.7  
67 KE BT A. gam S1/S1 60 57.361 2.639 0.121 0.08  
68 KE BT A. gam S1/S2 0 0.831 -0.831 0.831 0.13  
69 KE BT A. gam S2/S2 0 0.003 -0.003 0.003 82  
       df = 3 ∑7.630 ∑84.38* 7.815 
70 KE KK A. ara R2/R2 0 0.800 -0.800 0.800 0.11  
71 KE KK A. ara R2/S1 1 2.400 -1.400 0.817 0.34  
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 Statistical Tests for the Hardy Weinberg Equilibrium 
Chi-square tests on the HWE. Asterisk (*) indicates significant deviation from the HWE at χ20.05, p>0.05. 
χ2 Cal  (1) =  standard χ2, while χ2 Cal  (2) = conservative χ2 that corrects for small sample size. See pages 22-23. 
 Country Site Species Genotype Obs Exp Obs-Exp χ2 Cal  (1) χ2 Cal (2) χ20.05  
72 KE KK A. ara S1/S1 4 1.800 2.200 2.689 1.61  
       df = 1 ∑4.306* ∑2.06 3.841 
73 KE KK A. gam R2/R2 2 0.333 1.667 8.333 4.08  
74 KE KK A. gam R2/S1 2 5.333 -3.333 2.083 1.51  
75 KE KK A. gam S1/S1 23 21.333 1.667 0.130 0.06  
       df = 1 ∑10,54* ∑5.65* 3.841 
76 KE MD A. ara R2/R2 4 3.571 0.429 0.051 0  
77 KE MD A. ara R2/S1 2 2.,857 -0.857 0.257 0.04  
78 KE MD A. ara S1/S1 1 0.571 0.429 0.321 0.01  
       df = 1 ∑0.630 ∑0.06 3.841 
79 KE MD A. mer R2/R2 3 1.455 1.545 1.642 0.75  
80 KE MD A. mer R2/R3 0 2.000 -2.000 2.000 1.13  
81 KE MD A. mer R2/S1 10 10.727 -0.727 0.049 0  
82 KE MD A. mer R2/S2 0 0.364 -0.364 0.364 0.05  
83 KE MD A. mer R3/R3 3 0.688 2.313 7.778 4.78  
84 KE MD A. mer R3/S1 5 7.375 -2.375 0.765 0.48  
85 KE MD A. mer R3/S2 0 0.250 -0.250 0.250 0.25  
86 KE MD A. mer S1/S1 22 19.778 2.222 0.250 0.15  
87 KE MD A. mer S1/S2 0 1.341 -1.341 1.341 0.53  
88 KE MD A. mer S2/S2 1 0.023 0.977 42.02 10.02  
       df = 6 ∑56.46* ∑18.14* 12.59 
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The full-length sequences of TEP1*R3 (highlighted in grey color) compared to *R1 and *R2 alleles 
from Mali, *R2 and *S1 alleles from Cameroon, and *R1,*R2, *S1 alleles from insectary strains. Intronic 
regions (in bold) with modifications for TEP1*R3 are highlighted in Turquoise color. 
Appendix 5. TEP*R3 full-length nucleotide alignment with other allele sequences 
*R1_ML 1 ATGTGGCAGTTCATAAGGTCACGAATATTAACGGTGATAATCTTCATAGGTGCTGCTCAT 
*R1_L3_5 1 ............................................................ 
*R2_4Arr    1 ............................................................ 
*R2_ML 1 ............................................................ 
*R3_KE 1 ............................................................ 
*R3_KE. 1 ............................................................ 
*S1_G3S3 1 ............................................................ 
*S1_CM 1 ............................................................ 
*S2_4Arr 1 ............................................................ 
*S2_CM 1 ............................................................ 
Intron 1 
*R1_ML 61 GGGTAGGAACAAACGTGCTGGAAGTGCTGTGCCAATCGATTGAGTTGAGAGTAATTTGTA 
*R1_L3_5   61 .----------------------------------------------------------- 
*R2_4Arr   61 ............................................................ 
*R2_ML 61 ............................................................ 
*R3_KE 61 ............................................................ 
*R3_KE. 61 .....................T...................................... 
*S1_G3S3   61 .----------------------------------------------------------- 
*S1_CM 61 ...........................................A.............A.. 
*S2_4Arr   61 ...............................----......................... 
*S2_CM 61 ...........................................A................ 
*R1_ML 121 CACTACGAAACGAAATATACTTTTTCTAGGCTACTGGTTGTGGGTCCGAAATTTATACGG 
*R1_L3_5   62 ----------------------------................................ 
*R2_4Arr  121 ..........T.............................................C... 
*R2_ML 121 ........................................................C... 
*R3_KE 121 ........................................................C... 
*R3_KE.   121 ........................................................C... 
*S1_G3S3   62 ----------------------------............................C... 
*S1_CM 121 ........................................................C... 
*S2_4Arr  117 ........................................................C... 
*S2_CM 121 ........................................................C... 
*R1_ML 181 GCCAACCAGGAATACACTCTGGTGATCAGCAACTTTAACTCACAGCTAAGCAAAGTGGAC 
*R1_L3_5   94 ............................................................ 
*R2_4Arr  181 ............................................................ 
*R2_ML 181 ............................................................ 
*R3_KE 181 ............................................................ 
*R3_KE.   181 ............................................................ 
*S1_G3S3   94 ............................................................ 
*S1_CM 181 ............................................................ 
*S2_4Arr  177 ............................................................ 
*S2_CM 181 ............................................................ 
*R1_ML 241 CTGCTGTTAAAACTGGAAGGCGAAACTGATAATGGTTTAAGCGTTCTGAACGTTACCAAG 
*R1_L3_5  154 ............................................................ 
*R2_4Arr  241 ............................................................ 
*R2_ML 241 ............................................................ 
*R3_KE 241 ............................................................ 
*R3_KE.   241 ............................................................ 
*S1_G3S3  154 ...T........................................................ 
*S1_CM 241 ...T........................................................ 
*S2_4Arr  237 ............................................................ 
*S2_CM 241 ...T........................................................ 
Intron 2
*R1_ML 301 ATGGTTGACGTGCGACGTAATATGAACCGAATGATCAACTTCAATGTATGAAGAGTGAGC 
*R1_L3_5  214 .............................................--------------- 
*R2_4Arr  301 ............................................................ 
*R2_ML 301 ............................................................ 
*R3_KE 301 ............................................................ 
*R3_KE.   301 ............................................................ 
*S1_G3S3  214 .............................................--------------- 
*S1_CM 301 ............................................................ 
*S2_4Arr  297 ............................................................ 
*S2_CM 301 ............................................................ 
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The full-length sequences of TEP1*R3 (highlighted in grey color) compared to *R1 and *R2 alleles 
from Mali, *R2 and *S1 alleles from Cameroon, and *R1,*R2, *S1 alleles from insectary strains. Intronic 
regions (in bold) with modifications for TEP1*R3 are highlighted in Turquoise color. 
*R1_ML 361 GATATTAGTTTTTAAGGCTTACAACTAAAACATTCGATCCTTTGCAGATGCCTGAGGATC 
*R1_L3_5  259 -----------------------------------------------............. 
*R2_4Arr  361 ............................................................ 
*R2_ML 361 ............................................................ 
*R3_KE 361 A........................................................... 
*R3_KE.  361 A........................................................... 
*S1_G3S3  259 -----------------------------------------------............. 
*S1_CM 361 ......................T..................................... 
*S2_4Arr  357 ...........C................................................ 
*S2_CM 361 ............................................................ 
*R1_ML 421 TGACGGCTGGAAACTACAAAATAACTATCGATGGACAGCGTGGCTTCAGCTTTCACAAGG 
*R1_L3_5  272 ............................................................ 
*R2_4Arr  421 ............................................................ 
*R2_ML 421 ............................................................ 
*R3_KE 421 ........................................A................... 
*R3_KE.   421 ........................................A................... 
*S1_G3S3  272 ............................................................ 
*S1_CM 421 ............................................................ 
*S2_4Arr  417 ............................................................ 
*S2_CM 421 ............................................................ 
*R1_ML 481 AGGCAGAGCTGGTGTATCTCAGCAAATCGATATCGGGGCTAATACAGGTCGATAAGCCCG 
*R1_L3_5  332 ............................................................ 
*R2_4Arr  481 ............................................................ 
*R2_ML 481 ............................................................ 
*R3_KE 481 ............................................................ 
*R3_KE.   481 ............................................................ 
*S1_G3S3  332 ............................................................ 
*S1_CM 481 ............................................................ 
*S2_4Arr  477 ............................................................ 
*S2_CM 481 ............................................................ 
*R1_ML 541 TATTTAAACCTGGGGATACGGTGAACTTCCGTGTGATCGTGCTGGACACGGAGCTGAAAC 
*R1_L3_5  392 ............................................................ 
*R2_4Arr  541 ............................................................ 
*R2_ML 541 ............................................................ 
*R3_KE 541 .............C............................................G. 
*R3_KE.   541 .............C............................................G. 
*S1_G3S3  392 ..........................................................G. 
*S1_CM 541 ..........................................................G. 
*S2_4Arr  537 ..........................................................G. 
*S2_CM 541 ..........................................................G. 
*R1_ML 601 CGCCGGCGAGGGTCAAGTCGGTTTATGTAACTATACGAGATCCTCAGCGCAATGTGATTC 
*R1_L3_5  452 ............................................................ 
*R2_4Arr  601 ............................................................ 
*R2_ML 601 ............................................................ 
*R3_KE 601 .A..A....................................................... 
*R3_KE.   601 .......................C.................................... 
*S1_G3S3  452 .......................C.................................... 
*S1_CM 601 .......................C.................................... 
*S2_4Arr  597 ....A....................................................... 
*S2_CM 601 .......................C.................................... 
*R1_ML 661 GCAAATGGTCCACGGCAAAACTGTATGCCGGTGTGTTCGAGAGCGATCTACAGATAGCGC 
*R1_L3_5  512 ............................................................ 
*R2_4Arr  661 .................................................G.......... 
*R2_ML 661 .................................................G.......... 
*R3_KE 661 .................................................G........A. 
*R3_KE.   661 .................................................G........A. 
*S1_G3S3  512 .................................................G.......... 
*S1_CM 661 .................................................G.......... 
*S2_4Arr  657 ...................G.............................G.......... 
*S2_CM 661 .................................................G.......... 
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The full-length sequences of TEP1*R3 (highlighted in grey color) compared to *R1 and *R2 alleles 
from Mali, *R2 and *S1 alleles from Cameroon, and *R1,*R2, *S1 alleles from insectary strains. Intronic 
regions (in bold) with modifications for TEP1*R3 are highlighted in Turquoise color. 
*R1_ML 721 CTACTCCAATGCTCGGGGTCTGGAATATCTCGGTGGAGGTGGAAGGAGAAGAGCTTGTGT 
*R1_L3_5  572 ............................................................ 
*R2_4Arr  721 ...........................................G................ 
*R2_ML 721 ...........................................G................ 
*R3_KE 721 ...........................................G................ 
*R3_KE.   721 ............................................................ 
*S1_G3S3  572 ...............................A............................ 
*S1_CM 721 ...............................A............................ 
*S2_4Arr  717 ............................................................ 
*S2_CM 721 ...............................A............................ 
*R1_ML 781 CAAAGACGTTTGAGGTGAAGGAGTACGTGTTGTCAACGTTCGACGTGCAGGTCATGCCAT 
*R1_L3_5  632 ............................................................ 
*R2_4Arr  781 .........................T.................................. 
*R2_ML 781 .........................T.................................. 
*R3_KE 781 ............................................................ 
*R3_KE.   781 ............................................................ 
*S1_G3S3  632 ................A........................................... 
*S1_CM 781 ................A........................................... 
*S2_4Arr  777 ............................................................ 
*S2_CM 781 ................A........................................... 
*R1_ML    841 CGGTGATTCCACTGGAAGAGCATCAAGCTGTGAATCTTACAATCGAAGCGAACTATCACT 
*R1_L3_5  692 ............................................................ 
*R2_4Arr  841 ......................C.......................C............. 
*R2_ML 841 ......................C.......................C............. 
*R3_KE 841 ......................C..........C.......................... 
*R3_KE.   841 ......................C..................................... 
*S1_G3S3  692 ............................................................ 
*S1_CM 841 ............................................................ 
*S2_4Arr  837 ............................................................ 
*S2_CM 841 ............................................................ 
*R1_ML 901 TTGGTAAGCCAGTGCAAGGAGTGGCCAAGGTGGAGCTGTACCTAGACGACGATAAGCTAA 
*R1_L3_5  752 ............................................................ 
*R2_4Arr  901 ............................................................ 
*R2_ML 901 ............................................................ 
*R3_KE 901 .........................T....................A............. 
*R3_KE.   901 .........................T....................A............. 
*S1_G3S3  752 ............................................................ 
*S1_CM 901 ............................................................ 
*S2_4Arr  897 ............................................................ 
*S2_CM 901 ............................................................ 
*R1_ML 961 AACTGAAAAAAGAGCTGACTGTGTACGGAAAGGGCCAGGTAGAGTTGCGCTTTGACAATT 
*R1_L3_5  812 ............................................................ 
*R2_4Arr  961 .T.A..................A.......................A.....C....... 
*R2_ML 961 .T.A..................A.......................A.....C....... 
*R3_KE 961 .T.A.................................................A...... 
*R3_KE.   961 .T.A.................................................A...... 
*S1_G3S3  812 .T.AA....................................................... 
*S1_CM 961 .T.AA....................................................... 
*S2_4Arr  957 .T.A........................................................ 
*S2_CM 961 .T.AA....................................................... 
*R1_ML   1021 TTGCAATGGATGCGGATCAGCAGGATGTACCAGTGAAGGTGTCGTTCATCGAGCAGTACA 
*R1_L3_5  872 ...............................................G............ 
*R2_4Arr 1021 ............................G.G.........................C... 
*R2_ML   1021 ............................G.G.........................C... 
*R3_KE   1021 .............A................G............A..T.........C... 
*R3_KE.  1021 ..............................G............A..T.........C... 
*S1_G3S3  872 ..............................G............................. 
*S1_CM   1021 ..............................G............................. 
*S2_4Arr 1017 ..............................G............................. 
*S2_CM   1021 ..............................G............................. 
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The full-length sequences of TEP1*R3 (highlighted in grey color) compared to *R1 and *R2 alleles 
from Mali, *R2 and *S1 alleles from Cameroon, and *R1,*R2, *S1 alleles from insectary strains. Intronic 
regions (in bold) with modifications for TEP1*R3 are highlighted in Turquoise color. 
 
               Intron 3       
*R1_ML   1081 CAAGTAAGAATCATGTTCGAGATACCGTTGCTAACAGTGATTAAATAAGAAATATCTCTT 
*R1_L3_5  932 ...--------------------------------------------------------- 
*R2_4Arr 1081 ....................A....................................... 
*R2_ML   1081 ....................A....................................... 
*R3_KE   1081 .......C.................................................... 
*R3_KE.  1081 .......C.................................................... 
*S1_G3S3  932 ...--------------------------------------------------------- 
*S1_CM   1081 ....................A...........T........................... 
*S2_4Arr 1077 ....................A...........T........................... 
*S2_CM   1081 ....................A...........T........................... 
 
*R1_ML   1141 CATAGATCGTACGGTGGTCAAACAGTCACAAATCACGGTATATAGGTATGCGTACCGAGT 
*R1_L3_5  935 -----....................................................... 
*R2_4Arr 1141 ............................................................ 
*R2_ML   1141 ............................................................ 
*R3_KE   1141 ..C......................................................... 
*R3_KE.  1141 ..C......................................................... 
*S1_G3S3  935 -----....................................................... 
*S1_CM   1141 ............................................................ 
*S2_4Arr 1137 ............................................................ 
*S2_CM   1141 ............................................................ 
 
*R1_ML   1201 AGAGTTGATAAAAGAGAGTCCACAGTTTCGTCCGGGACTCCCGTTCAAATGTGCGCTTCA 
*R1_L3_5  990 ............................................................ 
*R2_4Arr 1201 .........................................................G.. 
*R2_ML   1201 .........................................................G.. 
*R3_KE   1201 .........................................................G.. 
*R3_KE.  1201 .........................................................G.. 
*S1_G3S3  990 .........................................................G.. 
*S1_CM   1201 .........................................................G.. 
*S2_4Arr 1197 ...A..................................................A..G.. 
*S2_CM   1201 .........................................................G.. 
 
*R1_ML   1261 GTTTACACACCATGATGGAACACCGGCTAAAGGCATTAGCGGTAAGGTAGAGGTATCCGA 
*R1_L3_5 1050 ............................................................ 
*R2_4Arr 1261 ......................................C...G................. 
*R2_ML   1261 ......................................C...G................. 
*R3_KE   1261 ............................................................ 
*R3_KE.  1261 ............................................................ 
*S1_G3S3 1050 ......................................C...G..............T.. 
*S1_CM   1261 ......................................C...G..............T.. 
*S2_4Arr 1257 ......................................C...G................. 
*S2_CM   1261 ......................................C...G................. 
 
*R1_ML   1321 TGTACGATTCGAAACGACAACAACGAGTGATAACGATGGATTGATTAAGCTCGAGCTGCA 
*R1_L3_5 1110 ............................................................ 
*R2_4Arr 1321 ....G....................................................... 
*R2_ML   1321 ....G....................................................... 
*R3_KE   1321 ....G....................................................... 
*R3_KE.  1321 ....G....................................................... 
*S1_G3S3 1110 ....G...............A....................................... 
*S1_CM   1321 ....G....................................................... 
*S2_4Arr 1317 ....G....................................................... 
*S2_CM   1321 ....G....................................................... 
                                                Intron 4       
*R1_ML   1381 ACCAAGTGAGGGTACTGAACAACTCAGTATTCACGTAAGTATCTAGAATGTTTAGTTAAT 
*R1_L3_5 1170 ..................................-------------------------- 
*R2_4Arr 1381 .........................G.....A..................G...T..... 
*R2_ML   1381 .........................G.....A..................G...T..... 
*R3_KE   1381 .........................G.....AG..........G......G...T..... 
*R3_KE.  1381 .........................G.....AG..........G......G...T..... 
*S1_G3S3 1170 .............T...........G.....A..-------------------------- 
*S1_CM   1381 .........................G.....A..................G...T..... 
*S2_4Arr 1377 .........................G.....A..................G...T..... 
*S2_CM   1381 .........................G.....A..................G...T..... 
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The full-length sequences of TEP1*R3 (highlighted in grey color) compared to *R1 and *R2 alleles 
from Mali, *R2 and *S1 alleles from Cameroon, and *R1,*R2, *S1 alleles from insectary strains. Intronic 
regions (in bold) with modifications for TEP1*R3 are highlighted in Turquoise color. 
*R1_ML   1441 GGTTGACAAAGCATCTTAAAGGGTCAGTTCTTTTGCAGTTCAATGCTGTTGATGGATTCT 
*R1_L3_5 1204 --------------------------------------...................... 
*R2_4Arr 1441 .................G.......................................... 
*R2_ML   1441 .................G.......................................... 
*R3_KE   1441 C................G.......................................... 
*R3_KE.  1441 C................G.......................................... 
*S1_G3S3 1204 --------------------------------------...................... 
*S1_CM   1441 .................G.......................................... 
*S2_4Arr 1437 .................G.......................................... 
*S2_CM   1441 .................G.......................................... 
*R1_ML   1501 TTTTTTATGAAGATGTGAATAACGTAGAAACGGTTACAAATGCGTATATTAAACTGGAGC 
*R1_L3_5 1226 ......................G..............GG..................... 
*R2_4Arr 1501 ......................G..............GG..................... 
*R2_ML   1501 ......................G..............GG..................... 
*R3_KE   1501 ......................G..............GG....T..C............. 
*R3_KE.  1501 ......................G..............GG....T..C............. 
*S1_G3S3 1226 ......................G..............GG..................... 
*S1_CM   1501 ......................G..............GG..................... 
*S2_4Arr 1497 ......................G..............GG..................... 
*S2_CM   1501 ......................G..............GG..................... 
Intron 5
*R1_ML   1561 TGAAATCACCGTGAGTAATAACTCGCTACAAAGTGAAACTGGCAGTGTGATGTATAACAT 
*R1_L3_5 1286 ..........-------------------------------------------------- 
*R2_4Arr 1561 ............................................................ 
*R2_ML   1561 ............................................................ 
*R3_KE   1561 .......................T.............GG..................... 
*R3_KE.  1561 .......................T.............GG..................... 
*S1_G3S3 1286 ..........-------------------------------------------------- 
*S1_CM   1561 ....................................................A....... 
*S2_4Arr 1557 ....................................................A....... 
*S2_CM   1561 ....................................................A....... 
*R1_ML   1621 AACATATCGTTCTAGCATCAAACGGAACAAATTGATGCGTTTCATGGTGACGTGCACGGA 
*R1_L3_5 1296 ---------------............................................. 
*R2_4Arr 1621 .......................................C.................... 
*R2_ML   1621 .......................................C.................... 
*R3_KE   1621 .......................................C.................... 
*R3_KE.  1621 .......................................C.................... 
*S1_G3S3 1296 ---------------........................C.................... 
*S1_CM   1621 .......................................C.................... 
*S2_4Arr 1617 .......................................C.................... 
*S2_CM   1621 .......................................C.................... 
*R1_ML   1681 GCGCATGACATTCTTCGTGTACTATGTCATGTCAAAGGGCAATATCATCGATGCAGGCTT 
*R1_L3_5 1341 .........................................................A.. 
*R2_4Arr 1681 ............................................................ 
*R2_ML   1681 ............................................................ 
*R3_KE   1681 ...............T..........................C..T.............. 
*R3_KE.  1681 ...............T..........................C..T.............. 
*S1_G3S3 1341 ............................................................ 
*S1_CM   1681 ............................................................ 
*S2_4Arr 1677 ............................................................ 
*S2_CM   1681 ............................................................ 
*R1_ML   1741 CATGCGACCCAACAAGCAACCGAAGTACCTGTTGCAGCTGAACGCAACAGAAAAGATGAT 
*R1_L3_5 1401 ............................................................ 
*R2_4Arr 1741 ...................A.......T...........A.................... 
*R2_ML   1741 ...................A...................A.................... 
*R3_KE   1741 ...................A...................A.................... 
*R3_KE.  1741 ...................A...................A.................... 
*S1_G3S3 1401 ...................A...................A.................... 
*S1_CM   1741 ...................A...................A.................... 
*S2_4Arr 1737 ...................A...................A.................... 
*S2_CM   1741 ...................A...................A.................... 
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*R1_ML   1801 TCCGAGGGCGAAAATTCTCATCGCTACCGTAGCGGGCCGCACGGTGGTGTACGACTTCGC 
*R1_L3_5 1461 ............................................................ 
*R2_4Arr 1801 .....A...................................................... 
*R2_ML   1801 .....A...................................................... 
*R3_KE   1801 .....A...................................................... 
*R3_KE.  1801 .....T...................................................... 
*S1_G3S3 1461 .....A.......................................A..........A... 
*S1_CM   1801 .....A.......................................A..........A... 
*S2_4Arr 1797 .....A.......................................A..........A... 
*S2_CM   1801 .....A.......................................A..........A... 
 
                                             Intron 6       
*R1_ML   1861 AGACCTCGATTTCCAAGAGCTTCGCAATAATGTAAGCATTTGTTTGTCGTGTTGTTTAAC 
*R1_L3_5 1521 ...............................----------------------------- 
*R2_4Arr 1861 ............................................................ 
*R2_ML   1861 ............................................................ 
*R3_KE   1861 ............................................................ 
*R3_KE.  1861 ......................................A....A....AC.........G 
*S1_G3S3 1521 ...............................----------------------------- 
*S1_CM   1861 ............................................................ 
*S2_4Arr 1857 ............................................................ 
*S2_CM   1861 ............................................................ 
 
*R1_ML   1921 GTAACACTTATTCATGTTGTGTGGAAACAGTTTGATTTAAGCATTGACGAGCAAGAGATC 
*R1_L3_5 1552 ------------------------------.............................. 
*R2_4Arr 1921 ....A....................................................... 
*R2_ML   1921 ....A....................................................... 
*R3_KE   1921 ....A....................................................... 
*R3_KE.  1921 .............G......T..A.................................... 
*S1_G3S3 1552 ------------------------------.............................. 
*S1_CM   1921 ............................................................ 
*S2_4Arr 1917 ............................................................ 
*S2_CM   1921 ............................................................ 
 
*R1_ML   1981 AAGCCGGGACGACAAATCGAGCTGAGCATGTCTGGACGCCCAGGAGCGTACGTTGGGCTG 
*R1_L3_5 1582 ............................................................ 
*R2_4Arr 1981 ...............................T............................ 
*R2_ML   1981 ............................................................ 
*R3_KE   1981 ............................................................ 
*R3_KE.  1981 ............................................................ 
*S1_G3S3 1582 ............................................................ 
*S1_CM   1981 ............................................................ 
*S2_4Arr 1977 ............................................................ 
*S2_CM   1981 ............................................................ 
 
*R1_ML   2041 GCCGCGTATGACAAAGCCTTGCTGCTTTTCAACAAGAACCACGACCTGTTCTGGGAGGAC 
*R1_L3_5 1642 ............................................................ 
*R2_4Arr 2041 ..........................G................................. 
*R2_ML   2041 ..........................G................................. 
*R3_KE   2041 .......................A..G................................. 
*R3_KE.  2041 .......................A..G................................. 
*S1_G3S3 1642 ..........................G................................. 
*S1_CM   2041 ..........................G................................. 
*S2_4Arr 2037 ..........................G................................. 
*S2_CM   2041 ..........................G................................. 
 
*R1_ML   2101 ATTGGGCAGGTGTTTGATGGGTTCCATGCAATCAATGAGAACGAGTTTGACATATTCCAC 
*R1_L3_5 1702 ............................................................ 
*R2_4Arr 2101 ............................................................ 
*R2_ML   2101 ............................................................ 
*R3_KE   2101 ............................................................ 
*R3_KE.  2101 ............................................................ 
*S1_G3S3 1702 ............................................................ 
*S1_CM   2101 ............................................................ 
*S2_4Arr 2097 ............................................................ 
*S2_CM   2101 ............................................................ 
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The full-length sequences of TEP1*R3 (highlighted in grey color) compared to *R1 and *R2 alleles 
from Mali, *R2 and *S1 alleles from Cameroon, and *R1,*R2, *S1 alleles from insectary strains. Intronic 
regions (in bold) with modifications for TEP1*R3 are highlighted in Turquoise color. 
Intron 7
*R1_ML   2161 GTATGTATGATGCGAAAATCGAGCAAGAG------ATATCAGAA---------------- 
*R1_L3_5 1762 ------------------------------------------------------------
*R2_4Arr 2161 .............................------.........---------------- 
*R2_ML   2161 .............................------.........---------------- 
*R3_KE   2161 .............T...............CAAGAT...C.....TTTATCACAAACAATT 
*R3_KE.  2161 .............A...............CAAGAT...C.....TTTATCACAAACAATT 
*S1_G3S3 1762 ------------------------------------------------------------
*S1_CM   2161 .............................------.........---------------- 
*S2_4Arr 2157 .............................------.........---------------- 
*S2_CM   2161 .............................------.........---------------- 
*R1_ML   2199 AACAATTATCAAAAACGAGACGCGTAATTATTTTTGCAGAGCTTGGGTCTGTTCGCCAGG 
*R1_L3_5 1762 ---------------------------------------..................... 
*R2_4Arr 2199 .........................G....C............................. 
*R2_ML   2199 .........................G....C............................. 
*R3_KE   2221 .T.........C.....G............C............................. 
*R3_KE.  2221 .T.........C.....G............C............................. 
*S1_G3S3 1762 ---------------------------------------..................... 
*S1_CM   2199 ..............................C............................. 
*S2_4Arr 2195 ..............................C............................. 
*S2_CM   2199 ..............................C............................. 
*R1_ML   2259 ACATTGGACGATATCTTGTTCGACAGTGCAAATGAAAAGACGGGGCGTAATGCACTGCAG 
*R1_L3_5 1783 ............................................................ 
*R2_4Arr 2259 ............................................................ 
*R2_ML   2259 ............................................................ 
*R3_KE   2281 ...C...................T.................................... 
*R3_KE.  2281 ...C........................................................ 
*S1_G3S3 1783 ............................................................ 
*S1_CM   2259 ............................................................ 
*S2_4Arr 2255 ............................................................ 
*S2_CM   2259 ............................................................ 
*R1_ML   2319 TCAGGCAAGCCGATCGGCAAGCTGGTGTCGTATCGGACGAACTTCCAGGAATCGTGGTTG 
*R1_L3_5 1843 ............................................................ 
*R2_4Arr 2319 ............................................................ 
*R2_ML   2319 ............................................................ 
*R3_KE   2341 ............................................................ 
*R3_KE.  2341 ............................................................ 
*S1_G3S3 1843 ............................................................ 
*S1_CM   2319 ............................................................ 
*S2_4Arr 2315 ............................................................ 
*S2_CM   2319 ............................................................ 
*R1_ML   2379 TGGAAAAATGTTTCCATCGGACGATCGGGAAGTCGCAAGTTGATCGAGGTAGTACCGGAC 
*R1_L3_5 1903 ............................................................ 
*R2_4Arr 2379 ............................................................ 
*R2_ML   2379 ............................................................ 
*R3_KE   2401 ............................................................ 
*R3_KE.  2401 ............................................................ 
*S1_G3S3 1903 ............................................................ 
*S1_CM   2379 ............................................................ 
*S2_4Arr 2375 ............................................................ 
*S2_CM   2379 ............................................................ 
*R1_ML   2439 ACGACCACCTCCTGGTATCTGACGGGCTTCTCGATCGATCCCGTGTACGGGTTGGGTATC 
*R1_L3_5 1963 ............................................................ 
*R2_4Arr 2439 ..A.....T..............C.................................... 
*R2_ML   2439 ..A.....T..............C.................................... 
*R3_KE   2461 ............................................................ 
*R3_KE.  2461 ............................................................ 
*S1_G3S3 1963 ............................................................ 
*S1_CM   2439 ............................................................ 
*S2_4Arr 2435 ............................................................ 
*S2_CM   2439 ............................................................ 
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*R1_ML   2499 ATCAAGAAGCCAATCCAGTTCACAACAGTCCAGCCGTTCTACATCGTAGAGAACTTACCA 
*R1_L3_5 2023 ............................................................ 
*R2_4Arr 2499 ............................................................ 
*R2_ML   2499 ............................................................ 
*R3_KE   2521 ............................................................ 
*R3_KE.  2521 ............................................................ 
*S1_G3S3 2023 ......................................................C..... 
*S1_CM   2499 ......................................................C..... 
*S2_4Arr 2495 .....................................................TC..... 
*S2_CM   2499 .....................................................TC..... 
 
*R1_ML   2559 TATTCAATCAAACGAGGCGAAGCGGTTGTGTTGCAGTTTACGCTGTTCAACAACCTTGGA 
*R1_L3_5 2083 ............................................................ 
*R2_4Arr 2559 ............................................................ 
*R2_ML   2559 ............................................................ 
*R3_KE   2581 ..........................C................................. 
*R3_KE.  2581 ..........................C................................. 
*S1_G3S3 2083 ..........................C................................. 
*S1_CM   2559 ..........................C................................. 
*S2_4Arr 2555 ..........................C................................. 
*S2_CM   2559 ..........................C................................. 
 
*R1_ML   2619 GCGGAGTATATAGCCGATGTGACGCTGTACAATGTGGCCAACCAGACCGAGTTCGTCGGA 
*R1_L3_5 2143 ............................................................ 
*R2_4Arr 2619 ............................................................ 
*R2_ML   2619 ............................................................ 
*R3_KE   2641 ............................................................ 
*R3_KE.  2641 ............................................................ 
*S1_G3S3 2143 ............................................................ 
*S1_CM   2619 ............................................................ 
*S2_4Arr 2615 ............................................................ 
*S2_CM   2619 ............................................................ 
                     
                                  Intron 8       
*R1_ML   2679 CGTCCAAATACGGGTGAGTGTGGTTTACATCAATCAACCCTTGATTATT-GAAAACTTCA 
*R1_L3_5 2203 .............----------------------------------------------- 
*R2_4Arr 2679 .................................................-.......... 
*R2_ML   2679 .................................................-.......... 
*R3_KE   2701 ......GT............A.....GT......A.------.....CATA....AA.A. 
*R3_KE.  2701 ......GT............A.....GT.........GA.....C...A-.....AA.A. 
*S1_G3S3 2203 ......G......----------------------------------------------- 
*S1_CM   2679 ......G............AA.....GT......A.------.....C--AT...AAAA. 
*S2_4Arr 2675 ......G............AA.....GT......A.------.....C--AT...AAAA. 
*S2_CM   2679 ......G............AA.....GT......A.------.....C--AT...AAA-. 
 
*R1_ML   2738 ACATTAATTTTATGTTCAGATCTCAGCTACACCAAATCCGTGAGCGTTCCTCCAAAAGTT 
*R1_L3_5 2216 -------------------......................................... 
*R2_4Arr 2738 ............................................................ 
*R2_ML   2738 ............................................................ 
*R3_KE   2755 .....T.C..----.C............G.........G..A...........G..G... 
*R3_KE.  2760 .....T....----.C............G.........G..A...........G..G... 
*S1_G3S3 2216 -------------------..........T........G..A...........G..G... 
*S1_CM   2731 .....T....----.C.............T........G..A...........G..G... 
*S2_4Arr 2727 .....T....----.C.............T........G..T...........G..G... 
*S2_CM   2730 .....T....----.C.............T........G..T...........G..G... 
 
*R1_ML   2798 GGTGTGCCAATCTCGTTCCTCATCAAGGCCCGCAAGCTCGGCGAGATGGCGGTTCGTGTA 
*R1_L3_5 2257 ............................................................ 
*R2_4Arr 2798 ............................................................ 
*R2_ML   2798 ............................................................ 
*R3_KE   2811 .....T..G.....A..TT..G.A...................................G 
*R3_KE.  2816 .....T..G.....A..TT..G.A...................................G 
*S1_G3S3 2257 .....T..G.....T..T.....A.............................A.....G 
*S1_CM   2787 .....T..G.....T..T.....A.............................A.....G 
*S2_4Arr 2783 .....T..G.....T..T.....A.............................A.....G 
*S2_CM   2786 .....T..G.....T..T.....A.............................A.....G 
 
Appendix 5 TEP1*R3 nucleotide modifications 
 
114 
The full-length sequences of TEP1*R3 (highlighted in grey color) compared to *R1 and *R2 alleles 
from Mali, *R2 and *S1 alleles from Cameroon, and *R1,*R2, *S1 alleles from insectary strains. Intronic 
regions (in bold) with modifications for TEP1*R3 are highlighted in Turquoise color. 
 
*R1_ML   2858 AAGGCTTCGATAATGCTGGGACACGAAACGGACGCCCTGGAAAAGGTAATACGGGTGATG 
*R1_L3_5 2317 ............................................................ 
*R2_4Arr 2858 ............................................................ 
*R2_ML   2858 ............................................................ 
*R3_KE   2871 ....................G...........T..GT..........G............ 
*R3_KE.  2876 ....................G...........T..GT..........G............ 
*S1_G3S3 2317 .............................A.....AT..........G...A........ 
*S1_CM   2847 .............................A.....AT..........G...A........ 
*S2_4Arr 2843 .............................A..T..AT..........G...A........ 
*S2_CM   2846 .............................A..T..AT..........G...A........ 
 
*R1_ML   2918 CCTGAAAGTTTGGTGCAGCCGAGAATGGATACACGCTTTTTCTGCTTCGACGATTACAAA 
*R1_L3_5 2377 ......................................................C..... 
*R2_4Arr 2918 ............................................................ 
*R2_ML   2918 ............................................................ 
*R3_KE   2931 ..C.....C................................................... 
*R3_KE.  2936 ..C.....C................................................... 
*S1_G3S3 2377 ..C..........C...A..A.A..........A.......................... 
*S1_CM   2907 ..C..........C...A..A.A..........A.......................... 
*S2_4Arr 2903 ..C..........C...A..A.A..........A.......................... 
*S2_CM   2906 ..C..........C...A..A.A..........A.......................... 
 
*R1_ML   2978 AATCAAACGTTTTCGATCAACTTGGACATCAACAAGAAGGCCGACAGTGGATCGACAAAG 
*R1_L3_5 2437 ............C............................................... 
*R2_4Arr 2978 ............C.................................A............. 
*R2_ML   2978 ............C.................................A............. 
*R3_KE   2991 ............C.......T.........................A........A.... 
*R3_KE.  2996 ............C.......T.........................A........A.... 
*S1_G3S3 2437 ...........CC.TT............................T.A........A.... 
*S1_CM   2967 ...........CC.TT............................T.A........A.... 
*S2_4Arr 2963 ...........CC.TT............................T.A........A.... 
*S2_CM   2966 ...........CC.TT............................T.A........A.... 
 
                                 Intron 9       
*R1_ML   3038 ATTGAGTTTCGACTAAATCGTAAGTAGAGGGTGT-GAAAGTTGTGAAAGGAGTTATTGAG 
*R1_L3_5 2497 ...................----------------------------------------- 
*R2_4Arr 3038 ..................................-......................... 
*R2_ML   3038 ..................................-......................... 
*R3_KE   3051 ..................................A......A...G....C..A...... 
*R3_KE.  3056 ..................................A......A...G....C..A...... 
*S1_G3S3 2497 .....A...A.......C.----------------------------------------- 
*S1_CM   3027 .....A...A.......C.......TA.A.....AC...C.A............T..... 
*S2_4Arr 3023 .....A...A.......C.......TA.A.....AC...C.A............T..... 
*S2_CM   3026 .....A...A.......C.......TA.A.....AC...C.A............T..... 
 
*R1_ML   3097 AGTTTTTTTCTTCTTTTTACCCAACCATTTCTGCAGCCAATTTGTTGACCACGGTCATCA 
*R1_L3_5 2516 ------------------------------------........................ 
*R2_4Arr 3097 ............................................................ 
*R2_ML   3097 ............................................................ 
*R3_KE   3111 .T......AAA.TC..........T...............C...C......T........ 
*R3_KE.  3116 .T......AAA.TC..........T...............C...C......T........ 
*S1_G3S3 2516 ------------------------------------....C...C......T........ 
*S1_CM   3087 ........A--.TC.A.....TG.T...............C...C......T........ 
*S2_4Arr 3083 ........A--.TC.A.....TG.T...............C...C......T........ 
*S2_CM   3086 ........A--.TC.A.....TG.T...............C...C......T........ 
 
*R1_ML   3157 AGAACCTGGACCATCTTCTCGGCGTTCCGACGGGATGTGGTGAGCAGAATATGGTCAAAT 
*R1_L3_5 2540 ............................................................ 
*R2_4Arr 3157 ............................................................ 
*R2_ML   3157 ............................................................ 
*R3_KE   3171 .......A...A....A....C........................A..C.......... 
*R3_KE.  3176 .......A...A....A....C........................A..C.......... 
*S1_G3S3 2540 ...........A....A....C...................................... 
*S1_CM   3145 ...........A....A....C...................................... 
*S2_4Arr 3141 ...........A....A....C...................................... 
*S2_CM   3144 ...........A....A....C...................................... 
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*R1_ML   3217 TTGTTCCCAACATTTTGGTGCTGGATTATTTGCATGCCATCGGGTCGAAAGAACAGCATC 
*R1_L3_5 2600 ...................A........................................ 
*R2_4Arr 3217 ............................................................ 
*R2_ML   3217 ............................................................ 
*R3_KE   3231 ............................................................ 
*R3_KE.  3236 ............................................................ 
*S1_G3S3 2600 .............................C..T......C...A.....G.......... 
*S1_CM   3205 .............................C..T......C...A.....G.......... 
*S2_4Arr 3201 .............................C..T......C...A.....G.......... 
*S2_CM   3204 .............................C..T......C...A.....G.......... 
 
*R1_ML   3277 TAATCGACAAAGCTACGAATTTGTTGCGACAAGGATATCAAAACCAGATGCGCTACCGTC 
*R1_L3_5 2660 ............................T............................... 
*R2_4Arr 3277 ............................T............................... 
*R2_ML   3277 ............................T............................... 
*R3_KE   3291 ............................T..........................T.... 
*R3_KE.  3296 ............................T..........................T.... 
*S1_G3S3 2660 ............................T..G........G...........T.....C. 
*S1_CM   3265 ............................T..G........G...........T.....C. 
*S2_4Arr 3261 ............................T..G........G...........T.....C. 
*S2_CM   3264 ............................T..G........G...........T.....C. 
 
*R1_ML   3337 AGACGGATGGTTCATTTGGTTTGTGGGAGACTACTAATGGTAGCGTGTTTCTCACCGCGT 
*R1_L3_5 2720 ............................................................ 
*R2_4Arr 3337 ...................................GG....................... 
*R2_ML   3337 ...................................GG....................... 
*R3_KE   3351 ................................T..GG.........A............. 
*R3_KE.  3356 ................................T..GG.........A............. 
*S1_G3S3 2720 ....A........G......G.........AA.G.GGCA.C................... 
*S1_CM   3325 ....A........G......G.........AA.G.GGCA.C................... 
*S2_4Arr 3321 ....A........G......G.........AA.G.GGCA.C................... 
*S2_CM   3324 ....A........G......G.........AA.G.GGCA.C................... 
 
*R1_ML   3397 TCGTTGGCACATCGATGCAAACTGCAGTAAATTACATAAGCGATATTGATGCAGCAGTGG 
*R1_L3_5 2780 ...............................A........................A... 
*R2_4Arr 3397 ...........................C...A........................A... 
*R2_ML   3397 ...........................C...A........................A... 
*R3_KE   3411 .........................TTC...A.......A......A.........A... 
*R3_KE.  3416 .........................TTC...A.......A......A.........A... 
*S1_G3S3 2780 ......C...................TCG..A.....G.A................A... 
*S1_CM   3385 ......C...................TCG..A.....G.A................A... 
*S2_4Arr 3381 ......C...................TCG..A.....G.A................A... 
*S2_CM   3384 ......C...................TCG..A.....G.A................A... 
 
*R1_ML   3457 TGGAGAAGGCATTGGATTGGTTAGCCTCGAAGCAGCATTTCTCGGGACGGTTTGACAAGG 
*R1_L3_5 2840 ............................................................ 
*R2_4Arr 3457 ............................................................ 
*R2_ML   3457 ............................................................ 
*R3_KE   3471 ..................................A....C.................... 
*R3_KE.  3476 ..................................A....C.................... 
*S1_G3S3 2840 .A....................G..............CAG......G.........G..A 
*S1_CM   3445 .A....................G..............CAG......G.........G..A 
*S2_4Arr 3441 .A....................G..............CAG......G.........G..A 
*S2_CM   3444 .A....................G..............CAG......G.........G..A 
 
*R1_ML   3517 CCGGTGCAGAGTATCACAAAGAAATGCAAGGAGGGTTGCGCAATGGTGTGGCCCTCACAT 
*R1_L3_5 2900 ............................................................ 
*R2_4Arr 3517 ............................................................ 
*R2_ML   3517 ............................................................ 
*R3_KE   3531 ............................................................ 
*R3_KE.  3536 ............................................................ 
*S1_G3S3 2900 .....AA..T..GG........T..................................... 
*S1_CM   3505 .....AA..T..GG........T..................................... 
*S2_4Arr 3501 .....AA..T..GG........T..................................... 
*S2_CM   3504 .....AA..T..GG........T..................................... 
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The full-length sequences of TEP1*R3 (highlighted in grey color) compared to *R1 and *R2 alleles 
from Mali, *R2 and *S1 alleles from Cameroon, and *R1,*R2, *S1 alleles from insectary strains. Intronic 
regions (in bold) with modifications for TEP1*R3 are highlighted in Turquoise color. 
 
*R1_ML   3577 CATATGTGTTGATGGCATTGCTGGAGAATGACATCGCCAAAGCAAAGCACGCAGAGGTGA 
*R1_L3_5 2960 ..................................T......................... 
*R2_4Arr 3577 ............................................................ 
*R2_ML   3577 ............................................................ 
*R3_KE   3591 ............C.........A...........T......................... 
*R3_KE.  3596 ............C.........A...........T...................C..... 
*S1_G3S3 2960 .G..........C.............................TG........G.T...A. 
*S1_CM   3565 .G..........C.............................TG.......TG.T...A. 
*S2_4Arr 3561 .G..........C.............................TG........G.T...A. 
*S2_CM   3564 .G..........C.............................TG........G.T...A. 
 
*R1_ML   3637 TTCAAAAAGGAATGACCTATCTGAGCAATCAGTTTGGATCCATCAACAATGCATACGACC 
*R1_L3_5 3020 ............................................................ 
*R2_4Arr 3637 ............................................................ 
*R2_ML   3637 ............................................................ 
*R3_KE   3651 ............................................................ 
*R3_KE.  3656 .C.............A...........................G...........T.... 
*S1_G3S3 3020 .C.....C.......A................C...C..T...T................ 
*S1_CM   3625 .C.....C.......A................C...C..T...T................ 
*S2_4Arr 3621 .C.....C.......A...............AC...C..T...T................ 
*S2_CM   3624 .C.....C.......A...............AC...C..T...T................ 
 
*R1_ML   3697 TATCGATAGCAACCTACGCGATGATGTTGAACGGACACACCATGAAGGAGGAGGCACTCA 
*R1_L3_5 3080 ............................................................ 
*R2_4Arr 3697 ............................................................ 
*R2_ML   3697 ............................................................  
*R3_KE   3711 ..........................................................G. 
*R3_KE.  3716 ..........................C...............................G. 
*S1_G3S3 3080 ...............................................A.A.........G 
*S1_CM   3685 ...............................................A.A.........G 
*S2_4Arr 3681 ..........................C....................A.A.........G 
*S2_CM   3684 ..........................C....................A.A.........G 
 
*R1_ML   3757 ATAAGCTGATTGATATGTCTTTCATTGATGCTGATAAAAACGAACGGTTCTGGAACACAA 
*R1_L3_5 3140 ............................................................ 
*R2_4Arr 3757 ............................................................ 
*R2_ML   3757 ............................................................ 
*R3_KE   3771 ....A..........................C.................T....GA.... 
*R3_KE.  3776 ....A..........................C.................T....GA.... 
*S1_G3S3 3140 ....................A...G....AA.A.......A.......A....GGA.... 
*S1_CM   3745 ....................A...G....AA.A.......A.......A....GGA.... 
*S2_4Arr 3741 ............................................................ 
*S2_CM   3744 ............................................................ 
 
*R1_ML   3817 CGAATCCAATAGAAACCACCGCATATGCTCTGCTGTCGTTTGTGATGGCCGAGAAGTACA 
*R1_L3_5 3200 ............................................................ 
*R2_4Arr 3817 ............................................................ 
*R2_ML   3817 ............................................................ 
*R3_KE   3831 A.....A..................C................................TC 
*R3_KE.  3836 A.....A..................C................................TC 
*S1_G3S3 3200 ....C.A............A.............................A........TT 
*S1_CM   3805 ....C.A............A.............................A........TT 
*S2_4Arr 3801 .................................................A........TT 
*S2_CM   3804 .................................................A........TT 
 
*R1_ML   3877 CAGACGGTATACCGGTCATGAATTGGTTGGTGAATCAACGTTACGTTACCGGTAGCTTTC 
*R1_L3_5 3260 ............................................................ 
*R2_4Arr 3877 ............................................................ 
*R2_ML   3877 ............................................................ 
*R3_KE   3891 TG.......................................................... 
*R3_KE.  3896 TG.......................................................... 
*S1_G3S3 3260 TG............A.T.......................G...........A....... 
*S1_CM   3865 TG............A.T.......................G...........A....... 
*S2_4Arr 3861 TG..............T.......................G...........A....... 
*S2_CM   3864 TG..............T.......................G...........A....... 
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The full-length sequences of TEP1*R3 (highlighted in grey color) compared to *R1 and *R2 alleles 
from Mali, *R2 and *S1 alleles from Cameroon, and *R1,*R2, *S1 alleles from insectary strains. Intronic 
regions (in bold) with modifications for TEP1*R3 are highlighted in Turquoise color. 
 
*R1_ML   3937 CGAGCACGCAAGACACGTTTGTGGGGCTGAAAGCGCTGACCAAAATGGCGGAAAAGATAT 
*R1_L3_5 3320 ............................................................ 
*R2_4Arr 3937 ............................................................ 
*R2_ML   3937 ............................................................ 
*R3_KE   3951 .........................C.................................. 
*R3_KE.  3956 .........................C.................................. 
*S1_G3S3 3320 .AC......................C..T...............T............... 
*S1_CM   3925 .AC......................C..T...............T............... 
*S2_4Arr 3921 .AC......................C..T...............T............... 
*S2_CM   3924 .AC......................C..T...............T............... 
 
*R1_ML   3997 CTCCGTCCCGAAACGACTACACCGTTCAACTGAAGTACAAGAAGTGTGCAAAATACTTCA 
*R1_L3_5 3380 ............................................A............... 
*R2_4Arr 3997 ............................................A............... 
*R2_ML   3997 ............................................A............... 
*R3_KE   4011 ............................................A............... 
*R3_KE.  4016 .......A....................................A............... 
*S1_G3S3 3380 .....................................T......A.CA....G....... 
*S1_CM   3985 .....................................T......A.CA....G....... 
*S2_4Arr 3981 .....................................T......A.CA....G....... 
*S2_CM   3984 .....................................T......A.CA....G....... 
 
*R1_ML   4057 AAATAAACTCGGAGCAAATTGATGTGGAAAACTTCGTGGGTATACCGGAGGACACAAAAA 
*R1_L3_5 3440 .......................................A.................... 
*R2_4Arr 4057 ............................................................ 
*R2_ML   4057 ............................................................ 
*R3_KE   4071 ....C..............................T...A.................... 
*R3_KE.  4076 ....C..............................T...A.................... 
*S1_G3S3 3440 .C..C..................T.CC....T...T...AA..............T.... 
*S1_CM   4045 .C..C..................T.CC....T...T...AA..............T.... 
*S2_4Arr 4041 .C..C....................CC....T...T...AA..............G.... 
*S2_CM   4044 .C..C....................CC....T...T...AA..............G.... 
 
*R1_ML   4117 AGCTCGAGATCAATGTGGGGGGCATTGGATTTGGGTTGTTAGAGGTGGTTTATCAATTTG 
*R1_L3_5 3500 ...........................................................A 
*R2_4Arr 4117 ...........................................................A 
*R2_ML   4117 ...........................................................A 
*R3_KE   4131 ........................................G.................C. 
*R3_KE.  4136 ........................................G................AC. 
*S1_G3S3 3500 ....T...........A.....T.....G.....A...C.G.....CA............ 
*S1_CM   4105 ....T...........A.....T.....G.....A...C.G.....CA............ 
*S2_4Arr 4101 ....T...........A..A..T.....G.....A...C.G.....CA............ 
*S2_CM   4104 ....T...........A..A..T.....G.....A...C.G.....CA............ 
 
*R1_ML   4177 ATTTGAATCTCGTCAACTTTGAGAATAGATTCCAACTAGACCTGGAGAAACAGAACACAG 
*R1_L3_5 3560 ............................................................ 
*R2_4Arr 4177 ............................................................ 
*R2_ML   4177 ............................................................ 
*R3_KE   4191 ............................................................ 
*R3_KE.  4196 ............................................................ 
*S1_G3S3 3560 ....A..................C..C.....A........................... 
*S1_CM   4165 ....A..................C..C.....A........................... 
*S2_4Arr 4161 ....A..................C..C.....A........................... 
*S2_CM   4164 ....A..................C..C.....A........................... 
 
*R1_ML   4237 GCTCTGACTACGAGCTGAGGCTGAAGGTCTGTGCCAGCTACATACCCCAGCTGACCGACA 
*R1_L3_5 3620 ............................................................ 
*R2_4Arr 4237 ............................................................ 
*R2_ML   4237 ............................................................ 
*R3_KE   4251 ...................A....G...T..............C...A............ 
*R3_KE.  4256 ...................A....G...T..............C...A............ 
*S1_G3S3 3620 ...................A....G...........A......C...G............ 
*S1_CM   4225 ...................A....G...........A......C...G............ 
*S2_4Arr 4221 ...................A....G...........A......C...G............ 
*S2_CM   4224 ...................A....G...........A......C...G............ 
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The full-length sequences of TEP1*R3 (highlighted in grey color) compared to *R1 and *R2 alleles 
from Mali, *R2 and *S1 alleles from Cameroon, and *R1,*R2, *S1 alleles from insectary strains. Intronic 
regions (in bold) with modifications for TEP1*R3 are highlighted in Turquoise color. 
 
*R1_ML   4297 GACGATCGAACATGGCACTGATTGAGGTAACCTTACCGAGCGGTTACGTGGTTGATCGCA 
*R1_L3_5 3680 ............................................................ 
*R2_4Arr 4297 ............................................................ 
*R2_ML   4297 ............................................................ 
*R3_KE   4311 ......................C.....G....................T..C....... 
*R3_KE.  4316 ......................C.....G....................T..C....... 
*S1_G3S3 3680 .T.A...............A..C.....G.......................C....... 
*S1_CM   4285 .T.A...............A..C.....G.......................C....... 
*S2_4Arr 4281 .T.A...............A..C.....G.......................C....... 
*S2_CM   4284 .T.A...............A..C.....G.......................C....... 
                                                 Intron 10       
*R1_ML   4357 ATCCGATCAGCGAGCAGACGAAGGTGAATCCGATTCAGGTAAGAATATTTGAATGTTGAA 
*R1_L3_5 3740 ...................................------------------------- 
*R2_4Arr 4357 ............................................................ 
*R2_ML   4357 ............................................................ 
*R3_KE   4371 ............................................................ 
*R3_KE.  4376 ...................A.C........TA............................ 
*S1_G3S3 3740 ....A................C............-------------------------- 
*S1_CM   4345 ....A................C............A........C...........C..T. 
*S2_4Arr 4341 ....A................C............A........C...........C..T. 
*S2_CM   4344 ....A................C............A........C...........C..T. 
 
*R1_ML   4417 TATCCAGAGCAGTTTGAGCTGACTATTATGTATTTACTTTTGATTGCATTCACAGAAAAC 
*R1_L3_5 3775 ----------------------------------------------------........ 
*R2_4Arr 4417 ............................................................ 
*R2_ML   4417 ............................................................ 
*R3_KE   4431 ............................................................ 
*R3_KE.  4436 .......GA..A................................................ 
*S1_G3S3 3774 ---------------------------------------------------......C.T 
*S1_CM   4405 A..GG..GAT.C..G...GC----.CC..T..A..G...GGA...T.....G.....C.T 
*S2_4Arr 4401 A..GG..GAT.C..G...GC----.CC..T..A..G...GGA...TT....G.....C.T 
*S2_CM   4404 A..GG..GAT.C..G...GC----.CC..T..A..G...GGA...TT....G.....C.T 
 
*R1_ML   4477 TGAAATCCGTTACGGTGGCACTTCAGTCGTTTTATACTACGACAATATGGGCAGCGAGCG 
*R1_L3_5 3783 ............................................................ 
*R2_4Arr 4477 .........C.................................................. 
*R2_ML   4477 .........C.................................................. 
*R3_KE   4491 ............................................................ 
*R3_KE.  4496 ...............................C.G......A................... 
*S1_G3S3 3783 G.....T........................C.G......T............C...... 
*S1_CM   4461 G.....T........................C.G......T............C...... 
*S2_4Arr 4457 G.....T........................C.G......T............C...... 
*S2_CM   4460 G.....T........................C.G......T............C...... 
 
*R1_ML   4537 TAACTGTTTCACCCTGACCGCGTACAGACGCTTTAAGGTCGCATTGAAGCGTCCAGCGTA 
*R1_L3_5 3843 ............................................................ 
*R2_4Arr 4537 ............................................................ 
*R2_ML   4537 ............................................................ 
*R3_KE   4551 ............................................................ 
*R3_KE.  4556 ............AA.........................A.................... 
*S1_G3S3 3843 .........T...G....T......................................... 
*S1_CM   4521 A........T...G....T......................................... 
*S2_4Arr 4517 A........T...G....T....................A.................... 
*S2_CM   4520 A........T...G....T....................A.................... 
                                           Intron 11       
*R1_ML   4597 TGTGGTTGTGTATGATTATTATAATACAAGTGAGTAGTAGTCATAGATTGGCTATGGAAT 
*R1_L3_5 3903 .............................------------------------------- 
*R2_4Arr 4597 ............................................................ 
*R2_ML   4597 ............................................................ 
*R3_KE   4611 ............................................................ 
*R3_KE.  4616 ...T........C..C......G..................................... 
*S1_G3S3 3903 ...T........C................------------------------------- 
*S1_CM   4581 ...T........C....................................A.......... 
*S2_4Arr 4577 ...T........C..............................A.....A.......... 
*S2_CM   4580 ...T........C..............................A.....A.......... 
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*R1_ML   4657 TGCACAGGGAATG----------TAACACCCGTTGCTT--TTTAAATTATTTACAGATCT 
*R1_L3_5 3932 --------------------------------------------------------.... 
*R2_4Arr 4657 .............----------...............--.................... 
*R2_ML   4657 .............----------...............--.................... 
*R3_KE   4671 ..........T..GTTATGGAATAG.............--.................... 
*R3_KE.  4676 .A........T..GTTATGGAAT.G....T......A.--.................... 
*S1_G3S3 3932 --------------------------------------------------------..T. 
*S1_CM   4641 .........C...----------.G....T........T-..................T. 
*S2_4Arr 4637 .........T...----------.G....T.A......TT...T..............T. 
*S2_CM   4640 .........T...----------.G....T.A......TT...T..............T. 
 
*R1_ML   4705 GAACGCCATCAAAGTGTACGAAGTGGACAAGCAGAATTTGTGCGAAATCTGTGACGAAGA 
*R1_L3_5 3936 ............................................................ 
*R2_4Arr 4705 ............................................................ 
*R2_ML   4705 ............................................................ 
*R3_KE   4729 ............................................................ 
*R3_KE.  4734 ............................................................ 
*S1_G3S3 3936 .....................................G.............C..G..... 
*S1_CM   4690 .....................................G.............C..G..... 
*S2_4Arr 4687 .....................................G.............C..G..... 
*S2_CM   4690 .....................................G.............C..G..... 
 
*R1_ML   4765 AGACTGTCCTGCAGAGTGC 
*R1_L3_5 3996 ................... 
*R2_4Arr 4765 ................... 
*R2_ML   4765 ................... 
*R3_KE   4789 ................... 
*R3_KE.  4794 ................... 
*S1_G3S3 3996 ................... 
*S1_CM   4750 .........C......... 
*S2_4Arr 4747 ................... 
*S2_CM   4750 .........C......... 
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The full-length sequences of TEP1*R3 (highlighted in grey color) compared to *R1 and *R2 alleles from 
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Appendix 6. TEP*R3 full-length amino acid sequence alignment with other alleles 
*R1_L3-5    1 MWQFIRSRILTVIIFIGAAHGLLVVGPKFIRANQEYTLVISNFNSQLSKVDLLLKLEGET 
*R1_ML      1 ............................................................ 
*R2_4Arr    1 ............................................................ 
*R2_ML      1 ............................................................ 
*R3_KE      1 ............................................................ 
*R3_KE.     1 ............................................................ 
*S1_G3S3    1 ............................................................ 
*S1_CM      1 ..................S......................................... 
*S2_4Arr    1 ............................................................ 
*S2_CM      1 ............................................................ 
 
*R1_L3-5   61 DNGLSVLNVTKMVDVRRNMNRMINFNMPEDLTAGNYKITIDGQRGFSFHKEAELVYLSKS 
*R1_ML     61 ............................................................ 
*R2_4Arr   61 ............................................................ 
*R2_ML     61 ............................................................ 
*R3_KE     61 ............................................................ 
*R3_KE.    61 ............................................................ 
*S1_G3S3   61 ............................................................ 
*S1_CM     61 .....................I.......E.............................. 
*S2_4Arr   61 ............................................................ 
*S2_CM     61 ............................................................ 
 
*R1_L3-5  121 ISGLIQVDKPVFKPGDTVNFRVIVLDTELKPPARVKSVYVTIRDPQRNVIRKWSTAKLYA 
*R1_ML    121 ............................................................ 
*R2_4Arr  121 ............................................................ 
*R2_ML    121 ............................................................ 
*R3_KE    121 ............................................................ 
*R3_KE.   121 ......................................H..................... 
*S1_G3S3  121 ......................................H..................... 
*S1_CM    121 ............................................................ 
*S2_4Arr  121 ............................................................ 
*S2_CM    121 ............................................................ 
 
*R1_L3-5  181 GVFESDLQIAPTPMLGVWNISVEVEGEELVSKTFEVKEYVLSTFDVQVMPSVIPLEEHQA 
*R1_ML    181 ............................................................ 
*R2_4Arr  181 ............................................................ 
*R2_ML    181 ............................................................ 
*R3_KE    181 ............................................................ 
*R3_KE.   181 ............................................................ 
*S1_G3S3  181 ............................................................ 
*S1_CM    181 ............................................................ 
*S2_4Arr  181 ............................................................ 
*S2_CM    181 ............................................................ 
                                       E266, N289, MG3 
*R1_L3-5  241 VNLTIEANYHFGKPVQGVAKVELYLDDDKLKLKKELTVYGKGQVELRFDNFAMDADQQDV 
*R1_ML    241 ............................................................ 
*R2_4Arr  241 .....D........................NQ............................ 
*R2_ML    241 .....D........................NQ............................ 
*R3_KE    241 .T.......................E....NQ................N........... 
*R3_KE.   241 .........................E....NQ................N........... 
*S1_G3S3  241 ..............................NQ............................ 
*S1_CM    241 ..............................NQ............................ 
*S2_4Arr  241 ..............................NQ............................ 
*S2_CM    241 ..............................NQ............................ 
 
*R1_L3-5  301 PVKVSFVEQYTNRTVVKQSQITVYRYAYRVELIKESPQFRPGLPFKCALQFTHHDGTPAK 
*R1_ML    301 ......I..................................................... 
*R2_4Arr  301 R.....I..H.................................................. 
*R2_ML    301 R.....I..H.................................................. 
*R3_KE    301 R.....I..H.................................................. 
*R3_KE.   301 R.....I..H.................................................. 
*S1_G3S3  301 R.....I..................................................... 
*S1_CM    301 R.....I..................................................... 
*S2_4Arr  301 R.....I..................................................... 
*S2_CM    301 R.....I..................................................... 
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The full-length sequences of TEP1*R3 (highlighted in grey color) compared to *R1 and *R2 alleles from 
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*R1_L3-5  361 GISGKVEVSDVRFETTTTSDNDGLIKLELQPSEGTEQLSIHFNAVDGFFFYEDVNKVETV 
*R1_ML    361 .......................................................N.... 
*R2_4Arr  361 ..T........G..........................G.N................... 
*R2_ML    361 ..T........G..........................G.N................... 
*R3_KE    361 ...........G..........................G.S................... 
*R3_KE.   361 ...........G..........................G.S................... 
*S1_G3S3  361 ..T........G....K.................S...G.N................... 
*S1_CM    361 ..T........G..........................G.N................... 
*S2_4Arr  361 ..T........G..........................G.N................... 
*S2_CM    361 ..T........G..........................G.N................... 
 
*R1_L3-5  421 TDAYIKLELKSPIKRNKLMRFMVTCTERMTFFVYYVMSKGNIIDAGFMRPNKQPKYLLQL 
*R1_ML    421 .N.......................................................... 
*R2_4Arr  421 .....................................................T...... 
*R2_ML    421 .....................................................T...... 
*R3_KE    421 .....................................................T...... 
*R3_KE.   421 .....................................................T...... 
*S1_G3S3  421 .....................................................T...... 
*S1_CM    421 .....................................................T...... 
*S2_4Arr  421 .....................................................T...... 
*S2_CM    421 .....................................................T...... 
 
*R1_L3-5  481 NATEKMIPRAKILIATVAGRTVVYDFADLDFQELRNNFDLSIDEQEIKPGRQIELSMSGR 
*R1_ML    481 ............................................................ 
*R2_4Arr  481 ........K................................................F.. 
*R2_ML    481 ........K................................................... 
*R3_KE    481 ........K................................................... 
*R3_KE.   481 ........M................................................... 
*S1_G3S3  481 ........K................Y.................................. 
*S1_CM    481 ........K................Y.................................. 
*S2_4Arr  481 ........K................Y.................................. 
*S2_CM    481 ........K................Y.................................. 
 
*R1_L3-5  541 PGAYVGLAAYDKALLLFNKNHDLFWEDIGQVFDGFHAINENEFDIFHSLGLFARTLDDIL 
*R1_ML    541 ............................................................ 
*R2_4Arr  541 ............................................................ 
*R2_ML    541 ............................................................ 
*R3_KE    541 ............................................................ 
*R3_KE.   541 ............................................................ 
*S1_G3S3  541 ............................................................ 
*S1_CM    541 ............................................................ 
*S2_4Arr  541 ............................................................ 
*S2_CM    541 ............................................................ 
 
*R1_L3-5  601 FDSANEKTGRNALQSGKPIGKLVSYRTNFQESWLWKNVSIGRSGSRKLIEVVPDTTTSWY 
*R1_ML    601 ............................................................ 
*R2_4Arr  601 ............................................................ 
*R2_ML    601 ............................................................ 
*R3_KE    601 ............................................................ 
*R3_KE.   601 ............................................................ 
*S1_G3S3  601 ............................................................ 
*S1_CM    601 ............................................................ 
*S2_4Arr  601 ............................................................ 
*S2_CM    601 ............................................................ 
 
*R1_L3-5  661 LTGFSIDPVYGLGIIKKPIQFTTVQPFYIVENLPYSIKRGEAVVLQFTLFNNLGAEYIAD 
*R1_ML    661 ............................................................ 
*R2_4Arr  661 ............................................................ 
*R2_ML    661 ............................................................ 
*R3_KE    661 ............................................................ 
*R3_KE.   661 ............................................................ 
*S1_G3S3  661 ............................................................ 
*S1_CM    661 ............................................................ 
*S2_4Arr  661 ............................................................ 
*S2_CM    661 ............................................................ 
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The full-length sequences of TEP1*R3 (highlighted in grey color) compared to *R1 and *R2 alleles from 
Mali, *R2 and *S1 alleles from Cameroon, and *R1,*R2, *S1 alleles from insectary strains. Regions with 
amino acid modifications for TEP1*R3 are highlighted in Turquoise color, and their positions give above 
the alignment. 
 
                             V737, C742, F759, V760, MG7 
*R1_L3-5  721 VTLYNVANQTEFVGRPNTDLSYTKSVSVPPKVGVPISFLIKARKLGEMAVRVKASIMLGH 
*R1_ML    721 ............................................................ 
*R2_4Arr  721 ............................................................ 
*R2_ML    721 ............................................................ 
*R3_KE    721 ................V....C................FV.................... 
*R3_KE.   721 ................V....C................FV.................... 
*S1_G3S3  721 ................D........................................... 
*S1_CM    721 ................D........................................... 
*S2_4Arr  721 ................D........................................... 
*S2_CM    721 ................D........................................... 
 
*R1_L3-5  781 ETDALEKVIRVMPESLVQPRMDTRFFCFDDHKNQTFPINLDINKKADSGSTKIEFRLNPN 
*R1_ML    781 ..............................Y.....S....................... 
*R2_4Arr  781 ..............................Y................N............ 
*R2_ML    781 ..............................Y................N............ 
*R3_KE    781 ..............................Y................N..K......... 
*R3_KE.   781 ..............................Y................N..K......... 
*S1_G3S3  781 ................A..K...S......Y......F.........N..K......... 
*S1_CM    781 ................A..K...S......Y......F.........N..K......... 
*S2_4Arr  781 ................A..K...S......Y......F.........N..K......... 
*S2_CM    781 ................A..K...S......Y......F.........N..K......... 
 
*R1_L3-5  841 LLTTVIKNLDHLLGVPTGCGEQNMVKFVPNILVLDYLHAIGSKEQHLIDKATNLLRQGYQ 
*R1_ML    841 ............................................................ 
*R2_4Arr  841 ............................................................ 
*R2_ML    841 ............................................................ 
*R3_KE    841 ...M......N..A.............................................. 
*R3_KE.   841 ...M......N..A.............................................. 
*S1_G3S3  841 ...M......N..A.......................Y.T.................... 
*S1_CM    841 ...M......N..A.......................Y.T.................... 
*S2_4Arr  841 ...M......N..A.......................Y.T.................... 
*S2_CM    841 ...M......N..A.......................Y.T.................... 
 
*R1_L3-5  901 NQMRYRQTDGSFGLWETTNGSVFLTAFVGTSMQTAVKYISDIDAAMVEKALDWLASKQHF 
*R1_ML    901 ....................................N........V.............. 
*R2_4Arr  901 ..................G................A........................ 
*R2_ML    901 ..................G................A........................ 
*R3_KE    901 .................SG................S...N...................S 
*R3_KE.   901 .................SG................S...N...................S 
*S1_G3S3  901 .............V..KSGS........A......S..MN...................S 
*S1_CM    901 .............V..KSGS........A......S..MN...................S 
*S2_4Arr  901 .............V..KSGS........A......S..MN...................S 
*S2_CM    901 .............V..KSGS........A......S..MN...................S 
 
*R1_L3-5  961 SGRFDKAGAEYHKEMQGGLRNGVALTSYVLMALLENDIAKAKHAEVIQKGMTYLSNQFGS 
*R1_ML    961 ............................................................ 
*R2_4Arr  961 ............................................................ 
*R2_ML    961 ............................................................ 
*R3_KE    961 ..............................T............................. 
*R3_KE.   961 ..............................T.............A......N........ 
*S1_G3S3  961 .....ET.KVW..D................T.........V...V...N..N.....LAF 
*S1_CM    961 .....ET.KVW..D................T.........V...V...N..N.....LAF 
*S2_4Arr  961 .....ET.KVW..D................T.........V...V...N..N.....LAF 
*S2_CM    961 .....ET.KVW..D................T.........V...V...N..N.....LAF 
                                                     R1065, K1067 ß2-TED 
*R1_L3-5 1021 INNAYDLSIATYAMMLNGHTMKEEALNKLIDMSFIDADKNERFWNTTNPIETTAYALLSF 
*R1_ML   1021 ............................................................ 
*R2_4Arr 1021 ............................................................ 
*R2_ML   1021 ............................................................ 
*R3_KE   1021 ............................................R.K.Q........... 
*R3_KE.  1021 M...........................................R.K.Q........... 
*S1_G3S3 1021 ......................K...D......IS.NN.K..Y.G...Q........... 
*S1_CM   1021 ...P..................K...D......IS.NN.K..Y.G...Q........... 
*S2_4Arr 1021 ......................K...D................................. 
*S2_CM   1021 ......................K...D................................. 
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The full-length sequences of TEP1*R3 (highlighted in grey color) compared to *R1 and *R2 alleles from 
Mali, *R2 and *S1 alleles from Cameroon, and *R1,*R2, *S1 alleles from insectary strains. Regions with 
amino acid modifications for TEP1*R3 are highlighted in Turquoise color, and their positions give above 
the alignment. 
 
*R1_L3-5 1081 VMAEKYTDGIPVMNWLVNQRYVTGSFPSTQDTFVGLKALTKMAEKISPSRNDYTVQLKYK 
*R1_ML   1081 ............................................................ 
*R2_4Arr 1081 ............................................................ 
*R2_ML   1081 ............................................................ 
*R3_KE   1081 ......L..................................................... 
*R3_KE.  1081 ......L..................................................... 
*S1_G3S3 1081 ......L....I...............R.............L.................. 
*S1_CM   1081 ......L....................R.............L.................. 
*S2_4Arr 1081 ......L....................R.............L.................. 
*S2_CM   1081 ......L....................R.............L.................. 
 
*R1_L3-5 1141 KSAKYFKINSEQIDVENFVDIPEDTKKLEINVGGIGFGLLEVVYQFNLNLVNFENRFQLD 
*R1_ML   1141 .C.................G..........................D............. 
*R2_4Arr 1141 ...................G........................................ 
*R2_ML   1141 ...................G........................................ 
*R3_KE   1141 ..................L...........................D............. 
*R3_KE.  1141 ..................L..........................YD............. 
*S1_G3S3 1141 ..T...N.......FQ..LE......................I...D.......H..K.. 
*S1_CM   1141 ..I...N.......FQ..LE..Q...................I...D.......H..K.. 
*S2_4Arr 1141 ..T...N........Q..LE......................I...D.......H..K.. 
*S2_CM   1141 ..T...N........Q..LE......................I...D.......H..K.. 
                                    K1223 MG8 
*R1_L3-5 1201 LEKQNTGSDYELRLKVCASYIPQLTDRRSNMALIEVTLPSGYVVDRNPISEQTKVNPIQK 
*R1_ML   1201 ............................................................ 
*R2_4Arr 1201 ............................................................ 
*R2_ML   1201 ............................................................ 
*R3_KE   1201 ..............R.......K..................................... 
*R3_KE.  1201 ..............R.......K..............................T..L... 
*S1_G3S3 1201 ..............R...N...E...SQ.........................T.....N 
*S1_CM   1201 ..............R...N...E...SQ.........................T.....N 
*S2_4Arr 1201 ..............R...N...E...SQ.........................T.....N 
*S2_CM   1201 ..............R...N...E...SQ.........................T.....N 
 
*R1_L3-5 1261 TEIRYGGTSVVLYYDNMGSERNCFTLTAYRRFKVALKRPAYVVVYDYYNTNLNAIKVYEV 
*R1_ML   1261 ............................................................ 
*R2_4Arr 1261 ............................................................ 
*R2_ML   1261 ............................................................ 
*R3_KE   1261 ............................................................ 
*R3_KE.  1261 ..............N..........M......................D........... 
*S1_G3S3 1261 M.............Y...T......V.................................. 
*S1_CM   1261 M.............Y...T......V.................................. 
*S2_4Arr 1261 M.............Y...T......V.................................. 
*S2_CM   1261 M.............Y...T......V.................................. 
 
*R1_L3-5 1321 DKQNLCEICDEEDCPAEC 
*R1_ML   1321 .................. 
*R2_4Arr 1321 .................. 
*R2_ML   1321 .................. 
*R3_KE   1321 .................. 
*R3_KE.  1321 .................. 
*S1_G3S3 1321 ....V....E........ 
*S1_CM   1321 ....V....E........ 
*S2_4Arr 1321 ....V....E........ 
*S2_CM   1321 ....V....E........ 
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Appendix 7. R script used to assess the infections of P. falciparum  
Assessing the infections of P. falciparum 
A P.  falciparum infection intensity on H3T1  mosquitoes 
 # define custom median function 
plot.median <- function(x) { 
  m <- median(x) 
  c(y = m, ymin = m, ymax = m) 
} 
# function for number of observations  
give.n <- function(x){ 
  return(c(y = median(x)*1.05, label = length(x))) 
  # experiment with the multiplier to find the perfect position 
}#usage: +stat_summary(fun.data = give.n, geom = "text", fun.y = median, 
colour="red") 
# function for median labels 
median.n <- function(x){ 
  return(c(y = median(x)*0.97, label = round(median(x),2))) 
  # experiment with the multiplier to find the perfect position 
}#usage: +stat_summary(fun.data = median.n, geom = "text", fun.y = median, 
colour = "red") 
# function for mean labels 
mean.n <- function(x){ 
  return(c(y = median(x)*0.97, label = round(mean(x),2))) 
  # experiment with the multiplier to find the perfect position 
}#usage: +stat_summary(fun.data = mean.n, geom = "text", fun.y = median, colour 
= "red") 
# function for mean labels 
#Easiest way of summarizing data using summarySE function together with a plyr 
package 
summarySE <- function(data=NULL, measurevar, groupvars=NULL, 
na.rm=FALSE, 
                      conf.interval=.95, .drop=TRUE) { 
    library(plyr) 
 
    # New version of length which can handle NA's: if na.rm==T, don't count them 
    length2 <- function (x, na.rm=FALSE) { 
        if (na.rm) sum(!is.na(x)) 
        else       length(x) 
    } 
    # This does the summary. For each group's data frame, return a vector with 
    # N, mean, and sd 
    datac <- ddply(data, groupvars, .drop=.drop, 
      .fun = function(xx, col) { 
        c(N    = length2(xx[[col]], na.rm=na.rm), 
          mean = mean   (xx[[col]], na.rm=na.rm), 
          sd   = sd     (xx[[col]], na.rm=na.rm) 
        ) 
      }, 
      measurevar 
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Assessing the infections of P. falciparum 
    ) 
    # Rename the "mean" column 
    datac <- rename(datac, c("mean" = measurevar)) 
    datac$se <- datac$sd / sqrt(datac$N)  # Calculate standard error of the mean 
    # Confidence interval multiplier for standard error 
    # Calculate t-statistic for confidence interval: 
    # e.g., if conf.interval is .95, use .975 (above/below), and use df=N-1 
    ciMult <- qt(conf.interval/2 + .5, datac$N-1) 
    datac$ci <- datac$se * ciMult 
    return(datac) 
}#Usage: data2 <- summarySE(data, measurevar="xxxx", groupvars=c("yyy", 
"zzz"),na.rm=TRUE) 
 #loading the data##read the csv file(MSDOS CSV). define the seperator & decimal sign 
infdat <- read.csv ("MalvecBlokInfections.csv",sep=",",dec=".",na.strings=c("","NA")) 
#for ploting 
## define custom median function 
plot.median <- function(x) { 
  m <- median(x) 
  c(y = m, ymin = m, ymax = m) 
} 
#Adding a new column "Infected" to show infection status 
infdat$Infected[as.numeric(infdat$Oocyst) > 0] <- "Yes" 
infdat$Infected[infdat$Oocyst == 0] <- "No" 
#cleaning the data 
infdat <- subset(infdat, !Genotype=="NEG") 
infdat <- subset(infdat, !Genotype=="-") 
infdat <- subset(infdat, !Oocyst=="-") 
infdat <- subset(infdat, !Genotype=="NA") 
infdat <- subset(infdat, !Oocyst=="NA") 
infdat <- subset(infdat, !Genotype == "<NA>") 
infdat <- subset(infdat, !Oocyst == "<NA>") 
infdat <- subset(infdat, !Genotype=="") 
infdat <- subset(infdat, !Genotype=="") 
head(infdat)#confirm the data from the head 
str(infdat)#check the structure of the data 
summary(infdat$Infected) 
summary(infdat$Genotype) 
#getting the NF54 set for analyses, and zeroing into experiment 1 
# Experiment 3 to 7 tests on influence on experiments o data sets 
NF54dat <- subset(infdat, Parasite=="NF54") 
NF54dat2to7<- subset(NF54dat, !Experiment== 1) 
NF54dat3to7<- subset(NF54dat2to7, !Experiment== 2) 
NF54dat$Oocyst<-as.numeric(as.character(NF54dat$Oocyst)) 
NF54dat3to7i<- subset(NF54dat, !Oocyst==0)#Exclude non-infected mosquitoes 
#NF54dat3to7i<- subset(NF54dat) 
#Infection intensity of NF54-experiments 3 to 7 
NF54dat3to7i$Genotype <- factor(NF54dat3to7i$Genotype) 
NF54dat3to7i$Oocyst <- as.numeric(as.charscter(NF54dat3to7i$Oocyst)) 
str(NF54dat3to7i) 
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Assessing the infections of P. falciparum 
####Read about data transformation of zero values: https://stat.ethz.ch/pipermail/r-sig-
ecology/2009-June/000676.html 
NF54dat3to7$Oocyst<-as.numeric(as.character(NF54dat3to7$Oocyst)) 
quantile(NF54dat3to7$Oocyst, .0) #get zero quartile= 0 
quantile(NF54dat3to7$Oocyst, .25) #get 1st quartile = 2 
quantile(NF54dat3to7$Oocyst, .50) #get 2nd quartile = 9 
quantile(NF54dat3to7$Oocyst, .75) #get 3rd quartile = 9 
quantile(NF54dat3to7$Oocyst, 1.0) #get 4rd quartile = 25 
#1. Eliminator (get rid of zeros). This way of eliminating zeros compromises on my 
phenotype of R1-allele bearing mosquitoes 
#2. Oner (log1p)#Inbult in RI but ones needs to understand how it works 
#3. Little-better (half of the smallest non-zero value). 2 way of adding half the 
lowest value e.g. in my case 1, is not convincing to our case as the data are skewed 
#4. Quantiler (ratio of squared first and third quantile) log transformation by using 
squared 1st quartle divided by the third quartile DOES NOT WORK or apply in this case 
in this case. 
#Conclusion. Either to include zeros and not to do log transformation for these 
analyses. However, its better to exclude oocyst ==0, in the assessment of infection loads, 
but include them when assessing the prevalence of infection to avoid bias in the data 
analyses, as has may have little effect on the phenotypes for (more) resistant genotypes 
e.g. *R1 alleles
#verify normality of the data 
#using Q-Q plot 
n=(NF54dat3to7i$Oocyst) 
qqnorm(n) 
abline(mean(n),sd(n)) 
#using shapiro test 
shapiro.test(n) 
#oocyst data set is not normally distributed therefore non-parametric statistical 
analyses is done on the infection loads. 
k.w=kruskal.test(NF54dat3to7i$Oocyst~NF54dat3to7i$Genotype)
pairwise.wilcox.test(NF54dat3to7i$Oocyst,NF54dat3to7i$Genotype,p.adj="bonferr
oni")#there is clear effect of R1 bearing genotypes on infection loads compared to S1 
and S2-bearing mosquitoes 
#run parametric test on transformed data 
NF54dat3to7i$Logload<-log(NF54dat3to7i$Oocyst)#log transform for parametric 
statistical analyses 
av=aov(NF54dat3to7i$Logload~NF54dat3to7i$Genotype) 
summary(av) 
TukeyHSD(av)#there are NO significant differences between treatments i.e. 
influence of genotypes (alleles) on infection load) 
#Plotting global infection intensity, Oocyst>=0 
Nfload <- ggplot(NF54dat3to7i, aes(colour = factor(Genotype), x=Genotype, y = 
Oocyst))+geom_jitter(position = position_jitter(width = 0.9, height = 0.1)) 
NF54dat3to7i$Oocyst 
Nfload <- Nfload + scale_colour_manual(values=c("#0072B2", "#999999", 
"#000000", "#009E73", "#E69F00", "#B2DF8A"),name="Genotype")+ 
  theme(legend.position="none")+ 
  theme(axis.text=element_text(size=10),axis.title=element_text(size=12)) + labs(x 
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Assessing the infections of P. falciparum 
= "TEP1 genotype", y = "PfNF54 oocyst\nper midgut (Log10)") 
Nfload<- Nfload + theme(plot.title = element_text(size = rel(1))) + labs(title = "") + 
stat_summary(fun.data="plot.median", geom="errorbar", colour="red", width=0.5, 
size=1)+scale_y_log10()#+   stat_summary(fun.data = give.n, geom = "text", fun.y = 
median, colour ="red") 
Nfload#Fig. 3-5A 
B Prevalence of P.  falciparum infection intensity in H3T1  mosquitoes 
 #experiment 3 (Note experiments 1 to 2 did not have R1/R1 genotypes so they were 
excluded from these analyses) 
NF54dat <- subset(infdat, Parasite=="NF54") 
NF54dat3<- subset(NF54dat, Experiment== 3) 
NF54dat3$Oocyst<-as.numeric(as.character(NF54dat3$Oocyst)) 
plot(NF54dat3$Oocyst~as.factor(NF54dat3$Genotype)) 
NF54dat3$Experiment<-drop.levels(NF54dat3$Experiment) 
NF54dat3$Oocyst 
mytable3 <- xtabs(~Infected+Genotype, data=NF54dat3, drop.unused.levels = T) 
mytable3 
NF54dat3$Genotype <- ordered(NF54dat3$Genotype, levels=c("R1/R1", "R1/S1", 
"R1/S2","S1/S1","S1/S2","S2/S2")) 
#Infection resistance in percentage 
NF54dat3$Genotype <- factor(NF54dat3$Genotype) 
str(NF54dat3) 
n3<- table(NF54dat3$Genotype,NF54dat3$Infected) 
rownames(n3) 
colnames(n3) 
addmargins(n3) 
Row_total <- n3[,1]+n3[,2] 
row.names <- factor(c("R1/R1", "R1/S1", "R1/S2", "S1/S1","S1/S2","S2/S2")) 
Resistance <- (n3[,1]/Row_total)*100 
Prevalence <- (n3[,2]/Row_total)*100 
Result_table3 <- as.data.frame(cbind(n3,Row_total,Resistance,Prevalence)) 
str(Result_table3) 
Result_table3$Genotype <- factor(c("R1/R1", "R1/S1", "R1/S2", 
"S1/S1","S1/S2","S2/S2")) 
Result_table3$Experiment <- factor(3) 
t3f$Resistance<-as.numeric(t3f$Resistance) 
#NF54 experiment 4 
NF54dat4<- subset(NF54dat, Experiment== 4) 
NF54dat4$Oocyst<-as.numeric(as.character(NF54dat4$Oocyst)) 
#Infection resistance in percentage 
NF54dat4$Genotype <- factor(NF54dat4$Genotype) 
n4<- table(NF54dat4$Genotype,NF54dat4$Infected) 
Row_total <- n4[,1]+n4[,2] 
row.names <- factor(c("R1/R1", "R1/S1", "R1/S2", "S1/S1","S1/S2","S2/S2")) 
Resistance <- (n4[,1]/Row_total)*100 
Prevalence <- (n4[,2]/Row_total)*100 
Result_table4 <- as.data.frame(cbind(n4,Row_total,Resistance,Prevalence)) 
Result_table4$Genotype <- factor(c("R1/R1", "R1/S1", "R1/S2", 
"S1/S1","S1/S2","S2/S2")) 
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Assessing the infections of P. falciparum 
Result_table4$Experiment <- factor(4) 
t4f<-Result_table4 
# NF54 Experiment 5 
NF54dat5<- subset(NF54dat, Experiment== 5) 
NF54dat5$Oocyst<-as.numeric(as.character(NF54dat5$Oocyst)) 
#Infection resistance in percentage 
NF54dat5$Genotype <- factor(NF54dat5$Genotype) 
n5<- table(NF54dat5$Genotype,NF54dat5$Infected) 
Row_total <- n5[,1]+n5[,2] 
Resistance <- (n5[,1]/Row_total)*100 
Prevalence <- (n5[,2]/Row_total)*100 
Result_table5 <- as.data.frame(cbind(n5,Row_total,Resistance,Prevalence)) 
Result_table5$Genotype <- factor(c("R1/S1", "R1/S2", "S1/S1","S1/S2","S2/S2")) 
Result_table5$Experiment <- factor(5) 
t5f<-Result_table5 
# NF54 Experiments 6 
NF54dat6<- subset(NF54dat, Experiment== 6) 
NF54dat6$Oocyst<-as.numeric(as.character(NF54dat6$Oocyst)) 
mytable6 <- xtabs(~Infected+Genotype, data=NF54dat6, drop.unused.levels = T) 
NF54dat6$Genotype <- ordered(NF54dat6$Genotype, levels=c("R1/S1", 
"R1/S2","S1/S1","S1/S2","S2/S2")) 
#Infection resistance in percentage 
NF54dat6$Genotype <- factor(NF54dat6$Genotype) 
n6<- table(NF54dat6$Genotype,NF54dat6$Infected) 
Row_total <- n6[,1]+n6[,2] 
Resistance <- (n6[,1]/Row_total)*100 
Prevalence <- (n6[,2]/Row_total)*100 
Result_table6 <- as.data.frame(cbind(n6,Row_total,Resistance,Prevalence)) 
Result_table6$Genotype <- factor(c("R1/S1", "R1/S2", "S1/S1","S1/S2","S2/S2")) 
Result_table6$Experiment <- factor(6) 
t6f<-Result_table6 
# NF54 Experiment 7 
NF54dat7<- subset(NF54dat, Experiment== 7) 
NF54dat7$Oocyst<-as.numeric(as.character(NF54dat7$Oocyst)) 
NF54dat7$Genotype <- factor(NF54dat7$Genotype) 
n7<- table(NF54dat7$Genotype,NF54dat7$Infected) 
Row_total <- n7[,1]+n7[,2] 
row.names <- factor(c("R1/R1", "R1/S1", "S1/S1","S1/S2","S2/S2")) 
Resistance <- (n7[,1]/Row_total)*100 
Prevalence <- (n7[,2]/Row_total)*100 
Result_table7 <- as.data.frame(cbind(n7,Row_total,Resistance,Prevalence)) 
Result_table7$Genotype <- factor(c("R1/R1", "R1/S1",  "S1/S1","S1/S2","S2/S2")) 
Result_table7$Experiment <- factor(7) 
t7f<-Result_table7 
#Bind the summary tables for t3f to t7 for doing the SE summary statistics 
library(dplyr) 
t3to7<-bind_rows(list(t3f, t4f,t5f,t6f,t7f)) 
#t3to7<-bind_rows(list(t3,t5f,t6,t7)) 
t3to7 
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Assessing the infections of P. falciparum 
detach("package:dplyr")#functions in dplyr masked those of plyr useful for running the 
summarrySE function for standard error, so I keep detaching it after use 
#Statistics on prevalence and resistance 
t3to7s<-t3to7 
#t3to7s$Prevalence<-round(t3to7s$Prevalence,digits=0) 
#t3to7s$Resistance<-round(t3to7s$Resistance,digits=0) 
t3to7s$Prevalence<-as.numeric(as.character(t3to7s$Prevalence)) 
t3to7s$Resistance<-as.numeric(as.character(t3to7s$Resistance)) 
t3to7s$Genotype<-factor(t3to7s$Genotype) 
names(t3to7s) 
#Verify normality of the data using Q-Q plot and shapiro test 
n=(t3to7s$Resistance) 
qqnorm(n) 
abline(mean(n),sd(n)) 
shapiro.test(t3to7s$Resistance) 
#My data is normally distributed so I will use parametric analyses to compare their 
medians 
#will not Run non-parametric tests 
k.w=kruskal.test(t3to7s$Resistance~t3to7s$Genotype) 
k.w 
pairwise.wilcox.test(t3to7s$Resistance,t3to7s$Genotype,p.adj="bonferroni") 
#Will run parametric test 
av=aov(t3to7s$Resistance~t3to7s$Genotype) 
summary(av) 
TukeyHSD(av) 
n=(t3to7s$Prevalence) 
qqnorm(n) 
abline(mean(n),sd(n)) 
shapiro.test(t3to7s$Prevalence) 
#My data is normally distributed so I will use parametric analyses to compare their 
means#will not Run non-parametric tests e.g. 
#k.w=kruskal.test(t3to7s$Prevalence~t3to7s$Genotype) 
#pairwise.wilcox.test(t3to7s$Prevalence,t3to7s$Genotype,p.adj="bonferroni") 
#But will run parametric test instead 
av=aov(t3to7s$Prevalence~t3to7s$Genotype) 
summary(av) 
TukeyHSD(av)#No significant differences 
#Convert groups into factor 
t3to7$Genotype<- factor(t3to7$Genotype) 
t3to7$Experiment<- factor(t3to7$Experiment) 
t3to7$Resistance<- as.numeric(as.character(t3to7$Resistance)) 
#Then sumarizing the data using the above summarySE function 
nfbd3to7 <- summarySE(t3to7, measurevar="Resistance", 
groupvars="Genotype",na.rm=TRUE) 
nfbd3to7p <- summarySE(t3to7, measurevar="Prevalence", 
groupvars=c("Genotype"),na.rm=TRUE) 
# Rename column Resistance and Prevalence to just Resistance.mean and 
prevalence.mean respectively 
names(nfbd3to7)[names(nfbd3to7)=="Resistance"] <- "Resistance.mean" 
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Assessing the infections of P. falciparum 
names(nfbd3to7p)[names(nfbd3to7p)=="Prevalence"] <- "Prevalence.mean" 
#used data frame t3to7 to do statistics on resistance or prevalence 
# Define the top and bottom of the errorbars 
limits3to7 <- aes(ymax = Resistance.mean + se, ymin=Resistance.mean - se)#for 
resistance 
limits3to7p <- aes(ymax = Prevalence.mean + se, ymin=Prevalence.mean - se)#for 
prevalence 
#Begin your ggplot 
#Here we are plotting Experiment vs mean of resistance and filling by another factor 
grouped variable Genotype 
nf3to7<-ggplot(nfbd3to7,aes(Genotype,Resistance.mean,fill=Genotype)) 
#Creating bar to show the factor variable position_dodge 
#ensures side by side creation of factor bars 
nf3to7<-nf3to7+geom_bar(stat = "identity",position = position_dodge()) 
#creation of error bar 
nf3to7<-nf3to7+geom_errorbar(limits3to7,width=0.25,position = position_dodge(width 
= 0.9)) 
#Making the final plot 
nf3to7<-nf3to7+ggtitle ("PfNF54 overall resistance") + 
  xlab ("TEP1 genotype") + ylab("Mean  % resistant mosquitoes") + 
  theme(legend.title = element_text(colour="black", size=10)) +ylim(c(0,100))+ 
  theme(legend.text = element_text(colour="black", size=10, 
face="italic"))+scale_fill_grey(start = 0.3, end = 0.8,na.value = 
"red")+theme(legend.position="none") 
#+scale_fill_manual(values=c("#0072B2", "#999999", "#000000","#009E73", 
"#E69F00", "#B2DF8A"),name="Genotype",labels=c("R1/R1", "R1/S1", "R1/S2", 
"S1/S1", "S1/S2","S2/S2")) 
nf3to7 
#Prevalence: Here we are plotting Experiment vs mean of prevalence and filling by 
another factor variable Genotype 
nf3to7p<-ggplot(nfbd3to7p,aes(Genotype,Prevalence.mean, fill=Genotype)) 
#Creating bar to show the factor variable position_dodge 
#ensures side by side creation of factor bars 
nf3to7p<-nf3to7p+geom_bar(stat = "identity",position = position_dodge()) 
#creation of error bar 
nf3to7p<-nf3to7p+geom_errorbar(limits3to7p,width=0.25,position = 
position_dodge(width = 0.9)) 
#Making the final plot 
nf3to7p<-nf3to7p+ggtitle ("") + 
  xlab ("TEP1 genotype") + ylab("Mean  % PfNF54 prevalence") + 
  theme(legend.title = element_text(colour="black", size=10)) +ylim(c(0,100))+ 
  theme(legend.text = element_text(colour="black", size=10, 
face="italic"))+scale_fill_grey(start = 0.3, end = 0.8,na.value = 
"red")+theme(legend.position="none") 
#+scale_fill_manual(values=c("#0072B2", "#999999", "#000000","#009E73", 
"#E69F00", "#B2DF8A"),name="Genotype",labels=c("R1/R1", "R1/S1", "R1/S2", 
"S1/S1", "S1/S2","S2/S2")) 
nf3to7p#Fig. 3.5B 
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